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Abstract 
Cell migration is a cellular process that plays a critical role in various physiological and 
pathological phenomena, including in cancer metastasis. Understanding at a fundamental level 
how cancer cells migrate and invade will help to delineate potential targets for the directed 
development of anti-metastatic therapeutic agents. For example, αv integrins are up-regulated 
or activated in many migratory cells, and are essential to the processes of wound healing, 
angiogenesis, and metastasis. Similarly, integrin αvβ5, a vitronectin (VN) receptor, is expressed 
in most patient carcinoma specimens and is functionally involved in growth factor-induced 
carcinoma cell migration in vitro and metastasis in vivo. However, the mechanisms of integrin 
αvβ5-mediated cell migration are not fully understood. In this project, we aimed to identify 
proteins that interact with the cytoplasmic tail of integrin β5, and to study their role in cell 
motility. Firstly, we employed a yeast two-hybrid screening of a mouse embryo cDNA library 
and thereby identified six proteins specifically interacting with the human integrin β5 
cytoplasmic domain.  One of the integrin β5-interacting proteins was p21-activated kinase 4 
(PAK4), which, in addition to its direct interaction with the integrin β5 cytoplasmic tail, also 
appeared to functionally regulate αvβ5-mediated migration of the human MCF-7 breast 
carcinoma cells. Importantly, engagement of integrin αvβ5 by cell attachment to VN led to a 
redistribution of PAK4 from the cytosol to dynamic lamellipodial structures where PAK4 co-
localized with integrin αvβ5. Functionally, PAK4 induced integrin αvβ5-mediated, but not 
integrin β1-mediated MCF-7 cell migration, without affecting the cell surface levels of integrin 
αvβ5.  
In addition, we found that PAK4 was activated by cell attachment to VN mediated by the 
PAK4 binding partner integrin αvβ5, and that active PAK4 induced accelerated integrin αvβ5 
turn-over within adhesion complexes. Accelerated integrin turn-over was the likely cause of 
additionally observed PAK4-mediated effects, including inhibited integrin αvβ5 clustering, 
reduced integrin to F-actin connectivity and perturbed maturation of cell adhesion complexes. 
These specific outcomes were ultimately associated with reduced cell adhesion capacity and 
increased cell motility. We thus demonstrate a novel mechanism deployed by cells to tune cell 
adhesion levels through the auto-inhibitory regulation of integrin-mediated adhesion.  
Furthermore, we identified a unique PAK4-binding membrane-proximal β5-SERS-motif in the 
cytoplasmic tail of β5, and demonstrated a key role for this motif in controlling cell adhesion 
and migration. We mapped the integrin β5-binding within PAK4 and observed that PAK4 
binding to integrin β5 was not sufficient to promote cell migration; instead the PAK4 kinase 
activity was required for PAK4 promotion of cell motility. In fact, PAK4 specifically 
phosphorylated the integrin β5 subunit at Ser 759 and Ser 762 within the β5-SERS-motif. 
Importantly, point mutation of these two serine residues abolished PAK4-mediated promotion 
of cell migration, indicating a functional role for these phosphorylations in cell migration.  
In conclusion, our results demonstrate that PAK4 interacts with and selectively phosphorylates 
integrin αvβ5 and thereby promotes αvβ5-mediated cell migration, a functional outcome 
paralleled by a concurrent decrease in total cellular adhesion to VN.  Given our finding that 
PAK4 is activated by αvβ5 ligation to VN, these results delineate an auto-inhibitory negative 
feedback loop that is initiated by cell adhesion to VN. Binding of integrin αvβ5 to VN drives 
translocation and activation of PAK4, leading to phosphorylation of αvβ5 and ultimately the 
limiting of total adhesion between cells and VN and increased cell migration. Thus, our 
findings provide a new mechanistic characterization of PAK4’s role in the functional regulation 
of integrin αvβ5. This knowledge may ultimately be important for understanding vascular 
permeability, angiogenesis and cancer dissemination.  
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1 Introduction 
1.1 Cell migration  
Cell migration is a cellular event that plays a critical role in various physiological 
processes and pathological responses, such as embryonic development, angiogenesis, 
immune function and inflammation, tissue repair, and cancer metastasis (Lauffenburger 
and Horwitz, 1996; Holly et al., 2000; Dormann and Weijer, 2006; Broussard et al., 
2008; Lock et al., 2008). Cancer cells display migratory activity during invasion and 
metastasis. Metastasis is a late stage of cancer that has a poor clinical outcome with 
90% of cancer deaths resulting from metastasized tumors. However, the molecular 
mechanisms involved in the metastatic process are only partially understood.  
Cell migration across a two-dimensional (2D) extracellular matrix (ECM) surface 
occurs in tissue such as the epithelia during wound healing (Kirfel and Herzog, 2004) 
and this type of migration is approximated in 2D cell culture conditions (Lauffenburger 
and Horwitz, 1996). However, in the body, cells can also migrate within three-
dimensional (3D) tissue. Cell migration is a dynamic and complex process. In general, 
cell migration is a cyclic process involving the repetitive extension of a protrusion at 
the leading edge of the cell, assembly of focal adhesions at the leading edge and 
disassembly at the cell body and rear, and cytoskeletal contraction to pull the cell body 
forward (Ananthakrishnan and Ehrlicher, 2007). The process of cellular movement 
requires highly coordinated interactions and involves a number of different sub-cellular 
systems (Lock et al., 2008). These sub-cellular systems of cell migration include the 
extracellular matrix; Cell-matrix adhesion complexes system; the cell polarity system; 
the microfilament system; plasma membrane (composition and dynamics); vesicular 
trafficking; microtubules (Figure 1). A number of molecular components in the each 
sub-cellular system drive the cell movement at different times. However, little is known 
about how these different sub-cellular systems are integrated within cell migration as a 
whole. 
Cell migration can be classed into two different types: single cell migration 
(mesenchymal or amoeboid) and collective cell migration (Friedl, 2004; Record 
Owner, 2010). Cancer cells can migrate either collectively or individually. In most 
epithelial cancers, the cells can convert to mesenchymal, individual cell migration, 
known as an epithelial-mesenchymal transition (EMT). EMT is induced by repression 
of transcriptional regulators such as Snail or Twist that leads to down-regulation of E-
cadherin and consequently to loss of the cell-cell adhesion (Kopfstein and Christofori, 
2006). Cells with a mesenchymal type of fibroblast-like motility are initiated by the 
formation of actin-rich filopodia and lamellipodia at the leading edge and exhibit an 
elongated cell morphology. This process is controlled by the small Rho-GTPases Rac 
and Cdc42 (Nobes and Hall, 1995). Interestingly, Cancer cells can also undergo a 
mesenchymal-to amoeboid transition by blocking extracellular proteolysis in a 3D 
environment (Friedl and Wolf, 2003a; Sahai and Marshall, 2003). Cells usually 
migrate in a 3D environment in vivo; however, the complex process of cell migration 
in 3D is poorly understood.  For this purpose, new and more suitable methods of the 
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3D cell migration models in vitro still need to improve, as well as suitable imaging 
techniques. A number of differences have been seen in 3D migration compared with 
2D migration, For example, in 3D cancer cells can exhibit a rounded shape and an 
amoeboid mode of migration and have smaller CMACs as compared to 2D, and 
CMAC components may be specifically involved in either 2D or 3D  (Even-Ram and 
Yamada, 2005; Fraley et al., 2010). By comparing results between 2D with 3D 
experiments the reasons for these differences may become clearer. It is currently 
thought that tension has a major influence in regulating CMAC function and since 
most 3D culture systems exhibit a relatively low tension than a 2D coated glass 
coverslip this may contribute to some of the differences at the CMAC level (Levental 
et al., 2009).  
 
Figure 1. Regulation of cell migration.  A large number of molecular belong to different sub-cellular 
systems and dynamically coordinated govern cell migration. ECM: extracellular matrix; CMACs: cell-
matrix adhesion complex. 
1.1.1 Extracellular matrix 
Extracellular matrix (ECM) is a network of proteins. ECM is produced by cells and 
excreted to the extracellular space within the tissue. The major ECM components 
include structural proteins (collagen and elastin), specialized proteins (e.g. fibrillin, 
fibronectin, and laminin) and proteoglycans (Chondroitin sulfate, Heparan sulfate, 
Keratan sulfate, Hyaluronic acid). Most ECM proteins act as ligands for integrins, 
with ECM-integrin binding providing both cell adhesion and signaling.  Examples of 
ECM components that bind specific subsets of integrins include fibronectin, laminin 
and vitronectin (VN) (Buzza et al., 2005). By expressing certain adhesion receptors 
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cells can bind specific ECM proteins which in turn modifies cell behaviour, for 
example, VN binding by integrin αvβ5, promotes cell adhesion and affects cell 
morphology, cytoskeletal organization and cell migration (Li et al., 2010b). Overall 
the ECM provides structural support for tissues, helps cells to bind together and 
regulates many cellular functions including adhesion and migration (Bornstein and 
Sage, 2002; Hynes, 2009).  
The ECM can also be remodelled in many different ways, such as by proteolytic 
degradation (Larsen et al., 2006). Studies in experimental conditions show that the  
ECM density, stiffness, geometrical array and topography affect the properties of 
migrating cells (Lehnert et al., 2004; Chown and Kumar, 2007; Parsons et al., 2010). 
For example, increased stromal collagen density increases mammary tumor 
formation, local invasion, and metastasis in 3D collagen gel and mammary tissues in 
mice  (Provenzano et al., 2008a); parallel arrays of collagen can promote cancer cell 
invasion, while a non-linear matrix reduces invasion  (Provenzano et al., 2008b). 
Further studies, using a combination of in vivo and 3D culture systems with live cell 
imaging should gain new insights into the relationship between cancer cell invasion, 
metastasis and ECM remodelling.  
1.1.2 Cell-matrix adhesion complexes 
When cells attach to ECM, integrins cluster within the plasma membrane and 
associate with numerous proteins to form organized adhesive contact sites containing 
large protein networks, called cell-matrix adhesion complexes (CMACs) (Geiger et 
al., 2001; Campbell, 2008; Lock et al., 2008). To date, more than 150 proteins have 
been shown to reside in CMACs and related integrin-mediated contacts including  
many different proteins, such as the actin cytoskeleton associated proteins (tensin, 
vinculin, paxillin, α-actinin, talin, zyxin, kindlins), tyrosine kinases (Srcs, FAK, 
PYK2, Csk and Abl), serine/threonine kinases (ILK, PKC and PAK), modulators of 
small GTPases (ASAP1, Graf and PSGAP), phosphatases (SHP-2 and LAR PTP) and 
other enzymes (PI 3-kinase and the protease calpain II) (Geiger et al., 2001; Zamir 
and Geiger, 2001a; Zaidel-Bar et al., 2007; Moser et al., 2009).  
CMACs can be classified into different types based on their size, stability, location in 
the cell. These classifications include nascent adhesions, focal complexes (FCs), focal 
adhesions (FAs), fibrillar adhesions, and podosomes (Figure 2) (Zamir and Geiger, 
2001b; Berrier and Yamada, 2007; Lock et al., 2008). Assembly, maturation and 
disassembly of CMACs is a sequential process driven by a coordinated interaction of 
numerous molecules, and the activation of specific signaling pathways (Webb et al., 
2002). During cell migrating on ECM-coated surfaces, small GTPase Cdc42 and 
Rac1 signaling pathways trigger formation of membrane protrusions at the cell 
leading edge, resulting in formation of nascent adhesions in the lamellipodium behind 
the leading edge (Raftopoulou and Hall, 2004; Galbraith et al., 2007; Choi et al., 
2008). Transient nascent adhesion structures either disappear or develop into larger 
FCs, which reside at the base of lamellipodium. FCs either disassemble within a short 
time of their formation, or continue to grow into FAs (Zamir and Geiger, 2001b; 
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Webb et al., 2002; Berrier and Yamada, 2007; Parsons et al., 2010).  FAs connect 
with actin stress fibers that transmit the contractile forces in the cell that are required 
for cell movement (Shemesh et al., 2005; Ananthakrishnan and Ehrlicher, 2007).  
When fibroblast cells attach on fibronectin-coated surfaces, via α5β1 integrin, they 
form elongated, rod-shaped adhesions, called fibrillar adhesions. This transition 
process from FAs to fibrillar adhesions depends on actomyosin-driven contractility. 
Fibrillar adhesions promote fibrillogenesis (Zamir et al., 2000). During formation of 
the CMACs, the CMAC protein components present in different types of adhesion 
structures are not identical. Vinculin for example is present in nascent adhesions and 
FCs, whereas zyxin only appears in mature FAs, and fibrillar adhesions lack paxillin 
and vinculin (Zamir et al., 1999; Zaidel-Bar et al., 2003; Zaidel-Bar et al., 2004; 
Lock et al., 2008). 
Other adhesive structures include podosomes and invadopodia. Podosomes are ring 
structures that have an actin core, which is surrounded by CMAC proteins such as 
talin and vinculin. Podosomes have been found in osteoclasts, macrophages and 
endothelial cells (Linder and Kopp, 2005). Invadopodia are podosome-like structures 
in invasive cancer cells and Src-transformed cells (Weaver, 2006, 2008). RhoGTPases 
and Src are involved in the assembly and dynamics of invadopodia and podosomes 
(Burns et al., 2001; Roskoski, 2004). An important function of podosomes and 
invadopodia is matrix degradation. 
 
Figure 2: The illustration shows different types of CMAC structures. Note particular types of CMACs 
may only be present in specific cell types.  
In migrating cells, the CMACs can sense the extracellular environment transmitting 
signals into the cell and mediate the traction force to drive cell movement (Geiger et 
al., 2001; Lock et al., 2008; Askari et al., 2010). The dynamic assembly and 
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disassembly of adhesion complexes plays a critical role at all stages of cell migration. 
During cell migration, both the composition and the morphology of the adhesion 
complexes change. The formation of focal complexes in the lamellipodia of migrating 
cells is an important step for extending lamellipodia to the ECM (Betapudi, 2010). 
Adhesion complexes at the leading edge anchor the actinomyosin force generating 
system to the ECM, resulting in a force on the cell to pull the cell body forward over 
the ECM. Mechanical tension generated within the cell by the actinomyosin system is 
clearly important for adhesion maturation, but different adhesion components show 
differential sensitivity to tension (Pasapera et al., 2010). CMACs also disassemble at 
the front and rear of the cell to allow cell detachment (Bretscher, 1996b; Carragher 
and Frame, 2004). The protease calpain also mediates focal adhesion disassembly 
during cell migration (Franco and Huttenlocher, 2005). However, the mechanism of 
adhesion dynamic assembly and disassembly in migrating cells is still not well 
understood, but clearly require tight spatial and temporal regulation.  
The attachment strength between the cell and the ECM can be controlled by levels of 
matrix concentration, integrin abundance (CMACs), and the integrin activation state 
(Palecek et al., 1997; Holly et al., 2000). In many cell types, the migration rate is 
optimized at intermediate levels of these three components. Change in any one of 
these properties will affect the rate of cell migration in a manner that is dependent on 
the original position of the cell on the bell shaped curve (Figure 3) (Palecek et al., 
1997; Holly et al., 2000; Peyton and Putnam, 2005; Gupton and Waterman-Storer, 
2006). 
Figure 3. Cell migration 
in relation to adhesion 
strength follows an 
approximate bell-shaped 
curve (from Holly et al., 
Exp. Cell Res. 2000). 
 
 
 
 
1.1.3 Polarity in migrating cells 
Polarization is essential for directional cell migration in a variety of cell types. Without 
polarization, the cells would move in all directions at once, or remain stationary (Ridley 
et al., 2003).  Studies have shown that the Rho family GTPase play a key role in cell 
polarity (Etienne-Manneville and Hall, 2002; Fukata et al., 2003; Funasaka et al., 
2010). When cells respond to a migratory stimulus, such as growth factor (chemotaxis) 
or ECM (haptotaxis), the cells generate a polarized phenotype and migrate toward 
regions of higher chemical concentrations. At initial stages of the polarization, actin 
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polymerization at the leading edge generate a protrusive force (Lauffenburger and 
Horwitz, 1996). Further more, the stabilization of microtubules at the front of the cell,  
a reorientation of the microtubule organizing center (MTOC) (or centrosome), and the 
Golgi to a location in front of the nucleus, toward the direction of cell migration, 
contribute to establishing and maintaining cell polarity in 2D environments (Orlando 
and Guo, 2009). Although this mechanism of the migrating cell polarization has not 
been completely clarified, Cdc42, PAR6, PAR3 and a typical protein kinase (αPKC) 
appears to be involved in the polarization events (Etienne-Manneville and Hall, 2003; 
Etienne-Manneville, 2004b). Also, the phosphoinositide 3-kinase (PI3K) pathway is 
involved in the polarization process (Weiner, 2002).  However, recent studies found 
that the Golgi complex and the centrosome are located behind the nucleus during cell 
migration in 3D environments  (Pouthas et al., 2008; Doyle et al., 2009). This suggests 
that the polarization has distinct mechanisms in 2D and 3D environments. It will also 
be interesting to investigate whether any of these polarity proteins could be potential 
drug targets for cancer treatment. 
1.1.4 The actinomyosin system and cell migration  
Tractional force is created at focal adhesion sites by integrins connecting the 
actinomyosin force-generating system to the ECM. Integrins in focal adhesion sites 
serve as the both traction force driving the cell movement and as mechanosensors 
transmitting the physical state of the extracellular environment into the cell and altering 
F-actin cytoskeleton dynamics (Galbraith et al., 2002). Individual actin filaments can be 
assembled into two general types of structures: cortical actin networks and stress fibers, 
which play different roles in cell migration. 
The migration cycle begins with the process of protrusions, where actin polymerization 
promotes extension of two types of protrusions, filopodia and lamellipodia. The thin, 
spike-like filopodia are formed through the direct polymerization of long parallel actin 
bundles by members of the formin family (Peng et al., 2003; Pellegrin and Mellor, 
2005). The large, broad lamellipodia are formed through actin polymerization of an 
actin network suggested to be branched (Mullins et al., 1998). However, recent studies 
show that the actin filament networks in lamellipodia may not be branched, but 
instead form overlapping arrays where individual actin filaments approach the leading 
cell edge at angles between 15 and 90 degrees. (Koestler et al., 2008; Urban et al., 
2010). In protruding lamellipodia, a high proportion of filaments are oriented at angles 
orthogonal to the advancing cell edge.  In contrast, an increased proportion of actin 
filaments and microspike bundles are oriented at angles parallel to the cell edge in 
stable or retracting lamellipodia. This provides a new model for understanding actin-
driven protrusion in cell migration. In lamellipodia, the barbed ends of F-actin are 
oriented towards the leading edge. Continuous assembly at barbed ends and removal of 
actin monomers from the pointed ends of filaments creates a treadmilling process that 
generates protrusive force (Neuhaus et al., 1983; Revenu et al., 2004). These F-actin 
networks may also engage with focal complexes within lamellipodia via adhesion 
adaptor proteins in a dynamic manner with “clutch-like” properties. This permits the 
asymmetric orientation of F-actin assembly-derived forces to push out the leading edge 
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membrane; alternatively, when the actin filaments disengage from FCs, F-actin 
retrograde flow is increased (Theriot and Mitchison, 1991; Atilgan et al., 2005; 
Mogilner and Rubinstein, 2005; Atilgan et al., 2006). This process may depend on the 
actin-related protein 2/3 (Arp2/3) complex activation to create free barbed ends 
(Mullins et al., 1998), and on the actin depolymerizing factor (ADF) cofilin-mediated 
severing that increases both the number of barbed and pointed ends (Ghosh et al., 
2004). Barbed end-capping proteins and depletion of the polymerization-competent 
pool of actin monomers limit filament growth (Record Owner, 2003). The formation of 
lamellipodia and filopodia, respectively, are regulated by small GTPases of the Rho 
family, Rac1 and Cdc42 (Nobes and Hall, 1995). These two forms of protrusion appear 
to have very distinct functions. The filopodia act as sensors that explore the local 
environment, whereas the lamellipodia forms broad protrusions in the direction of cell 
migration to provide a strong foundation over which the cell can move forward (Ridley 
et al., 2003).  
Through Rho-ROCK signaling pathways, myosin II is activated (Watanabe et al., 1999; 
Wang et al., 2009). The activated myosin II binds to F-actin filaments to form stress 
fibers (Byers et al., 1984). The stress fibers anchor to mature FAs in lamellae (back of 
the lamellipodia) via adaptor proteins facilitating a contractile force and pulling the cell 
body forward.  Although myosin II-mediated intracellular mechanical tension is clearly 
important for adhesion maturation, it also contributes to adhesion disassembly in 
migrating cells (Broussard et al., 2008). For example, this tension can lead to activation 
of calpain, which contributes to adhesion disassembly at the cell rear by cleaving a 
number of focal adhesion proteins, including integrins, talin and vinculin (Franco et al., 
2004; Wells et al., 2005). However, these processes are not yet fully understood.  
1.1.5 Proteolysis in cell migration 
Cell migration in 3D requires the overcoming of the physical resistance of three-
dimensional tissue networks, one way this can be achieved is via proteolytic 
degradation of the ECM components in different cell types and cancer. For example, 
matrix metalloproteinases (MMPs) cleave specific targets in the ECM to facilitate cell 
migration (Heissig et al., 2005). MMPs have been identified as key secreted enzymes 
for the breakdown and remodelling of the ECM in both normal and cancer cell 
migration (Dufour et al., 2008). Cell can migrate as single cells (amoeboid or 
mesenchymal) or collectively (in cell sheets, strands, tubes, or clusters) (Friedl and 
Wolf, 2003b). However, when matrix metalloproteinases are inhibited in 3D 
environments cells can switch towards an amoeboid movement by a mesenchymal-
amoeboid transition (Friedl and Wolf, 2003a; Wyckoff et al., 2006).  
1.1.6 Recycling of integrin receptors and plasma membrane in cell migration 
Several studies have shown that cell migration requires recycling of the integrin 
molecules by internalization from the plasma membrane into endosomal compartments 
and exocytosis to form new adhesion sites (Lawson and Maxfield, 1995; Pierini et al., 
2000; Pellinen and Ivaska, 2006; Howes et al., 2010). Integrins are internalized at the 
plasma membrane by clathrin-dependent and clathrin-independent endocytic 
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mechanisms (Caswell et al., 2009). In clathrin-dependent integrin endocytosis, for 
example, the NXXY motif of the integrin β1 subunit cytoplasmic tail interacts with 
endocytic adaptor proteins such as AP2, which recruits integrin α5β1 to clathrin-coated 
structures (Vignoud et al., 1994). In clathrin-independent integrin endocytosis, for 
example, αLβ2 integrin is internalized and rapidly recycled by a cholesterol-sensitive 
pathway (Fabbri et al., 2005). However, many integrins can be internalized by more 
than one mechanism, for instance the αvβ3 integrin be internalized into coated 
structures or be internalized by other routes (Caswell et al., 2009). 
Following endocytosis, integrins travel to early endosomes and can then be targeted to 
lysosomes for degradation or recycled to plasma membrane. These recycling processes 
depend on  Rab family small GTPases, such as Rab11 and Rab4 (Caswell et al., 2008; 
Caswell et al., 2009).  Although the recycling loop has important roles in cell 
migration, the regulatory mechanisms remain to be determined.  
The plasma membrane recycling system also removes membrane from the cell surface 
and adds membrane at the front in migrating cell may contribute to extension of the 
cellular leading edge (Bretscher, 1996a). Plasma membrane trafficking pathways that 
contribute to cell migration have not been fully elucidated, but recent studies have 
implicated several SNAREs (SNAP23, VAMP3, VAMP4 and syntaxin13) that are 
involved in the process (Jahn and Scheller, 2006; Cocucci et al., 2008). In addition, 
integrins are also involved in the regulation of endocytosis and the recycling of the lipid 
membrane by Rac-PAK signaling (del Pozo et al., 2004). To clarify the mechanisms of 
polarized delivery of membranes during cell migration will help to understand the 
process of cell motility. 
1.1.7 Microtubules in cell migration 
Microtubules are a class of cytoskeletal components that are involved in regulation of 
cell division, cell migration, vesicle transport and cell polarization (Watanabe et al., 
2005; Chien et al., 2009). During cell migration in 2D, microtubules are oriented and 
organized at the leading edge (Etienne-Manneville, 2004a; Watanabe et al., 2005), 
while residing at the rear of the nucleus during migration in 3D (Doyle et al., 2009). 
Microtubules also target to CMACs and regulate cell attachment (Wu et al., 2008). A 
recent study reports that an AMP-activated protein kinase (AMPK) phosphorylates the 
microtubule plus end protein CLIP-170 thereby controlling directional cell migration 
(Nakano et al., 2010).  
1.2 Cancer   
In the body, normal cells progress through a tightly regulated process of growth, 
division, and death, which are controlled by the genes and the microenvironment. 
Sometimes the regulation of this process goes wrong and cancer begins to form. Cancer 
is a genetic disease caused by sequential accumulation of mutations in genes (Balmain 
et al., 2003; Michor et al., 2004). Environmental factors increase cancer risk, such as 
smoking, radiation from the sun, X-rays and chemicals toxins. Cancer also can be 
caused by viruses, such as the human papilloma virus (HPV) and the epstein barr virus 
(EBV). Age and hereditary also are important risk factors for cancer. 
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Alterations in the three different types of genes mainly contribute to cancer 
progression. These are tumor suppressor genes, oncogenes and DNA repair genes 
(Balmain et al., 2003; Osborne et al., 2004). These represent the main types of genes 
involved in cancer; however other mutated genes may also contribute to cancer 
progression. Data collected from the Network of Cancer Genes (NCG) show 736 genes 
that are mutated in different cancer types (Syed et al., 2010). 
Cancer cells are able to invade nearby tissues and spread to other parts of the body 
through blood and lymphs system, for example breast cancer can invade to nearby 
lymph nodes and spread to the liver (Müller et al., 2001). The spread of cancer is called 
metastasis. Metastasis is the most lethal stage of cancer. Cell attachment to the ECM is 
a basic requirement to build a multi-cellular organism but is also responsible for a wide 
range of normal and abnormal cellular activities including cancer cell invasion and 
metastasis (Hanahan and Weinberg, 2000; Holly et al., 2000; Bergers and Benjamin, 
2003). Studies have shown that αv integrins play a role in cancer, for example integrin 
αvβ3 in melanoma increases lymphatic metastases (Nip et al., 1992), in prostate cancer 
αvβ3 increases bone metastasis (McCabe et al., 2007); αvβ6 in colon and cervical 
cancers decrease patient survival (Bates et al., 2005; Hazelbag et al., 2007); and αvβ5 in 
Glioblastoma increases cancer invasion (Bello et al., 2001). Although integrins are not 
oncogenic, studies have shown that some oncogenes require integrin signaling to 
mediate tumorigenesis and metastasis. Also crosstalk between specific integrins and 
growth factors promote tumour progression (Desgrosellier and Cheresh, 2010).  
1.3 The p21-activated kinase family 
The p21-activated kinase (PAK) is a family of serine/threonine kinases that was 
initially identified as binding partners of the Rho GTPases Cdc42 and Rac1 (Manser et 
al., 1994). The PAK family members play essential roles in cell signaling and control a 
variety of cellular functions including cell morphology, cytoskeletal dynamics and 
motility, (Abo et al., 1998; Zhang et al., 2002; Bokoch, 2003; Kumar et al., 2006; 
Eswaran et al., 2009; Paliouras et al., 2009).  However, the role of the PAK family in 
physiological and pathological processes is not completely understood. 
1.3.1 Structure 
Six PAK isoforms are expressed in the human. Based on their structural and functional 
similarities, the six members of the human PAK family are classified into two groups: 
group I consisting of PAK1, PAK2 and PAK3, and group II consisting of PAK4, PAK5 
and PAK6 (Manser et al., 1994; Abo et al., 1998; Dan et al., 2002; Lee et al., 2002; 
Hofmann et al., 2004). All PAKs consist of an N-terminal PBD (p21-GTPase-binding 
domain) and a highly conserved C-terminal serine/threonine-kinase domain (Figure 4). 
The group I PAKs contains an N-terminal autoinhibitory domain as a means to inhibit 
their kinase activity (Lei et al., 2000). This proline-rich region of PAKs is associated 
with binding to Nck, an adapter protein that is known to be involved in the regulation 
of actin cytoskeletal dynamics (Zhao et al., 2000). Both Rac and Cdc42 can bind to the 
p21-GTPase-binding domain in group I PAKs.  
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The central regions in group II PAKs are less conserved and contain various numbers 
of proline-rich potential SH3 (Src homology 3) domain-binding sites (Figure 4). A 
RhoA GEF-binding site has been identified in the central region of PAK4 but this 
sequence is not present in PAK5 and PAK6 (Callow et al., 2005). We also found an 
integrin-binding motif within the PAK4 kinase domain that is reasonably conserved in 
all PAK family members (Zhang et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Structure of the two group of p21-activated kinase: All six PAKs have an N-terminal PBD and 
a C-terminal serine/threonine kinase domain. The central region is more divergent, with various numbers 
of putative SH3-domain-binding sites. 
1.3.2 Activation of PAK4 kinase and its substrates 
PAK1 can be activated by both the small GTPases Cdc42 and Rac (Manser et al., 1994; 
Bagrodia and Cerione, 1999). Unlike PAK1, PAK4 has a constitutive basal kinase 
activity (Abo et al., 1998). The PAK4 interaction with Cdc42 only targets the 
translocation of PAK4 to the Golgi, and it may have no influence on enzymatic activity 
(Abo et al., 1998; Dan et al., 2001). However, other studies show that PAK4 and PAK5 
are activated by small GTPases Cdc42 and Rac1 (Ching et al., 2003; Koh et al., 2008). 
Although the mechanism of PAK4 activation remains to be elucidated, it is clear that 
PAK4 can be activated by growth factor stimulation, such as hepatocyte growth factor 
(HGF) and keratinocyte growth factor (KGF) (Wells et al., 2002; Lu et al., 2003; 
Ahmed et al., 2008). In addition, the MKK6/p38 MAP kinase pathway also regulates 
PAK4 activation (Kaur et al., 2005).   
A number of PAK4 substrates have been identified. For examples, PAK4 
phosphorylates LIMK1 and increases its ability to phosphorylate cofilin resulting in 
polymerization of actin filaments; PAK4 promotes cell survival  by phosphorylating the 
pro-apoptotic protein BAD; PAK4 phosphorylates GEF-H1 thereby reducing RhoA 
activity; and PAK4 phosphorylates integrin β5, regulating cell migration (Dan et al., 
2001; Gnesutta et al., 2001; Callow et al., 2005; Li et al., 2010c).  
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1.3.3 PAK4 function in cell migration and cancer   
The PAK members show different tissue-specific expression patterns (Abo et al., 1998; 
Callow et al., 2002). PAK1, PAK3, PAK5 and PAK6 have limited tissue expression 
patterns, whereas PAK2 is ubiquitously expressed (Manser et al., 1994; Teo et al., 
1995; Jaffer and Chernoff, 2002; Pandey et al., 2002; Wang et al., 2002). PAK4 is also 
ubiquitously expressed at low levels in adult tissues but is highly expressed during 
development (Qu et al., 2003). PAK4 is involved in many cellular functions, such as in 
organ development, cell growth, cell survival, cell proliferation, neurological disorders, 
as well as in angiogenesis and luminogenesis (Gnesutta et al., 2001; Qu et al., 2003; 
Cammarano et al., 2005; Li and Minden, 2005; Danzer et al., 2007; Koh et al., 2008; 
Tian et al., 2009). PAK4 is also highly over-expressed in most tumor cell lines, and can 
promote tumorigenesis in vivo (Callow et al., 2002; Kimmelman et al., 2008; Liu et al., 
2008; Siu et al., 2010). 
Accumulating evidence indicate an important function of PAK4 in regulating cell 
migration (Figure 5). PAK4 dynamically regulates adhesion complex formation (Zhang 
et al., 2002; Li et al., 2010b), mediates the induction of linear F-actin polymerization 
and filopodia in response to Cdc42 (Abo et al., 1998), and induces a increase in stress 
fibers via LIMK1 and cofilin signaling pathways (Dan et al., 2001). However, other 
studies show that activated PAK4 decrease the amount of stress fibers (Qu et al., 2001; 
Wells et al., 2002; Li et al., 2010b), suggesting a more complex role for PAK4 in the 
regulation of the cell migration. The knowledge of the molecular mechanisms of 
PAK4´s involvement in cell migration still contains gaps. For example, it still has to be 
clarified how the multiple functions of PAK4 are regulated in time and space during the 
different steps of cell migration.   
Figure 5. PAK4 signaling pathways: PAK4 can 
be activated by the HGF-Met RTK-PI3K 
pathway. The activated PAK4 phosphorylates 
GEF-H1 on serine 885, which inhibits RhoA 
activity. Actin stress-fibre formation 
downstream of RhoA activity is mediated by 
ROCK promotion of myosin II phosphorylation 
or inactivation of myosin light-chain 
phosphatase (MLCP). However, PAK4 can also 
drive the polymerization of actin filaments by 
the phosphorylation of cofilin through activating 
LIMK1 and inactivating SSH-1 by 
phosphorylation. The interaction of  PAK4 with 
a DiGeorge syndrome critical region 6-like 
protein (DGCR6L) also induces the 
phosphorylation of LIMK1(Li et al., 2010a). In 
parallel, activated PAK4 can phosphorylate 
paxillin on serine 272, driving the dissolution of actin stress fibres and focal adhesions. Cell 
attachment to the ECM can also activate PAK4 and activated PAK4 can phosphorylate the integrin β 
subunit to regulate cell-matrix adhesion complexes. Thus, PAK4 dynamically regulates both 
rearrangement of the actin cytoskeleton and turnover of adhesion complexes that facilitate cell motility. 
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1.4 Integrins 
Integrins are heterodimeric cell surface trans-membrane receptors. They mediate 
attachment between the cell and the extracellular matrix (ECM) or to other cells  
(Hynes, 1992). Integrins transmit bi-directional signals across the plasma membrane 
that are central to many basic cellular functions and pathological processes, such as 
proliferation, differentiation, apoptosis, wound healing, tumor invasion and metastasis 
(Hirsch et al., 1996; Clezardin, 1998; Zheng et al., 1999; Holly et al., 2000; Miyata et 
al., 2000; Zheng et al., 2000; Paulhe et al., 2001; Hollenbeck et al., 2004). 
 
Figure 6. A. Representation of 
the integrin family. In 
vertebrates, integrin α and β 
subunits form 24 distinct 
heterodimers.  B. schematic of 
the domain structure of an 
integrin heterodimer. Integrin 
heterodimer of α and β subunits 
forms a large extracellular 
domain that consists of a ligand-
binding pocket, one 
transmembrane domain, and a 
short C-terminal cytoplasmic tail 
for each subunit.  
 
1.4.1 Integrin structure and ligands 
Integrins contain two distinct chains, that are termed α and β subunits. In mammals, 18 
α and 8 β subunits have been characterized and different combinations of these α and β 
subunits form 24 distinct integrin hetrodimers (Figure 6A) (Berman and Kozlova, 
2000; Humphries, 2000; Takada et al., 2007). However, a cell line normally does not 
express all 24 integrins. Individual cells selectively express different integrins and 
modulate their integrin specificity and affinity for ligands (Hynes, 1992). Integrin α and 
β subunit both contain a large amino-terminal extracellular domain, a single trans-
membrane domain, and a short carboxyl-terminal cytoplasmic tail (except the integrin 
β4) (Figure 6B). Their extracellular domains can bind to either ECM macromolecules 
or counter-receptors on adjacent cell surfaces (Hynes, 2002). A specific integrin can 
often bind to several different ligands and different ligands are recognized by more than 
one integrin, such as the αvβ5 integrin to vitronectin, and the αvβ3 integrin to a variety 
of ECM proteins containing the peptide sequence arginine-glycine-aspartate (RGD) 
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which can be found in ECM proteins including collagen, vitronectin, fibronectin, 
fibrinogen. 
1.4.2 Integrin activation 
Integrins require an activation step to bind to physiological ligands (Hynes, 1992). 
Structural studies have revealed that integrins may exist in low-, intermediate-, and 
high-ligand binding affinity states, it is thought that integrins are in a low-affinity state 
when their extracellular domains are in  a bent conformation (inactive) and in a high-
affinity state when those are extended conformation (active) (Figure 7) (Xiong et al., 
2001; Takagi and Springer, 2002; Xiao et al., 2004). The integrin-ligand binding 
affinity regulation (activation)  can be controlled by the interaction of the integrin 
cytoplasmic tails with cytoplasmic proteins (inside-out signaling) or the extracellular 
domain with their ligand (outside-in signaling) (Liddington and Ginsberg, 2002). For 
example talin, a major cytoskeletal protein at integrin adhesion sites, binds to integrin β 
subunit cytoplasmic tails and regulates integrin activation, and also kindlin family 
proteins also contribute to regulate integrin activation (Tadokoro et al., 2003; Wegener 
et al., 2007; Moser et al., 2009).  The activation, and de-activation, of integrins is 
crucial for cell migration and tumor cell invasion (Hood and Cheresh, 2002). 
 
 
 
Figure 7. A schematic diagram of inside-out or outside-in signaling controls integrin activation. 
Opening of the head or legs/feet opens the other end of the integrin perhaps through an intermediate 
state(s). The ligand-occupied active integrin causes further conformational changes resulting in clustering 
and cell signaling. (Based on Xiong 2003 Blood 102) 
 
1.4.3 Integrin cytoplasmic tails 
The integrin α and β cytoplasmic tails are very short and lack enzymatic activities. The 
membrane-proximal regions of the α and β cytoplasmic domains can interact with each 
other via a salt bridge (Hughes et al., 1996). Disruption of this salt bridge can change 
the integrin from low-affinity to high-affinity state, indicating that the short 
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cytoplasmic domains of integrins are essential for both inside-out and outside-in 
signaling (Giancotti and Ruoslahti, 1999; Liddington and Ginsberg, 2002).  
The integrin cytoplasmic tails (which offer various cytoplasmic protein-binding sites) 
can transmit signals through interactions with the cytoskeleton, signaling molecules, 
and other cellular proteins to control integrin activity to regulate cell behavior. So far, 
a growing number of the integrin cytoplasmic tail-binding proteins have been 
identified, including actin-binding proteins, such as talin, filamin, zyxin and a-actinin; 
enzymes, such as ILK and FAK; and adaptor proteins, such as paxillin, viculin (Liu et 
al., 2000; Lock et al., 2008). The integrin α and β cytoplasmic tails contain many 
motifs that dynamically interact with specific integrin-binding proteins (Liu et al., 
2000). One of the best studied motifs in integrin-signaling events is the NPXY (where 
X is any amino acid) motif found in many of the integrin β subunit cytoplasmic tails 
(Reszka et al., 1992). The conserved NPXY motif frequently binds to phosphotyrosine-
binding (PTB) domains of other protein, such as talin. Studies indicate that NPXY-talin 
binding is a key step to integrin activation (Liddington and Ginsberg, 2002; Wegener et 
al., 2007). In this thesis, six integrin β5 cytoplasmic tail-binding proteins were 
identified by yeast two-hybrid screening (Zhang et al., 2002). We also determined a 
membrane-proximal integrin β5-SERS-motif  to be involved in controlling cell 
attachment and migration (Zhang et al., 2002). 
1.4.4 Phosphorylation of integrin cytoplasmic tails  
Another important mechanism where cellular signaling influences cellular behavior is 
through the phosphorylation of integrin cytoplasmic tails by intracellular proteins (Liu 
et al., 2000; Phillips et al., 2001; Fagerholm et al., 2004; Anthis et al., 2009; Legate 
and Fassler, 2009). Phosphorylation of integrin cytoplasmic tails may also regulate the 
activation state of integrins, for example, β integrin tyrosine phosphorylation can 
regulate talin-induced integrin activation (Calderwood et al., 1999; Tadokoro et al., 
2003; Wegener et al., 2007; Millon-Fremillon et al., 2008; Anthis et al., 2009). Integrin 
phosphorylation at tyrosine residues has been found in the cytoplasmic domains of 
α6A, β1, β3 and β4 (Gimond et al., 1995; Sakai et al., 1998; Cowan et al., 2000; 
Boettiger et al., 2001; Dans et al., 2001; Datta et al., 2002). Also, serine/threonine 
phosphorylation of integrin cytoplasmic domains has been found in α4, β1, β2, β3 and 
β7 subunits (Dahl and Grabel, 1989; Reszka et al., 1992; Barreuther and Grabel, 1996; 
Valmu et al., 1999a; Valmu et al., 1999b; Kirk et al., 2000; Han et al., 2001; 
Fagerholm et al., 2002; Hilden et al., 2003). However, so far only a few protein kinases 
that phosphorylate integrin cytoplasmic domains have been identified. c-Src was found 
to be responsible for tyrosine phosphorylation, whilst protein kinase C and integrin-
linked kinase may mediate serine/threonine phosphorylation of integrins (Novak et al., 
1998; Sakai et al., 2001; Fagerholm et al., 2002).  
1.4.5 Integrin αvβ5 in cancer   
αv integrins are up-regulated or activated in migratory and invasive mechanisms in 
vivo, including in wound healing, angiogenesis, and metastasis (Felding-Habermann 
and Cheresh, 1993; Brooks et al., 1994; Friedlander et al., 1995; Strömblad and 
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Cheresh, 1996b; Strömblad and Cheresh, 1996a; Brooks et al., 1997). Integrin αvβ5 
mediates cell attachment and migration on vitronectin (Wayner et al., 1991; Strömblad 
and Cheresh, 1996b; Yebra et al., 1996; Hynes, 2002; Lock et al., 2008). Importantly, 
growth factor activation of integrin αvβ5 mediated cell motility has been functionally 
linked to angiogenesis as well as carcinoma cell dissemination (Friedlander et al., 1995; 
Strömblad and Cheresh, 1996b; Brooks et al., 1997). Furthermore, integrin αvβ5 is 
induced in keratinocytes during wound healing and facilitates vascular endothelial 
growth factor-mediated vascular permeability (Larjava et al., 1993; Eliceiri et al., 2002; 
Sheppard, 2004). In addition, most carcinoma specimens from patients express integrin 
αvβ5 (Lehmann et al., 1994; Jones et al., 1997). However, the role of integrin αvβ5 in 
cancer is still not clear.  
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2 Aims of present study 
Dissemination by metastasis is the most common cause of death in cancer patients. 
While the molecular mechanisms involved in the metastatic process are poorly 
understood; it is clear that integrins are crucial to cell migration and tumor metastasis 
(Hynes, 2002).  To understand how cells migrate may help us to find new ways for 
development of cancer therapy. The overall aim of this project was to clarify 
functionality and mechanisms of the integrin β5 cytoplasmic tail in regulating cancer 
cell adhesion and motility. 
Specific aims: 
1. To identify integrin β5 subunit cytoplasmic tail binding proteins and address 
their role in cancer cell lines. (Paper I) 
2. To elucidate molecular mechanisms of PAK4 regulation of cell-matrix adhesion 
complex dynamics. (Paper II) 
3. To determine the influence on cell migration of the PAK4-integrin β5 
interaction. (Paper III) 
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3 Methodological considerations 
All materials and methods used in this thesis are presented in detail in the 
corresponding papers. However, some general principles and backgrounds of the 
methodologies will be described in this section. 
3.1 Cell culture   
Cell lines derived from tumor or normal mammalian tissues are grown in cell culture 
under controlled conditions. Cell culture is a core laboratory technique and provides the 
cellular materials for various biological assays. Cell culture is a relatively simple 
technique compared to studies using animal organs. 
Cell culture in vitro is a useful model for studying cell migration. For example, cultured 
cells can be transfected with specific genes to produce proteins or with RNAi to knock-
down specific genes, the cells can be then plated on a variety of ECM substrates, and 
subcellular structures can be immunostained and observed under a flourescent or 
confocal microscope. Furthermore, we can select different cell lines for specific 
purposes. For example, to analyze integrin αvβ5-mediated cell adhesion on VN, in 
order to avoid interference from integrin αvβ3 (both αvβ5 and αvβ3 are major 
vitronectin receptors), we used human MCF-7 breast carcinoma cells (expressing αvβ5 
but not αvβ3) and CS-1 hamster melanoma cells (expressing endogenous integrin αv 
but not integrin β3 or β5) in this study. 
Traditional 2D cell culture lacks many features of tissues, such as blood circulation, 
hormone level, oxygen pressure, loosing original tissue organization and structure; 
since cells are not entirely in contact with each other.  
Because 2D cell culture is not a natural environment for cell growth, 3D cell culture 
techniques have been developed to more closely mimic in vivo tissue environments and 
has been applied to study cell motility (Even-Ram and Yamada, 2005).  In 3D model 
systems will likely be very helpful in future investigations to understand the 
mechanisms of cancer cell migration and invasion.  
3.2 Flow cytometry analysis  
Cell-surface expression of integrins can be regulated by intracellular pools. Flow 
cytometry or FACS (Fluorescence Activated Cell Sorter) is a powerful technique to 
detect particular integrins expressed at the cell surface. Cells expressing a particular 
integrin (or transfected integrin) can also be selected and sterilely sorted for further 
studies and propagation (Filardo et al., 1996). Through this method, a portion of the 
cell population can be isolated that have, for example, low or high expression of a 
particular integrin. Further growth of these selected cells creates a population with 
slightly higher or lower expression of integrins. In this study, we successfully created 
stable cells expressing the same level of integrin β5-WT and integrin β5 mutants in CS-
1 cells by FACS sorting after staining with anti-integrin αvβ5 mAb P1F6 and a FITC-
conjugated goat anti-mouse secondary antibody as described (Filardo et al., 1996; Bao 
and Strömblad, 2004).  
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3.3 RNA interference  
RNA interference (RNAi) was firstly described in plants in the early 1990s, also 
referred to as post-transcriptional gene silencing (PTGS) (Napoli et al., 1990). It is a 
powerful tool used for specific gene silencing by siRNA triggering a sequence-specific 
mRNA degradation in mammalian cultured cells. There are two general methods for 
producing siRNAs in cultured cells: delivery of synthetic siRNAs, and introduction of a 
DNA construct that expresses short hairpin RNA sequences (shRNA) (Figure 8). In the 
cells, a specific cellular enzyme called DICER recognizes the double-stranded RNA 
and cleaves it to 21-27 nucleotide fragments. One strand of the siRNA (the guide 
strand) is then assembled into an RNA-induced silencing complex (RISC). The 
incorporated RNA strand determines the sequence-specificity of the target gene 
silencing. RISC binds to the mRNA that is targeted by the single RNA strand within 
the complex and cleaves the mRNA. This cleaved mRNA cannot be translated into 
protein. Then the RISC dissociates from the mRNA and can cleave other mRNAs. By 
this way, even a low number of the RNA-induced silencing complex can lead to high-
level gene silencing. In this study, we specifically silenced PAK4 gene in MCF-7 cells 
by delivery of synthetic siRNAs or introduction of a shRNA plasmid.  
Figure 8. RNA interference (RNAi) triggers mRNA degradation by vector to express short hairpin RNA 
(shRNA) or by synthetic short interfering RNA (siRNA). In each case, gene silencing results from 
destruction of mRNA that is complementary to the input siRNA or the siRNA molecules created by Dicer 
cleavage shRNAs.  Dicer: cytoplasmic nuclease; RISC: RNA-induced silencing complex; mRNA: 
messenger RNA. 
However, use of RNAi silencing can cause off-target effects (Jackson et al., 2003; 
Sledz and Williams, 2004). Off-target effects in RNAi are still poorly understood. 
Off-target effects by RNAi may occur by sequence overlaps with the target gene, but 
non-specific effects are also possible (Jackson et al., 2003; Sledz and Williams, 
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2004). High doses of RNAi is cause off-target effects (Jackson et al., 2003).  When 
using siRNA, it is important to use more than one siRNA that have non-overlapping 
sequences, to use appropriate negative controls, and to confirm depletion of the target 
protein by Western blot and/or immunofluorescence. An add-back experiment is also 
a very useful control and can also be used to test the function of a mutated gene, 
where the wild-type is depleted by RNAi and then the mutant is introduced.  
One of the challenges of using this as therapy for medical needs will be the 
development of methods that will allow for the introduction of interfering RNAs into 
various cells and tissues of the body. Access to the blood stream and the cells is 
relatively easy; however it is usually difficult to induce interfering RNAs into most 
other cells and tissues. Delivery systems that allow this technology to be applied to 
specific tissues will be a great advantage in the future. 
3.4 Yeast two-hybrid screening and yeast mating tests 
The yeast two-hybrid assay is a molecular biology technique used to discover protein-
protein interactions by testing for interactions between two proteins (Young, 1998). 
The yeast two-hybrid assay can be used either to screen a cDNA library to find protein-
protein interactions or to test for interactions between two previously cloned proteins. 
Yeast two-hybrid assay used a series of yeast transformations followed by selection of 
positives in nutrient-deficient media.  
The yeast two-hybrid system is an in vivo technique testing protein interactions in 
living cells, and it does not require isolated protein (only the gene) that is fairly easy to 
perform. The system is also very sensitive and can detect weak protein-protein 
interactions. On the other hand, the yeast cell environment may not fully mimic 
mammalian cells (e.g. post-translational modifications may not be replicated in yeast). 
False positives can also occur in the yeast two-hybrid system. Therefore, after yeast 
two-hybrid system screening, the results require verification by other methods, such as 
in vitro binding, co-immunoprecipitation and co-localization assays.  In this study, we 
successfully identified an integrin β5 cytoplasmic tail interacting protein, PAK4, by 
using the DupLEX-A Yeast Two-Hybrid System (OriGen Technologies) (Figure 9).  
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Figure 9.   Schematic diagram of the yeast two-hybrid system to detect interactions between two 
proteins: The integrin β5 cytoplasmic domain is fused with E.Coli Lex A Binding Domain (BD) in the 
pEG202 bait vector and the PAK4-CD is fused with B42 Activation Domain (AD) in pJG4-5 prey vector. 
If the two proteins (Bait and Target) do not interact, there is no expression of the LacZ reporter gene. If 
they do interact, then the LacZ reporter gene is expressed. (from Li et al., Journal of Biological 
Chemistry. 2010) 
3.5 Kinase activity assay 
Protein kinases phosphorylate substrate proteins by transferring phosphate groups from 
ATP to serine, threonine, tyrosine or other residues of the substrate proteins. In 
particular, protein phosphorylation plays a significant role in a wide range of cellular 
processes. Thus, assessing the catalytic activity of a specific protein kinase may provide 
valuable information on signal-transduction pathways that affect cell behaviors (Brabek 
and Hanks, 2004). Also identification of specific phosphorylation sites in proteins is 
important for understanding protein-protein interactions, intracellular signaling 
pathways, such as in the regulation of cell survival, proliferation, differentiation and 
death. In this study, we successfully determined the PAK4 kinase activity by in vitro 
and in vivo radiometric kinase activity assays as described in our papers (Zhang et al., 
2002; Li et al., 2010b; Li et al., 2010c). 
In the protein kinase assays, the protein kinase usually is purified by immune-
precipitation from a cell extract. However, the purified protein kinase may be 
contaminated by other kinases, and therefore appropriate negative controls are needed. 
It should also be noted that some antibodies may inhibit or activate a kinase to affect 
the kinase assay result. The harmful effects of radioactivity is a concern for human 
health and environment protection, which makes use of other non-radiometric methods 
advantageous, for example use of phosphorylation-specific antibodies. 
3.6 Cell migration assay  
There are different types of cell migration: migration of cells based on chemoattractants 
(chemotaxis); cell migration towards or within a gradient of substratum (haptotaxis); 
movement of cells through the vascular endothelium (transmigration); migration of 
cells into a wound to close the gap (wound healing); and random movement of cells 
stimulated by chemical reagents (chemokinesis). 
The Boyden Transwell chamber was constructed by Stephen Boyden for a leukocyte 
chemotaxis assay (Boyden, 1962). The Transwell chamber assay has been developed, 
and widely used in 2D and 3D cell migration and/or invasion assays, including 
chemotaxis, haptotaxis, as well as chemokinesis. In general, cells are added in the 
upper chamber and are allowed to migrate through a micro-porous membrane into the 
lower chamber below the membrane, where addition of growth factors (chemotaxis) 
and/or coating with ECM (haptotaxis) can be applied. However, for the chemokinesis 
assay, equal concentrations of an agent are added in both ends. After an appropriate 
incubation time, the membrane is fixed and stained, and the number of cells that have 
migrated to the lower side of the membrane is determined (Figure 10).  
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Figure 10. Schematic of Boyden Transwell 
shows the separation of upper and lower 
chambers by a microporous membrane. Cells 
are added in the upper chamber and allow 
migrating cells through the microporous 
membrane into the lower side of membrane. 
 
 
 
 
 
The Boyden Transwell chamber-based cell motility assay is easy to perform and the 
results are generally very robust. In addition, the results are not affected by cell 
proliferation. In this study, we use Transwell chambers with 8.0 µm pore size (Costar 
Inc.) coated with different ECM to analyze haptotactic cell migration in two different 
cell types (MCF-7 and CS-1 cells). In our experience, the number of cells loaded and 
the incubation time affect the result. Therefore, this assay needs to be optimized for 
each individual cell types.  
3.7 Immunofluorescent staining and adhesion complex quantifications 
Immunofluorescent staining of cultured cells is a useful technique for studying the 
localization of a specific protein in the cell, using a specific antibody chemically 
conjugated with a fluorescent dye to bind a specific protein or antigen in cells. Two 
major types of immunofluorescent staining methods are most commonly used: direct 
immunofluorescent staining and indirect immunofluorescent staining. The direct 
immunofluorescent staining uses a primary antibody directly labeled with a fluorescent 
dye, and indirect immunofluorescent staining uses a secondary antibody linked with a 
fluorescent dye to recognize a primary antibody. The procedure of direct 
immunofluorescent staining is more simple and faster than the indirect 
immunofluorescent staining, and can avoid some non-specific binding that can lead to 
increased background signal while indirect staining gives an enhanced signal. 
Immunofluorescent staining can be performed on cells fixed on slides. The stained 
samples are observed under a fluorescent microscope or a confocal microscope.  
In this study, we used indirect immunofluorescent staining method to stain actin and 
focal adhesion structures in different cell types. The slides were examined by using an 
IX71 Olympus microscope with a 100×/1.35 oil objective and a Hamamatsu CCD 
camera or a Zeiss LSM510 confocal microscope with a 63×/1.4 oil objective. The 
numbers of focal CMACs at the cellular periphery were quantified manually. Because 
automatic image analysis for the CMACs is more accurate than manual, we also used 
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Patch Morphology Assay 5.2.0 software (Digital Cell Imaging Labs, Edegem, 
Belgium) to analyze the CMAC number, size and density. 
3.8 Fluorescence Recovery After Photobleaching (FRAP) 
Fluorescence Recovery After Photobleaching (FRAP) is typically used to study the 
mobility of fluorescently labeled proteins (Axelrod et al., 1976; Reits and Neefjes, 
2001). With this technique, the recovery of fluorescence in a defined region of interest 
(ROI) of a sample is monitored after a bleaching event by taking a time series of 
images. Bleaching is performed with high intensity light, particularly using lasers, 
which permit a tightly delimited application of energy. The recovery of fluorescence 
results from the movement of unbleached fluorophores from the surroundings into the 
bleached area. To represent the recovery data, the mean intensity in the bleached ROI is 
normally plotted versus time. In this context, the recovery half-time (time taken to 
achieve 50% of maximal recovery - t1/2) indicates the speed of recovery/mobility, e.g. 
diffusion speed, and the maximum level of recovered intensity gives information on 
ratio of mobile/immobile species within the fluorescent molecule population (Figure 
11). 
It is commonly observed that maximal recovery of a FRAP curve is often lower than 
the pre-bleach fluorescence intensity. This occurs because some of the bleached 
molecules within the FRAP ROI are immobile. Hence these immobile proteins do not 
make available free binding sites within the FRAP ROI, thereby limiting the 
recruitment of unbleached proteins and reducing maximal fluoresence recovery. The 
difference (usually expressed as a percentage) between the pre-bleach intensity and 
post recovery maximal intensity is therefore referred to as the immobile fraction (of the 
total molecular population within the bleached ROI). Conversely, the fraction of 
molecules exits the bleached ROI and is replaced by unbleached molecules represent 
the mobile fraction.  
Within biological systems, the combined kinetics of molecular diffusion and 
molecular interactions affect the mobility of molecules. Therefore, the FRAP 
recovery curve is determined by both diffusion rates and the chemical interactions of 
the studied molecules. In general, molecular diffusion is determined by the molecule 
size, environment viscosity, and the temperature of the surrounding medium, as well 
as by physical structures. If the diffusion rate is faster than the interaction rate of the 
molecule, the rate limiting factor for mobility will be the interaction, and in this case 
the FRAP recovery curve is also dominated by the chemical interaction. If the 
interaction of the molecule is faster than the diffusion, then the mobility of the 
molecule is dominated by the diffusion.  
We assessed integrin β5 turnover rates within focal adhesion complexes by applying 
FRAP within MCF-7 cells over-expressing mRFP and β5-EGFP or mRFP-PAK4 and 
β5-EGFP. Integrin β5-EGFP was bleached using 40 iterations at 40% of total laser 
power from the 488 nm line of a 4-line argon laser (Coherent). β5-EGFP was imaged 
pre (×3) and post (×31) bleaching using 0.24% of total 488 nm laser power at an 
interval of 30 s. mRFP was imaged using 35% of total laser power from a 543 nm laser 
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(Coherent). Entire adhesions were bleached and recovery of adhesions measured using 
free drawn ROIs and mean intensity quantified in Image J software (version 1.32), 
followed by analysis using Microsoft Office Excel 2003. We analyzed the random 
intra-plasma membrane diffusion of individual integrin heterodimers and microclusters 
(diffusion model), and total recovery including both random intra-plasma membrane 
diffusion of individual integrin heterodimers and microclusters, and the selective 
recruitment and concentration of integrins into existing focal adhesion structures 
(reaction-diffusion model). We also showed the data without diffusion of individual 
integrin by removing the diffusion recovery from the total recovery (reaction model).  
 
Figure 11.   An idealized plot of a 
FRAP recovery curve.  
II: initial intensity 
I0: intensity at timepoint t0 (first 
postbleach intensity) 
I1/2: half recovered intensity (I1/2 
= (IE - I0) / 2) 
IE: end value of the recovered 
intensity 
thalf: Halftime of recovery 
corresponding to I1/2 (t1/2 - t0)   
Mobile fraction Fm = (IE - I0) / (II 
- I0) 
Immobile fraction Fi = 1 – Fm 
(from EAMNET FRAP on-line 
teaching module, EMBL). 
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4 Summary of results and discussion 
4.1 Paper I:  
p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell 
migration. 
Rack1 was previously the only protein known to directly interact with the integrin β5 
cytoplasmic tail (Liliental and Chang, 1998). In this thesis, we identified six additional 
proteins specifically interacting with the human integrin β5 cytoplasmic tail by use of 
yeast two-hybrid screening of a 19-d mouse embryonic cDNA library. One of the 
proteins was p21-activated kinase 4 (PAK4). The interaction of integrin β5 with PAK4 
was then verified by GST pull-down and co-immunoprecipitation assays, concluding 
that the integrin β5 cytoplasmic tail associates with PAK4 in mammalian cells. 
Furthermore, we mapped the PAK4 binding to the membrane-proximal region of 
integrin β5, and identified an integrin-binding domain at aa 505-533 in the C-terminus 
of PAK4. 
Given that PAK4 associated with integrin αvβ5, we analyzed the effect on the cellular 
distribution of endogenous PAK4 by αvβ5-mediated attachment to VN in MCF-7 cells. 
We observed a cytosolic distribution of PAK4 in MCF-7 cells during regular culture 
conditions. However, after replating cells onto VN, we found a remarkable re-
distribution of PAK4 to forming lamellipodial structures in the cellular periphery. To 
examine whether the lamellipodia-localized PAK4 may interact with integrin αvβ5 at 
the cell membrane, we re-plated MCF-7 cells onto VN and co-stained the cells for 
endogenous PAK4 and endogenous integrin αvβ5.  
PAK4 and integrin αvβ5 in early forming adhesion complexes both localized 
proximally to the cellular edge but without specific co-localization at the sites of 
clustered integrins. The presence of PAK4 in the zone where the integrin αvβ5-
mediated adhesions were forming would most likely allow interactions between PAK4 
and integrin αvβ5, but they occur at a spatial and temporal resolution not able to be 
detected by light microscopy. Because lamellipodia structures are involved in the 
process of cell migration, this led us to hypothesize that PAK4 may not only interact 
with αvβ5, but that PAK4 may also influence integrin-mediated motile events.  
The potential effect of PAK4 on αvβ5-mediated cell motility was therefore examined 
using a Transwell haptotactic cell migration assay. The results indicated that PAK4 
specifically induced integrin αvβ5-mediated MCF-7 human breast carcinoma cells 
motility. Given that cell adhesion strongly affects cell migration, it was interesting to 
examine whether PAK4 may also impact cell adhesion on VN. Our cell adhesion data 
showed that MCF-7 cells expressing EGFP-PAK4 showed a markedly decreased cell 
adhesion on VN compared to EGFP-transfected cells. However, over-expression of 
PAK4 did not change the abundance of integrin αvβ5 expression on the cell membrane. 
This suggests that PAK4 inhibition of cell adhesion might be caused by an alteration of 
integrin αvβ5 binding capacity for its ligand VN. 
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Taken together, this study suggests that PAK4 binds to the integrin β5 cytoplasmic 
domain in motile cellular structures and that PAK4 modulates integrin αvβ5-mediated 
cell adhesion and migration. This may be brought about by PAK4 regulation of 
cytoskeletal components and/or by directly influencing integrin αvβ5 function, thereby 
modulating cell migration.  
In this study, we concluded that:  
1. PAK4 can directly interact with the integrin β5 subunit cytoplasmic tail. 
2. PAK4 translocates to the lamellipodia upon integrin ligation to VN. 
3. PAK4 selectively induces αvβ5-mediated cell motility. 
4.2 Paper II:  
Integrin-mediated cell attachment induces a PAK4-dependent feedback loop regulating 
cell adhesion through modified integrin αvβ5 clustering and turn-over. 
Cell adhesion to the ECM induces integrin activation and triggers a variety of 
intracellular signaling cascades, including the activation of PAK1 (Price et al., 1998). 
By using an in vitro kinase assay, we found that PAK4 could also be activated by 
replating of cells onto the ECM ligand VN using two different cell lines (COS-7 and 
MCF-7 cells). To examine whether cell attachment-induced PAK4 activation may play 
a role in integrin αvβ5-mediated cellular functions, we performed cell adhesion and 
migration assays using the human breast carcinoma MCF-7 cell line (which expresses 
only integrin αvβ5 as its VN receptor) with either over-expression or RNAi-mediated 
depletion of PAK4. The results were consistent with our previous results showing that 
wt PAK4 over-expression reduced cell adhesion capacity and enhanced cell migration 
(Zhang et al., 2002). Conversely, knock-down of PAK4 increases cell adhesion and 
reduces cell migration. These results further suggest that PAK4 plays an important role 
in the regulation of integrin αvβ5-mediated cell adhesion and migration (Zhang et al., 
2002; Ahmed et al., 2008). 
Cell motility is closely related to cell spreading. Although over-expression of PAK4 
markedly promoted cell migration onto VN (Zhang et al., 2002) and a hyper-active 
PAK4 mutant caused cell rounding (Qu et al., 2001). It has therefore been unclear to 
what extent PAK4 may affect cell spreading. To this end, we quantitatively compared 
the area of MCF-7 cells either over-expressing PAK4 or with PAK4 knocked-down by 
shRNA, after re-plating onto VN. We observed that PAK4 over-expression reduced cell 
spreading capacity, while knock-down of PAK4 markedly induced cell spreading. 
Thus, our findings indicate a clear role for PAK4 in the regulation of carcinoma cell 
spreading.  
Integrin-mediated cell-matrix adhesion complex (CMAC) dynamics are critically 
involved in cell migration (Huttenlocher et al., 1996; Lock et al., 2008). Based on the 
physical and functional correlations between cell motility and the PAK4-integrin β5 
interaction, we hypothesized that PAK4 may play a role in regulating CMAC 
dynamics. Accordingly, we performed detailed, quantitative, imaging-based analyses of 
the impact of PAK4 in hundreds of cells and on several thousand cell-matrix adhesion 
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complexes. We focused on the impact of PAK4 on peripheral CMACs, defined as those 
found within 5 µm of the cell border, because this region gives rise to the key 
assemblages of cell motility, including lamellipodia and filopodia (Wehrle-Haller and 
Imhof, 2003). Our findings indicated that PAK4 over-expression causes a general 
depletion of CMAC number, size, integrin clustering density and integrin-to-F-actin 
connectivity, with an especially potent effect on the development of larger adhesion 
complexes. This is implying a key role for PAK4 in the inhibition of CMAC formation 
and particularly on the maturation of focal adhesions (FAs). Importantly, PAK4-
shRNA expression caused a marked increase in the number and size of CMACs, 
enhanced integrin clustering, with small CMACs displaying a higher integrin clustering 
density. PAK4 knock-down also significantly increased the amount of F-actin recruited 
to CMACs, implying enhanced connectivity of these complexes to the actin 
cytoskeleton, as compared to control cells. Overall, CMACs in the absence of PAK4 
matured more efficiently, as denoted by enhanced integrin clustering with respect to 
CMAC area, as well as more frequently and with greater actin connectivity than 
CMACs in control shRNA expressing cells.  
Although PAK1 has been suggested to regulate overall CMAC stability (Manser et al., 
1997; Kiosses et al., 1999; Stofega et al., 2004), it has been unclear whether PAKs may 
affect integrin turn-over within existing CMACs. Given that mature, relatively stable 
FAs have been shown to display higher integrin turn-over rates than smaller/more 
immature and less stable FCs (Ballestrem et al., 2001; Wehrle-Haller and Imhof, 2003), 
the inhibitory effect of PAK4 on CMAC maturation was expected to correlate with 
decreased integrin turn-over. However, surprisingly, PAK4 over-expression accelerated 
integrin turn-over as determined by fluorescence recovery after photo-bleaching 
(FRAP) analysis.  
Combined with data indicating reduced CMAC number, size, density and F-actin 
connectivity, these findings clearly identify a role and plausible mechanism for PAK4 
in the destabilization of αvβ5-mediated CMACs, ultimately resulting in reduced cell-
ECM adhesion strength. Together, our data show that PAK4 is activated by integrin 
αvβ5 ligation to VN, and that active PAK4 can then act to de-stabilize integrin-
mediated adhesion structures to limit cellular adhesion levels. This biological circuit 
represents a novel auto-inhibitory feedback loop that is intrinsic to the core machinery 
of cell adhesion, providing cells the capacity to autonomously tune and optimize total 
cell-extracellular matrix adhesion levels. 
In this study, we concluded that:  
1. PAK4 can be activated by the cell ligation to integrin αvβ5 ligand vitronectin. 
2. Activated PAK4 in turn regulates integrin αvβ5-mediated MCF-7 cell adhesion, 
spreading and migration.   
3. PAK4 enhances integrin αvβ5 molecular turn-over within CMACs, thereby de-
stabilizing these CMACs and likely causing the inhibition of integrin clustering, 
as well as of CMAC maturation and F-actin association.  
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4. PAK4 is also shown to act upon integrin αvβ5 in environments that are devoid 
of detectable actin connectivity, such as in nascent CMAC clusters and outside 
of detectable CMACs, thereby supporting an actin-independent integrin 
regulatory capacity.  
4.3 Paper III:  
p21-activated kinase 4 phosphorylation of integrin β5 Ser 759 and Ser 762 regulates 
cell migration. 
Cytoplasmic tails of integrins play key roles in a variety of integrin-mediated events 
including adhesion and migration (Hynes, 2002). We previously found a role for PAK4 
in selective regulation of integrin αvβ5-mediated cell motility (paper I) (Zhang et al., 
2002). However, whether PAK4 promotes cell motility through its interaction with 
integrin αvβ5 and/or its effects on the actin cytoskeleton remained unclear. In this 
paper, we focus on the molecular mechanisms of this regulation. Firstly, we fine 
mapped the PAK4 binding site in the integrin β5 cytoplasmic tail and identified a 
unique PAK4-binding membrane-proximal integrin β5-SERS-motif. We then tested the 
potential role of the integrin β5 SERS-motif in the regulation of cell adhesion and 
migration. We found that this integrin β5-SERS-motif was indeed involved in 
controlling cell attachment and migration. 
Secondly, we aimed to clarify whether PAK4 kinase activity and/or its integrin-binding 
capacity may be responsible for PAK4-induced cell migration. In paper I, we identified 
an integrin binding domain (IBD) of 29 amino acids in the PAK4 C-terminal region 
(Zhang et al., 2002). By an in vitro kinase assay and GST pull-down experiments 
combined with mutational and functional analyses, we found that PAK4 binding to 
integrin β5 was not sufficient to promote cell migration, but that PAK4 kinase activity 
was required for the PAK4 promotion of cell motility. 
Phosphorylation of integrin cytoplasmic tails has been proposed as a means to regulate 
integrin functions (Fagerholm et al., 2004). Given the role of PAK4 kinase activity in 
the promotion of cell motility, we examined potential PAK4-mediated phosphorylation 
of the integrin β5 cytoplasmic tail. We found that the β5 cytoplasmic domain was a 
specific substrate for PAK4 in vitro. Furthermore, we identified two distinct PAK4 
phosphorylation sites at serine residues within the membrane-proximal PAK4-binding 
SERS motif (amino acids Ser 759 and Ser 762). Finally, we found that integrin β5 Ser 
759 and Ser 762 are critical for PAK4-induced cell motility and that PAK4-mediated 
phosphorylation of the β5 cytoplasmic tail appears to regulate cell motility. This may 
contribute to the understanding of intracellular signaling behind vascular permeability, 
angiogenesis and carcinoma cell dissemination where activation of integrin αvβ5 has 
been found to be involved (Lewis et al., 1996; Brooks et al., 1997; Eliceiri et al., 2002).   
In this study, we concluded that:  
1. A unique PAK4-binding membrane-proximal integrin β5-SERS-motif was 
identified. 
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2. The integrin β5-SERS-motif was involved in controlling cell attachment and 
migration. 
3. The β5 cytoplasmic tail SERS-motif can be phosphorylated by PAK4. 
4. Phosphorylation of the SERS-motif in the integrin β5 cytoplasmic tail is critical 
for PAK4-induced integrin αvβ5-mediated carcinoma cell motility.  
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5 Conclusions 
In this thesis, we demonstrated functional mechanisms by which PAK4’s interaction 
with integrin β5 regulates cancer cell adhesion and motility. Our studies suggest a 
model wherein signaling is initiated by cell adhesion to VN, leading to the translocation 
of PAK4 from the cytosol to lamellipodia where PAK4 is activated. Activated PAK4 
can then phosphorylate the integrin β5 cytoplasmic domain. This reduces CMAC 
number and size, enhances integrin turnover, inhibits integrin clustering and limits the 
association of F-actin with CMACs. Exactly how PAK4 may regulate the dynamic 
linkage between CMACs and F-actin needs to be further investigated. Nonetheless, this 
array of molecular level effects cumulatively reduces total cell adhesion, while 
simultaneously facilitating enhanced cell migration (Figure 12). Conceptually, this 
overall mechanism represents a regulatory negative feedback loop that is initiated by 
cell adhesion to VN and functions thereafter to limit the level of cell adhesion to VN 
(Figure 13). This indicates that PAK4 may form part of a tuning mechanism that 
contributes to the optimization of cell adhesion levels, with strong resulting effects on 
migration capacity. 
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Figure 12: Regulatory impact of PAK4 at molecular and cellular levels. A. At the cellular level, when 
cells in suspension (A-a) are replated and attach onto ECM at an early stage (A-b and c), PAK4 is 
translocated into lamellipodia in cells over-expressing PAK4 (+PAK4; A-b). At the late attachment stage, 
PAK4 reduces cell attachment, inhibits cell spreading and induces cell migration in cells over-expressing 
PAK4 (+PAK4; A-d) compared with control cells (-PAK4; A-e). B. At the molecular level, integrin is 
initially in the inactive state (B-a). Ligand-binding to the extracellular domain of integrins induce integrin 
activation, integrin outside-in signaling pathways and integrin clustering (B-b and c). The outside-in 
signaling may facilitate the translocalisation of PAK4 from the cytosol to lamellipodia, as well as 
activation of PAK4 (B-b). Activated PAK4 can in turn phosphorylate the integrin β5 cytoplasmic domain 
and may cause reduction of CMAC number, size and density, as well as inhibition of F-actin-CMAC 
connectivity (B-d). Thus, PAK4 may induce cell motility through regulating cell-ECM adhesion strength 
by reducing ECM to CMAC connectivity (as indicated by the red arrows in d and e).   
 
Figure 13: PAK4 is part of a negative feedback loop that limits cell adhesion levels. 
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6 Relevance and perspectives 
PAK4-mediated regulation of cell migration can contribute to cancer invasion and 
metastasis. It will therefore be important to elucidate the role of PAK4 in cancer 
invasion in 3D environments and metastasis in animal models. Pak4 knock-out mice 
die in early embryogenesis, indicating that PAK4 is important for early embryonic 
development (Qu et al., 2003). PAK4 conditional knock-out mice have been 
constructed, allowing the role for PAK4 to be studied in specific tissues (Liu et al., 
2008). A future challenge is to further elucidate PAK4 biological function in vivo.  
Protein kinases currently constitute a major focus for drug discovery with most major 
pharmaceutical companies developing inhibitors. In recent years, a number of protein 
kinase inhibitors have successfully been taken through clinical trials to enter clinical 
practice. Our studies indicate that PAK4 kinase activity is critical for its function in 
regulation of cell migration (Zhang et al., 2002; Li et al., 2010c). Although a number of 
components can activate PAK4, such as VN, HGF and KGF (Wells et al., 2002; Lu et 
al., 2003; Ahmed et al., 2008; Li et al., 2010b), the mechanism of PAK4 activation is 
still unclear. It is of importance to elucidate the precise mechanism of regulation of 
PAK4 kinase activity. Development of PAK4 kinase inhibitors may also facilitate new 
therapy for cancer. An optimal phosphorylation sequence (RRRRRSWASP) for the 
group II PAKs has been identified by use of a positional scanning peptide library 
approach (Rennefahrt et al., 2007). The data provided by peptide library screening may 
help to identify PAK4-specific phosphorylation sites to identify additional PAK4 
substrates. 
In addition, a couple of PAK4 down-stream effectors have been identified and they 
control a variety of cellular functions in different signaling pathways including cell 
survival, tumorigenesis and cell motility as described in the introduction section of this 
thesis (Eswaran et al., 2009). Those studies also indicate that PAK4 has a more 
complex role in regulation of the cell migration (Wells and Jones, 2010). The molecular 
mechanism of PAK4 in regulation on cell motility, however, still has to be clarified. 
Therefore, it is important for future studies to focus on the role of PAK4 in dynamic 
regulation of cell motility in the different steps of cell migration.   
A “clutch” model describes temporal-spatial regulation of the connection between F-
actin forces and substrate adhesion in the process of cell migration (Giannone et al., 
2009). Focal adhesion adaptor proteins provide a dynamic link between F-actin and 
adhesion complexes, such as vinculin and paxillin (Humphries et al., 2007). We have 
observed that PAK4 inhibits focal adhesion-actin cytoskeleton connections, suggesting 
a potential clutch role for PAK4. However, how PAK4 may be involved in the 
regulation of the clutch between F-actin and adhesion complexes remains to be 
determined. 
Integrin cytoplasmic tails play  important roles in integrin-mediated cellular functions 
(Thiery, 2003; Berrier and Yamada, 2007; Streuli, 2009). In recent years, many cellular 
proteins have been identified that directly or indirectly interact with integrin 
cytoplasmic tails and this number of  CMAC proteins will continue to grow (Zaidel-Bar 
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et al., 2007). Further studies will be needed to understand how integrins are regulated in 
vivo. It is becoming increasingly clear that CAMC components that can interact with 
integrin cytoplasmic tails are involved in modulating integrin function. A current 
challenge is to characterize the effects CMAC components have and to try and 
understand how CMACs are regulated at the systems level. This may lead to new 
insights that can be used to provide better clinical therapy for cancer metastasis.  
Indeed, some integrin inhibitors, such as cilengitide (an inhibitor of both αvβ3 and 
αvβ5 integrins) have been used in preclinical and clinical trials (Smith et al., 1990; 
Alghisi and Ruegg, 2006). In preclinical studies, the cilengitide effectively inhibited 
angiogenesis and the growth of orthotopic glioblastoma (Yamada et al., 2006). So far, 
treatment with cilengitide in late-stage glioblastoma patients has shown extending 
patient survival with minimal side effects (Nabors et al., 2007; Reardon et al., 2008; 
Desgrosellier and Cheresh, 2010). An oral PAK4 inhibitor, PF-03758309 has also been 
tested in clinical phase I trials, but these trials have been discontinued for reasons not 
made public. 
PAK4 is over-expressed in an array of different cancers, involves in various oncogenic 
signaling pathways and links to promote cell survival, growth, tumorigenesis  and 
metastasis (Callow et al., 2002; Li and Minden, 2005; Kimmelman et al., 2008; 
Eswaran et al., 2009; Siu et al., 2010). Based on these studies, PAK4 appears to be a 
critical effector in cancer. Our data revealed novel signaling by PAK4 to regulate of 
cell motility and provides new insights to understand molecular mechanisms involved. 
In future studies, elucidating the role of PAK4 in caner invasion and metastasis in 3D 
and animal models will allow the hypotheses generated by this thesis to be tested in 
more physiological systems. Such refinement of our knowledge of PAK4’s function 
will hopefully be useful for therapeutic development of PAK4 targeting compounds. 
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p21-activated kinase 4 interacts with integrin 
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and regulates 
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5-mediated cell migration
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21-activated kinase 1 (PAK1) can affect cell migration
(Price et al., 1998; del Pozo et al., 2000) and modulate
myosin light chain kinase and LIM kinase, which are
components of the cellular motility machinery (Edwards,
D.C., L.C. Sanders, G.M. Bokoch, and G.N. Gill. 1999.
Nature Cell Biol. 1:253–259; Sanders, L.C., F. Matsumura,
G.M. Bokoch, and P. de Lanerolle. 1999. Science. 283:
2083–2085). We here present a novel cell motility pathway
by demonstrating that PAK4 directly interacts with an integrin
intracellular domain and regulates carcinoma cell motility
in an integrin-speciﬁc manner. Yeast two-hybrid screening
identiﬁed PAK4 binding to the cytoplasmic domain of the
integrin
 
5 subunit, an association that was also found in
mammalian cells between endogenous PAK4 and integrin
p
 
v
 
5. Furthermore, we mapped the PAK4 binding to the
membrane-proximal region of integrin 
 
5, and identiﬁed
an integrin-binding domain at aa 505–530 in the COOH
terminus of PAK4. Importantly, engagement of integrin
 
v
 
5 by cell attachment to vitronectin led to a redistribution
of PAK4 from the cytosol to dynamic lamellipodial structures
where PAK4 colocalized with integrin 
 
v
 
5. Functionally,
PAK4 induced integrin 
 
v
 
5–mediated, but not 
 
1-mediated,
human breast carcinoma cell migration, while no changes
in integrin cell surface expression levels were observed. In
conclusion, our results demonstrate that PAK4 interacts
with integrin 
 
v
 
5 and selectively promotes integrin 
 
v
 
5–
mediated cell migration.
Introduction
The p21-activated kinase (PAK)* family contains homologous
serine/threonine protein kinases that can act as downstream
effectors of the small GTPases Cdc42 and Rac (Lim et al.,
1996; Bagrodia and Cerione, 1999; Bar-Sagi and Hall, 2000).
So far, six human PAKs (hPAKs) have been identified, and
based on homology, they can be classified into two groups:
group I including PAK1–3 and group II including PAK4–6
(Dan et al., 2001b). A marked difference between the two
PAK groups is the autologous inhibitory sequence in the
NH2-terminal regulatory domain found in group I PAKs,
with no obvious homologous sequence in group II (Dan et
al., 2001b). Due to the presence of an inhibitory sequence
that binds to the COOH terminus of group I PAKs, PAK1
displays little or no endogenous kinase activity, but can be
activated by the presence of GTP-bound active Cdc42 or
Rac, which opens up the folded structure of PAK1 (Lei et
al., 2000). PAK1 is known to regulate cell morphology and
cytoskeletal reorganization (Sells et al., 1997). Further-
more, membrane-targeted PAK1 has been found to induce
neurite outgrowth from PC12 cells (Daniels et al., 1998).
In fibroblasts, activated PAK1 has been shown to localize
in the leading edge of motile cells (Sells et al., 1999), and
in human endothelial cells, PAK1 has been suggested to
coordinate the formation of new substrate adhesions at the
front of the cell with contraction and detachment at the rear
(Kiosses et al., 1999), indicating that PAK1 may be involved in
the regulation of cell motility.
PAK4 is the first identified member of the group II
PAKs, and is implicated in cytoskeletal reorganization and
filopodia formation (Abo et al., 1998). Importantly, PAK4
was recently found to be overexpressed in 78% of a variety
of human cancer cell lines, an overexpression that might be
mediated by gene amplification and may play a role in Ras-
mediated transformation (Callow et al., 2002). In addition,
overexpression of a hyperactive PAK4 mutant can protect
cells from apoptosis induced by TNF
 
 (Gnesutta et al.,
2001). The capability of PAK4 to promote cell survival is
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shared with PAK1, but the anti-apoptotic properties of
PAK1 and PAK4 may be mediated by distinct mechanisms
(Schurmann et al., 2000; Gnesutta et al., 2001). In addi-
tion, hyperactive PAK4 is able to transform fibroblasts to
grow in soft agar in an anchorage-independent manner
(Qu et al., 2001), perhaps in part due to it’s ability to pro-
mote cell survival.
Integrins are heterodimeric transmembrane receptors and
the major group of receptors for ECM proteins. Integrins are
essential during development, in tissue homeostasis, and in
the progression of various diseases (Hynes, 1992; Giancotti
and Ruoslahti, 1999). By mediating cellular attachment to
ECM, integrins are also a central part of the cellular motility
machinery, where they are regulated by intracellular signaling
molecules, which influence integrin localization, clustering,
and binding to the ECM. In addition, integrin engagement
to the ECM initiates various signaling events, e.g., activation
of the ERK1/2 pathway, which is also important for the reg-
ulation of cell motility (Giancotti and Ruoslahti, 1999).
Previous studies have shown that 
 
v integrins are up-
regulated or activated in migratory and invasive mecha-
nisms in vivo, including wound healing, angiogenesis,
and metastasis (Felding-Habermann and Cheresh, 1993;
Brooks et al., 1994; Friedlander et al., 1995; Strömblad et
al., 1996; Brooks et al., 1997). Integrin 
 
v
 
5 is the pre-
dominant vitronectin (VN) receptor for carcinoma cells in
vivo, because most carcinoma specimens from patients ex-
press
 
v
 
5 but not 
 
v
 
3 (Lehmann et al., 1994; Jones et
al., 1997). Importantly, integrin 
 
v
 
5 has been found to
be functionally involved in growth factor–induced carci-
noma cell migration in vitro and metastasis in vivo (Klemke
et al., 1994; Yebra et al., 1996; Brooks et al., 1997).
Furthermore, activation of integrin 
 
v
 
5 is implicated in
VEGF-induced angiogenesis (Friedlander et al., 1995). In
this report, we present a novel role for PAK in cell motility.
We found that PAK4 directly interacts with the integrin
 
5 subunit and specifically regulates 
 
v
 
5-mediated cell
migration.
Table I. Identified interactors with human integrin 
 
5 subunit cytoplasmic domain by yeast two-hybrid screening
Interacting cDNA clones Number of clones GenBank/EMBL/DDBJ accession no.
PAK4 6 AJ011855
Myosin X 5 AJ249706
Bodenin (ICAP) 3 AJ001373
Miz-1 9 AF039567
Mouse cDNA clone 1 AA445617
Mouse myotubes MPLRB5 1 AA816006
Six clones were identical to mPAK4. Five clones represented mouse myosin-X (Yonezawa et al., 2000) and bodenin is the mouse version of human integrin
cytoplasmic domain–associated protein (ICAP) (Faisst and Gruss, 1998). Miz-1 is a Myc-interacting zinc finger protein (Seoane et al., 2001). The other two
clones have unknown functions.
Figure 1. PAK4 interacts with the 
integrin 5 subunit. (A) Amino acid 
sequence comparison of mPAK4 KD, 
found by the yeast two-hybrid screening 
with hPAK4, Drosophila MBT (MBT), and 
hPAK1 KDs. Dashes stand for identical 
amino acids and the variations of amino 
acids are indicated by letters in hPAK4, 
MBT, and hPAK1 sequences. The 
mPAK4 KD is numbered according to 
that of hPAK4 (Abo et al., 1998). (B) 
PAK4 association with integrin 5 in 
GST pull-down assays. GST–PAK4 KD 
fusion protein pulled down endogenous 
integrin 5 in cell lysates (top panel). 
GST–5 cytoplasmic domain fusion 
protein pulled down overexpressed HA–
PAK4 (bottom). The positive controls 
represent Western blot of the input lysates 
for marking the size and showing the 
presence of integrin 5 and PAK4. (C) PAK4 association with integrins in living cells. (C, top) Anti–integrin 
3 mAb AP3 and anti–integrin v5 mAb P1F6 coimmunoprecipitation of PAK4 in COS-7 cells expressing 
HA–PAK4. (C, middle and bottom) An anti-HA mAb coimmunoprecipitated HA–PAK4 with both v and 5
integrin subunits. The positive controls represent Western blot of the input lysates for marking the size and 
showing the presence of integrins and PAK4. (D) Association of endogenous PAK4 with endogenous integrin 
v5 in MCF-7 cells analyzed by IP. IP using rabbit IgG or -Rab1 are negative controls.
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Results
PAK4 directly interacts with the integrin 
 
5 subunit 
cytoplasmic domain
By means of yeast two-hybrid screening of a 19-d mouse
embryo cDNA library and following remating tests, we
identified six known or hypothetic proteins specifically in-
teracting with the human integrin 
 
5 cytoplasmic domain
(Table I). 25 clones were found to interact with the integrin
 
5 cytoplasmic domain. Sequence analysis revealed that six
of these mouse cDNA clones encoded a sequence highly ho-
mologous to hPAK4 kinase domain (KD), and were there-
fore identified as mouse PAK4 (mPAK4), which strongly
and specifically interacted with integrin 
 
5 cytoplasmic do-
main in the repeated yeast mating tests (unpublished data).
An aa sequence comparison of the KD of mPAK4 with
hPAK4, hPAK1, and the Drosophila PAK homologue mush-
room body tiny gene product (MBT) (Melzig et al., 1998) is
shown in Fig. 1 A. mPAK4 KD shares 98% homology in aa
sequence with hPAK4 KD, 83% with MBT KD, and 56%
with hPAK1. The interaction of PAK4 with integrin 
 
5 was
then further analyzed by independent biochemical methods
both in vitro and in living cells. In GST pull-down assays,
we found an association of integrin 
 
5 from cell lysates to a
purified GST-fused PAK4 KD and of PAK4 to a purified
GST-fused
 
5 cytoplasmic domain (Fig. 1 B). In addition,
HA-tagged PAK4 was coimmunoprecipitated with integrins
 
3 and 
 
v
 
5 in living cells (Fig. 1 C, top). In Fig. 1 C, the
 
3 immunoprecipitation (IP) appears to bring down more
PAK4 than the IP for 
 
v
 
5. However, the expression levels
of the two integrins are different (unpublished data) and the
two antibodies used may be differently efficient for IP.
Therefore, differences in PAK4 amounts in this IP cannot
be used to indicate relative binding strengths. Furthermore,
the reverse IP of HA–PAK4 brought down both integrin 
 
v
and
 
5 subunits from a cell lysate (Fig. 1 C, middle and bot-
tom), whereas IP of an irrelevant HA-tagged p21CIP1 did not
(unpublished data). Importantly, by IP we also found an as-
sociation of endogenous PAK4 with endogenous integrin
 
v
 
5 in living cells (Fig. 1 D).
PAK4 interacts with the membrane-proximal region 
of the integrin 
 
5 cytoplasmic domain
To determine which region within the integrin cytoplasmic
domain interacts with PAK4, we generated cDNAs encoding
various regions of the cytoplasmic domain of integrin 
 
5 by
PCR and cloned them into the bait vector pEG202. Yeast
mating experiments were performed using a prey vector that
contains PAK4 KD (aa 239–591) and the various bait vec-
tors. The PAK4-binding region was mapped to aa 759–767
within the integrin 
 
5 cytoplasmic domain (Fig. 2 A). Fur-
thermore, association of endogenous PAK4 to the mem-
brane-proximal region of integrin 
 
5 subunit was verified by
a GST pull-down assay (Fig. 2 B), in which PAK4 associated
with GST–
 
5 cytoplasmic domain, but not with a GST–
 
5
deletion mutant lacking the PAK4-binding region identified
by yeast mating tests. Amino acid sequences of other integrin
 
 subunits corresponding to the PAK4-binding region of in-
tegrin
 
5 cytoplasmic domain were aligned (Fig. 2 C), dis-
playing a moderate sequence homology.
Integrin
 
5 interacts with a PAK4 
COOH-terminal region
To determine the region within PAK4 that interacts with the
integrin
 
5 cytoplasmic domain, we generated cDNAs en-
coding various regions of the PAK4 KD that were amplified
by PCR and cloned into the prey vector pJG4-5. Yeast mat-
ing experiments were performed using a bait vector that con-
tains the integrin 
 
5 cytoplasmic domain (aa 753–799) and
the various prey vectors. We mapped the integrin-binding
region to aa 505–530 within the PAK4 KD by yeast two-
hybrid mating tests (Fig. 3 A), and further confirmed the re-
quirement of this region of PAK4 for association with inte-
grin
 
v
 
5 in mammalian cells by IP using a PAK4 deletion
mutant (Fig. 3 B). Therefore, we denote this region as the in-
tegrin-binding domain (IBD) in PAK4. The aa sequences of
other PAK family members, including the Drosophila PAK4
homologue MBT, were aligned in comparison with the
PAK4 IBD (Fig. 3 C). The IBD region is highly homologous
among PAK family members, suggesting that family mem-
Figure 2. Mapping of the PAK4 binding region 
within the integrin 5 cytoplasmic domain.
(A) Mapping of the PAK4-binding region in the 
integrin 5 cytoplasmic domain. Various regions 
of the integrin 5 cytoplasmic domain were 
cloned into the bait vector pEG202 and then 
mated with PAK4 KD in the prey vector in a 
yeast two-hybrid assay. The PAK4 binding region 
was mapped to aa 759–767 of the 5 cyto-
plasmic domain. (B) Association of endogenous 
PAK4 with the membrane-proximal region 
within integrin 5 cytoplasmic domain was 
examined by a GST pull-down assay, including 
GST fused to a 5 deletion mutant lacking the 
PAK4-binding region mapped by yeast two-
hybrid analysis. (C) Sequence comparison of 
the PAK4-binding region of integrin 5 with 
other integrin cytoplasmic domains (top). The 
Rack1- (Liliental and Chang, 1998) and PAK4-
binding regions within integrin 5 are indicated 
(bottom).
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bers other than PAK4 might also hold the capacity to bind to
integrin cytoplasmic domains. In addition, a schematic illus-
tration of known PAK4 functional motifs indicates the loca-
tion of IBD within the PAK4 KD (Fig. 3 D).
Translocation of PAK4 to lamellipodia by integrin 
ligation to VN and colocalization with integrin v5
Given that PAK4 associates with integrin v5, we ana-
lyzed the effect on cellular distribution of endogenous
PAK4 by v5-mediated attachment to VN in MCF-7
cells, which exclusively use integrin v5 for attachment to
VN (unpublished data). Before replating, we observed a cy-
tosolic distribution of PAK4 in MCF-7 cells under normal
culture conditions (Fig. 4 A). We then examined the en-
dogenous PAK4 distribution after replating cells onto VN.
Interestingly, we found a remarkable redistribution of
PAK4 to forming lamellipodial structures in the cellular pe-
riphery as early as 10 min after replating on VN. With
longer cell attachment, PAK4 was distributed into mem-
brane ruffles and leading edges. However, cells replated
onto poly-L-lysine (PLL) that are attached in an integrin-
independent manner remained unspread with PAK4 dis-
Figure 3. Mapping of the integrin 5–binding region within the 
PAK4 KD. (A) Various regions of the PAK4 KD were cloned into the 
prey vector pJG4-5 and then mated in a yeast two-hybrid assay with 
the integrin 5 cytoplasmic domain in the bait vector. Amino acids 
505–530 in the PAK4 KD were identified as the responsible region 
for interaction with the integrin 5 cytoplasmic domain. Therefore, 
PAK4 aa 505–530 is designated as the IBD. (B) PAK4-IBD with 
deletion of aa 505–530 was incapable to associate with integrin 
v5 in mammalian cells, as examined by an IP analysis. Lower 
panel shows expression levels of PAK4 and PAK4-IBD in lysates 
used for IP. (C) The corresponding sequences in other PAK family 
members are compared with PAK4 IBD with identical amino acids 
in bold. (D) Schematic illustration of the PAK4 structure, including 
the Cdc42/Rac interactive domain ATP-binding domain, IBD, and 
KD within PAK4.
Figure 4. Relocalization of PAK4 to the cell membrane and 
colocalization of PAK4 and integrin v5 in MCF-7 cells.
(A) MCF-7 human breast carcinoma cells, under normal culture 
conditions or replated onto VN or PLL for indicated times, were 
stained for endogenous PAK4 using an anti-PAK4 pAb (green), 
for actin using phalloidin–rhodamine (red), and for nuclei by 
Hoechst (blue). Arrowheads indicate PAK4 localized to lamellipodia 
or ruffles after replating onto VN. (B) MCF-7 cells were replated 
onto VN and costained for endogenous PAK4 (green) and 
endogenous integrin v5 (red). In the top panel (30 min after 
replating), integrin v5 was found at lamellipodia (arrowheads). 
In the bottom panel (60 min after replating), integrin v5 has 
started to form focal complexes at lamellipodia where it colocalized 
with PAK4 (arrowheads). Bars, 10 m.
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tributed in the cytosol (Fig. 4 A). The fact that attachment
to VN is mediated by integrin v5, whereas attachment to
PLL is integrin independent, indicates that integrin ligation
may specifically stimulate relocalization of PAK4 to lamelli-
podia. Importantly, the redistribution of PAK4 upon cell
attachment may allow PAK4 to associate with integrins in
lamellipodia, which are sites of integrin attachment to the
underlaying ECM. In addition, we observed a similar relo-
calization of PAK4 in M21 human melanoma cells and
ECV 304 human bladder carcinoma cells (unpublished
data), suggesting that the relocalization of PAK4 upon re-
plating onto VN occurs in various cell types.
To examine whether the lamellipodia-localized PAK4
could physically meet with integrin v5 at the cell mem-
brane, we replated MCF-7 cells onto VN and costained the
cells for endogenous PAK4 and endogenous integrin v5.
As shown in Fig. 4 B, PAK4 and integrin v5 colocalized
in lamellipodia shortly after replating onto VN. PAK4 may
therefore be able to engage in integrin-mediated cellular
functions.
Relocalization of PAK4 to lamellipodia does not 
require its kinase activity, integrin interaction, 
or Cdc42/Rac binding
Given that PAK4 undergoes membrane relocalization upon
attachment onto VN, it was of interest to elucidate whether
the relocalization of PAK4 is dependent on its integrin or
Cdc42/Rac interaction and/or its kinase activity. Therefore,
Figure 5. PAK4 translocation to lamellipodia 
by integrin ligation to VN does not depend on 
Cdc42 binding, integrin interaction, or PAK4 
kinase activity. (A) Flag-tagged PAK4 mutants 
used for translocation studies. PAK4-L19, 22 
lacks binding capacity to Cdc42/Rac. PAK4-
M350 and PAK4-IBD are both kinase dead, 
and PAK4-IBD cannot bind integrin 5.
(B) M21 cells were transfected with Flag-tagged 
wt PAK4, PAK4 mutants, or the control Flag-BAP 
vector. Cells were stained using an anti-Flag 
mAb (green), and stained for actin using 
phalloidin–rhodamine (red) and for nuclei using 
Hoechst (blue) before (B) or after (C) replating 
onto VN for 1 h. Arrows indicate the distribution 
in lamellipodia of PAK4 and PAK4 mutants. 
Bars, 20 m. (D) Quantification of membrane-
localized wt PAK4 or PAK4 mutants before and 
after replating onto VN for 1 h. Bars represent 
percent of cells with membrane-localized wt 
PAK4 or PAK4 mutants of the total cells 
counted and are expressed as mean  SD. In a 
statistical evaluation comparing before and after 
cell replating onto VN, all PAK4 variants gave 
P  0.05 (*) or P  0.01 (**) by a paired t test. 
PAK4-L19, 22 localization to the membrane 
was also higher than wt PAK4 under normal 
culture conditions (P  0.05 [*]).
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we constructed Flag-tagged PAK4 mutants that lack the
binding capacity for Cdc42/Rac (PAK4-L19, 22), the IBD
(PAK4-IBD), or PAK4 kinase activity (PAK4-M350) as il-
lustrated in Fig. 5 A. Human M21 melanoma cells were
transfected with these PAK4 mutants and compared with
cells transfected with wild-type (wt) Flag–PAK4 and a vector
containing a nonrelated Flag-tagged BAP protein. Under
normal culture conditions, wt PAK4 mainly localized in the
cytosol (Fig. 5 B). However, upon cell replating onto VN,
the majority of cells transfected with PAK4 displayed a relo-
calization to lamellipodia (Fig. 5 C). A similar relocalization
to lamellipodia upon replating was also observed for the ki-
nase-dead and IBD PAK4 mutants, both of them lacking
kinase activity (unpublished data) and PAK4-IBD also
lacking integrin-binding capacity (Fig. 3 B). However, the
PAK4-L19, 22 that lacks GTPase-binding capacity was
found in lamellipodia in almost half of the cells in regular
culture and was then redistributed to the membrane in the
remaining cells upon replating onto VN. A quantification of
the PAK4 relocalization by counting the number of cells
with membrane-localized PAK4 is displayed in Fig. 5 D.
Taken together, these results suggest that PAK4 relocaliza-
tion to lamellipodia does not require its kinase activity or in-
tegrin or Cdc42/Rac binding. However, the Cdc42/Rac
binding capacity of PAK4 might be inhibitory for PAK4 lo-
calization in lamellipodia.
Dynamic distribution of PAK4 
in actively reshaping lamellipodia
To study the temporal and spatial localization of PAK4 in
living cells, we established MCF-7 human breast carci-
noma cells stably expressing a fluorescent EGFP–PAK4
fusion protein. These cells were plated onto VN-coated
glass slides and analyzed by time-lapse fluorescent micros-
copy. Consistent with our immunofluorescent staining of
endogenous PAK4 lamellipodial localization in MCF-7
cells (Fig. 4 A) and of Flag-tagged PAK4 (Fig. 5), EGFP–
PAK4 also localized in lamellipodial protrusions after re-
plating onto VN (Fig. 6 A). Interestingly, the PAK4 dis-
tribution changed in a highly dynamic fashion, whereas
EGFP control cells exhibited only cytoplasmic and nu-
clear or perinuclear distribution (Fig. 6 B). Furthermore,
like endogenous PAK4 (Fig. 4 B), EGFP–PAK4 was also
found to partially colocalize with integrin v5 in lamelli-
podia (unpublished data). The transient localization of
PAK4 in lamellipodia coinciding with lamellipodia of ac-
tively forming and retracting extensions indicates that
PAK4 may modulate these processes. Given that PAK4 as-
sociated with integrin v5 and colocalized with integrin
v5 in lamellipodia, the dynamic distribution of PAK4
in lamellipodia may reflect a transient and periodic inter-
action between PAK4 and integrin v5. This led us to
hypothesize that PAK4 may not only interact with v5,
but that PAK4 may also influence integrin-mediated mo-
tile events.
PAK4 stimulates integrin v5–specific cell migration 
in human breast carcinoma cells
Based on the above hypothesis, we examined the potential
effect of PAK4 on v5-mediated cell motility. Integrins
v3 and v5 both participate in cell attachment and cell
migration toward VN (Wayner et al., 1991). To assess the
integrin v5–mediated cell motility, it is ideal to use a cell
line expressing v5, but not v3, because v3 usually
dominates as VN receptor for cell migration if present,
which is the case in most cultured cell lines. Therefore, we
chose MCF-7 human breast carcinoma cells, which express
v5 but not v3 (unpublished data; Brooks et al., 1997;
Wong et al., 1998). In addition, we found that both PAK4
mRNA and protein are highly expressed in MCF-7 cells
compared with a number of other tumor cell lines tested
(unpublished data), consistent with the recent study by Cal-
low et al. (2002).
In a haptotactic cell migration assay, we found that tran-
sient expression of EGFP–PAK4 in MCF-7 cells specifically
induced MCF-7 cell migration on VN, but not integrin 1–
mediated cell migration on collagen type I (Fig. 7 A). Fur-
thermore, EGFP–PAK4-induced cell migration was blocked
by a functional blocking anti-v5 mAb, but not by an
anti-v3 mAb (Fig. 7 A, left). Taken together, this demon-
strates that PAK4 specifically induces integrin v5–medi-
ated cell motility. Moreover, stable expression of EGFP–
PAK4 in MCF-7 cells yielded numerically almost identical
results on induction of v5-mediated cell migration as
transient PAK4 expression, but did not influence cell motil-
ity on collagen (Fig. 7 B). Similarly, stable overexpression of
Figure 6. Dynamic localization of PAK4 in lamellipodia. MCF-7 
human breast carcinoma cells stably transfected with EGFP–PAK4 or 
EGFP were plated onto VN and visualized by immunofluorescent 
microscopy after being allowed to attach for 30 min. Images were 
taken by a CCD camera every minute and the displayed cells are 
representative for the respective transfection. (A) EGFP–PAK4 is 
transiently localized in actively reshaping lamellipodia. (B) EGFP 
control exhibits only nuclear or perinuclear localization. Bars, 20 m.  on
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a Flag-tagged constitutively active PAK4 mutant (S474E;
Callow et al., 2002) induced MCF-7 cell migration to VN
to the same degree as EGFP–PAK4 (unpublished data). This
indicates that overexpression of EGFP–PAK4 may saturate
PAK4-inducible motility in this cell type, which might be
explained by the observation that a large GST fusion partner
at the NH2 terminus of PAK1 causes constitutive PAK1 ac-
tivation, suggesting that the EGFP fusion to PAK4 may
cause PAK4 activation.
Given that cell adhesion is the basis for cell migration, it
was interesting to examine whether PAK4 may also im-
pact cell adhesion on VN. To this end, MCF-7 cells were
transfected with EGFP–PAK4 or control EGFP. As shown
in Fig. 7 C, overexpression of EGFP–PAK4 markedly in-
hibited cell adhesion on VN compared with EGFP-trans-
fected cells. One possibility that may explain the inhibi-
tion of cell adhesion on VN could be a down-regulation of
integrin v5 cell surface expression by PAK4. To exam-
ine this, we performed a flow cytometry analysis to deter-
mine the cell membrane distribution of integrin v5.
However, PAK4 overexpression did not change the abun-
dance of integrin v5 expressed on the cell membrane
(Fig. 7 D), or that of integrin 1 (unpublished data). This
suggests that PAK4 inhibition of cell adhesion might be
caused by an alteration of integrin v5 binding capacity
for its ligand VN.
Discussion
PAK interaction with integrins
Previously, only one intracellular molecule, Rack1 (Liliental
and Chang, 1998), had been identified to directly interact
with the integrin 5 cytoplasmic domain. By yeast two-
hybrid screening, we now add six novel intracellular interac-
tors of integrin 5, including PAK4. The PAK4 binding sites
within the integrin 5 cytoplasmic domain was mapped to a
conserved, membrane-proximal region (aa 759–767). Inter-
estingly, the Rack1-binding site within 5 cytoplasmic do-
main was also mapped to the membrane-proximal region
partially overlapping with the PAK4-binding region, but
more extended to the NH2 terminus (Fig. 2 C). Rack1 is a re-
ceptor for PKC and may play a role in linking PKC to inte-
grins. Slightly upstream of the PAK4-binding region, a con-
served integrin membrane-proximal region of 3 has been
shown to form a hinge with the integrin IIb subunit, thereby
controlling extracellular ligand-binding affinity of integrin
IIb3 (Hughes et al., 1995). In addition, a conserved region
in the 2 integrin membrane-proximal region (733–742),
which almost corresponds to the PAK4-binding region in 5,
has been suggested to be critical for endoplasmic reticulum
retention, – dimerization, and cytoskeletal association of
leukocyte integrin L2 (Pardi et al., 1995). The conserved
-integrin membrane-proximal region has also been shown
Figure 7. PAK4 stimulates integrin 
v5–mediated cell migration. (A) MCF-7 
cells transiently transfected with EGFP–
PAK4 or EGFP control were analyzed for 
haptotactic cell migration toward VN in 
the presence or absence of normal mouse 
IgG and functional blocking mAbs 
LM609 (anti-v3) or P1F6 (anti-v5)
(left panel) and toward collagen type I 
(right panel). Data represent the average 
of three independent experiments and 
were normalized to the transfection 
efficiency of individual vectors, as 
determined by flow cytometry. Statistical 
evaluation comparing EGFP to EGFP–
PAK4 on VN gave P  0.05 by t test. 
(B) Cell migration analyzed as in A of 
MCF-7 cells stably expressing EGFP–PAK4 or EGFP. All results are expressed as mean values  SEM of three independent experiments using 
triplicate analysis in each experiment. Statistical evaluation by t test gave P  0.05 for EGFP–PAK4 compared with EGFP on VN. (C) Overexpression 
of PAK4 decreases cell adhesion on VN. Cell attachment of MCF-7 cells stably expressing EGFP–PAK4 or EGFP at different coating concentrations 
of VN was determined. (D) Transient EGFP–PAK4 expression does not change the membrane expression levels of integrin v5 in MCF-7 
cells as measured by flow cytometry. v5 expression was plotted versus EGFP content and the v5 cell surface levels in EGFP-transfected cells 
(bottom left) was compared with that in EGFP–PAK4 cells (bottom right). Values indicate the mean fluorescence of v5 staining in EGFP-positive 
cells. Unstained MCF-7 cells (top left) and staining without primary mAb (top right) were used to determine specificity and background.
 o
n
 O
ctober 20, 2010
jcb.rupress.org
D
ow
nloaded from
 
Published September 23, 2002
1294 The Journal of Cell Biology | Volume 158, Number 7, 2002
to mediate integrin oligomerization, inhibition of integrin
conformation, and constraining of an integrin in the inactive
state (Zage and Marcantonio, 1998; Bodeau et al., 2001; Lu
et al., 2001). However, although it is possible that PAK4
binding to integrin 5 membrane-proximal region may affect
the association between the integrin v and 5 subunits or
binding between v5 and VN, further studies are required
to elucidate if modulation of the PAK4-binding region of 5
can affect integrin hinge formation or the integrin extracellu-
lar binding affinity to the ECM.
Intriguingly, interactions between PAK family members
and integrins may be conserved, because the IBD within
PAK family members is highly conserved (Fig. 3 C) and be-
cause we found that in addition to PAK4, both hPAK1 and
the Drosophila PAK4 homologue MBT are able to interact
with various integrin  subunits (unpublished data). The
wide interaction spectra between integrins and PAK family
members of man and Drosophila suggest that the capacity for
these interactions might be highly conserved during evolu-
tion and may thus fulfill vital functions in various species.
Relocalization of PAK4 to lamellipodia
PAK4 has been found to be localized in the cytosol and in
the Golgi apparatus (Abo et al., 1998; Callow et al., 2002).
In the current study, we found that PAK4 relocalized to mo-
tile structures in the cell membrane upon replating onto
VN, including relocalization of PAK4 to lamellipodia and
ruffles. In comparison, PAK1 can localize to focal adhesions
upon replating (unpublished data; Manser et al., 1997). The
NH2-terminal regulatory domain of PAK1:1–329, including
its Cdc42/Rac-binding motif, is sufficient to localize PAK1
to focal adhesions, and PAK1 has been indicated to be re-
cruited to focal adhesions dependent on its binding to
Cdc42/Rac (Manser et al., 1997; Brown et al., 2002). How-
ever, in a substantial part of the cells (40%), a PAK4 mu-
tant deficient in binding to Cdc42/Rac localized to the
membrane before cell replating onto VN, whereas wt PAK4
only localized to the membrane in a few cells before replat-
ing. This suggests that binding to Cdc42/Rac might nega-
tively regulate PAK4 membrane relocalization, which is
consistent with the finding by Abo et al. (1998) that over-
expression of activated Cdc42 results in localization of
PAK4 in the Golgi apparatus. In addition, binding to Nck
has been shown to mediate PAK1 membrane localization
(Lu et al., 1997), whereas Pix, but not Nck, binding is re-
quired for PAK1:1–329 localization to focal adhesions
(Brown et al., 2002). However, the Nck- and Pix-binding
regions of PAK1 are not conserved in PAK4, which might
explain why PAK1 can be readily detected in focal adhesions
(unpublished data; Manser et al., 1997), whereas PAK4 in-
stead mainly relocalizes to lamellipodia upon replating and is
rarely found in focal adhesions (unpublished data). It is un-
clear how PAK4 relocalization is mediated, but it appears to
be independent of its catalytic activity, Cdc42/Rac binding,
and integrin binding capacity, because PAK4 mutants defi-
cient in these capacities all still relocalized to lamellipodia
upon replating. However, it will be highly interesting to elu-
cidate how relocalization of PAK4 is regulated, because the
PAK4 localization at motile cellular structures may be im-
portant for its function in motility.
Role of PAK4 in the regulation of cell motility
Cell migration is important in many physiological and
pathological processes and the regulation of cell motility is
complicated, including both extracellular and intracellular
events. Among these, PAK1 has been found to regulate cell
motility in mouse fibroblasts (Sells et al., 1999), endothelial
cells (Kiosses et al., 1999; Master et al., 2001), and tracheal
smooth muscle cells (Dechert et al., 2001). Previous studies
have suggested that the regulation of phosphorylation of
myosin light chain kinase and LIM kinase (LIMK) by PAK1
and PAK2 might account for the role of these PAK family
members in regulation of cell motility on various ECM sub-
strates, but without displaying any apparent integrin speci-
ficity (Edwards et al., 1999; Sanders et al., 1999; Goeckeler
et al., 2000). However, in this report, we demonstrate that
PAK4 specifically induces v5-mediated cell migration on
VN, whereas 1 integrin–mediated cell migration on col-
lagen type I is not influenced.
A recent study indicated that unlike PAK1, PAK4 is un-
able to phosphorylate myosin light chain kinase (Qu et al.,
2001), which may rule out one possible route by which
PAK4 could stimulate cell migration. Therefore, the mecha-
nisms for induction of cell motility by PAK1 and PAK4 may
be distinct, which is also supported by their distinct localiza-
tion in cell adhesive structures of focal adhesions and lamelli-
podia, respectively. PAK4 was recently found to interact with
LIMK1, to phosphorylate LIMK1 and stimulate the ability
of LIMK1 to phosphorylate cofilin (Dan et al., 2001a). As a
consequence, PAK4 and LIMK1 may cooperatively regulate
cytoskeletal changes that impact cell motility. However, the
PAK4 interaction with integrin 5 cytoplasmic domain may
also directly modulate the extracellular motility machinery,
including cell adhesion to ECM for which PAK4 has been
indicated to play a functional role (Qu et al., 2001). PAK4
binding to integrin might directly effect the integrin func-
tion, and thereby cell motility, and/or localize PAK4 effects
to integrin-proximal sites of migratory regulation. For exam-
ple, we found that PAK4 can phosphorylate the integrin 5
cytoplasmic domain and this way might affect the integrin
v5 extracellular binding capacity (unpublished data).
Taken together, our study suggests a model where PAK4
binds to integrin 5 cytoplasmic domain in motile cellular
structures and modulates integrin v5–mediated cell mi-
gration. This may be brought about by PAK4 regulation of
cytoskeletal components and/or by directly influencing inte-
grin v5 function, thereby facilitating cell migration.
Possible role of PAK4 in tumor progression 
and metastasis
Intriguingly, PAK4 was recently found to be overexpressed
in 78% of an array of human cancer cell lines where its func-
tion may be to promote cell transformation (Callow et al.,
2002). In addition to this potential function, our study indi-
cates a role for overexpressed PAK4 in breast carcinoma cell
migration, suggesting a potential role also in metastasis. The
predominant VN receptor in human carcinomas in vivo is
integrin v5 (Lehmann et al., 1994; Jones et al., 1997), an
integrin that can be activated by growth factors for cell mi-
gration (Klemke et al., 1994; Yebra et al., 1996). In fact,
growth factor stimulation of breast and pancreatic carci-
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noma cells has been shown to cause tumor dissemination
and metastasis in vivo, which was functionally linked to acti-
vation of integrin v5–mediated cell migration (Brooks et
al., 1997). Given that PAK4 stimulated v5-mediated cell
migration in breast carcinoma cells, elucidation of its poten-
tial role in growth factor signaling pathways governing inte-
grin v5 activation will be very interesting; for example if
PAK4 might effect src and/or FAK pathways recently impli-
cated in integrin v5 activation (Eliceiri et al., 2002). In
addition, stimulation of angiogenesis by VEGF or TGF-
depends on integrin v5 activation (Friedlander et al.,
1995). Therefore, it will also be interesting to assess the po-
tential role of PAK4 in in vivo progression of carcinoma me-
tastasis as well as angiogenesis.
In conclusion, we report a novel cell motility pathway me-
diated by the serine/threonine kinase PAK4 that directly in-
teracts with integrin v5 and selectively induces v5-
mediated cell motility, a mechanism previously demonstrated
to mediate carcinoma dissemination.
Materials and methods
Cell culture, cDNA expression vectors, and antibody production
African green monkey kidney COS-7 cells, human breast carcinoma
MCF-7 cells, and human melanoma M21 cells were grown in DME suppl-
emented with 10% FCS, 10 g/ml Gentamycin (Life Technologies). Clones
of MCF-7 cells stably expressing EGFP or EGFP–PAK4 were selected in the
presence of 0.5 mg/ml G418 (Life Technologies). Pools of G418-resistant
EGFP and EGFP–PAK4-expressing clones were used for cell migration
studies. hPAK4 expression vector HA–PAK4-SR3 was provided by Dr.
Audrey Minden (Columbia University, New York, NY). Flag-tagged hPAK4
was constructed by cloning the full-length hPAK4 cDNA into the vector
p3	FLAG-CMV-10 (Sigma-Aldrich). EGFP–PAK4 expression vector was
generated by cloning the full-length hPAK4 cDNA into pEGFP-C2 (CLON-
TECH Laboratories, Inc.) and confirmed by sequencing. The PAK4 mutants
PAK4-M350, PAK4-L19, 22, and PAK4-IBD (deletion of aa 505–530)
were created by site-directed mutagenesis using the QuickChange kit
(Stratagene), followed by sequence confirmation of the mutated regions.
For anti-PAK4 antibody production, a PAK4 NH2-terminal sequence (aa
116–323) was amplified by PCR and cloned into the GST fusion protein
expression vector pGEM-1
T (Amersham Biosciences). GST fusion pro-
teins were purified using glutathione-Sepharose beads (Amersham Bio-
sciences), according to the manufacturer’s protocol, followed by separa-
tion in PAGE and extraction of the GST–PAK4 fusion protein. Two rabbits
were immunized with the GST–PAK4 fusion protein and the sera collected
by Dr. Arturo Galvani at Pharmacia Corp. (Nerviano, Italy). The anti-PAK4
antibody was purified by protein G affinity column (Pierce Chemical Co.)
after absorption by bacteria powder containing expressed GST protein.
The purified anti-PAK4 antibody was tested for reactivity with other PAK
family members and found to be specific for PAK4 (unpublished data).
Yeast two-hybrid screening and yeast mating tests
Integrin 5 cytoplasmic domain (aa 753–799; Ramaswamy and Hemler,
1990) was fused to Lex A-DBD in the pEG202 vector (OriGene). The insert
sequence and reading frame were confirmed by sequencing. Approxi-
mately 2 	 107 yeast transformants of a 19-d mouse whole embryo expres-
sion library (OriGene) were pooled and screened by the activation of leu-
cine and -galactosidase marker genes. 98 clones were His Leu Trp
Ura -gal and 25 of them specifically interacted with 5 cytoplasmic
domain in yeast mating tests. Sequence analysis and bioinformatics studies
indicated that 6 out of 25 5 cytoplasmic domain–interacting sequences
represented mPAK4. For yeast mating tests, different regions of the integrin
5 cytoplasmic domain were cloned into the pEG202 bait vector using
yeast strain RFY206 as host, and different regions of the KD of hPAK4 were
cloned into pJG4-5 prey vector using yeast strain EGY48 as host.
Protein–protein interaction assays
COS-7 cells were transfected with 4 g expression vector HA–PAK4-SR3
by LipofectAmine plus (Life Technologies). Cells were harvested 48 h after
transfection and lysed in RIPA buffer (1	 PBS, pH 7.4, 0.5% sodium de-
oxycholate, 1% Triton X-100, 0.1% SDS) with protease inhibitors (0.5 g/
ml leupeptin, 1 mM EDTA, 1 g/ml pepstatin A, 0.2 mM PMSF). Approxi-
mately 500 g of precleared lysates were immunoprecipitated by 4 g
rabbit anti-HA pAb Y11 (Santa Cruz Biotechnology, Inc.), anti-v5 mAb
P1F6 (Life Technologies), or anti-3 mAb AP3 (GTI) and were separated
and probed with rabbit anti–human integrin 5 cytoplasmic pAb, anti–
integrin v pAb (Chemicon), or anti–HA tag mAb F-7 (Santa Cruz Biotech-
nology, Inc.) and then with an HRP-conjugated secondary pAb (Jackson
ImmunoResearch Laboratories) and visualized by ECL technique as previ-
ously described (Bao et al., 2002). Alternatively, IP of endogenous PAK4
was performed using 2 g anti-PAK4 pAb. For testing the in vivo associa-
tion of PAK4-IBD mutant with integrin v5, COS-7 cells were trans-
fected with Flag–PAK4 and Flag–PAK4-IBD. Precleared lysates (100 g)
were immunoprecipitated by 6 l ascites fluid of anti–integrin v5 mAb
P1F6 (Life Technology) or rabbit IgG or -Rab pAb (C-19; Santa Cruz Bio-
technology, Inc.) followed by Western blot analysis using anti-Flag tag
mAb M2 (Sigma). As positive controls for the Western blot analyses, 10–15
g lysates were applied without IP. To make GST fusion proteins, PAK4
KD (aa 324–591) and 5 (aa 753–799) cytoplasmic domains were cloned
separately into the GST fusion protein expression vector pGEM-1
T (Amer-
sham Biosciences). GST fusion proteins were purified using glutathione-
Sepharose beads (Amersham Biosciences) according to the manufacturer’s
protocol. To pull down hPAK4, 2 g of GST 5 tail fusion protein was
mixed with 500 g cell lysate containing HA–hPAK4 in RIPA buffer. Re-
ciprocally, to pull down the endogenous integrin 5 subunit, 200 g COS-7
cell lysate was mixed with 5 g purified GST–hPAK4 KD fusion protein in
RIPA buffer and incubated overnight at 4C. Glutathione-Sepharose beads
(Amersham Biosciences) were used to capture the GST fusion proteins and
the interacting proteins. The bound proteins were visualized by Western
blotting with mAb F-7 or rabbit anti–human integrin 5 cytoplasmic do-
main pAb (Chemicon), respectively.
Fluorescent microscopy and time-lapse video microscopy
MCF-7 cells stably expressing EGFP–PAK4 or EGFP were established under
the selection of G418 (0.5 mg/ml). Cells were fixed by 4% paraformalde-
hyde after attachment on VN. For staining of endogenous PAK4 in MCF-7
cells, rabbit anti-PAK4 pAb was used. For integrin v5 staining, cells
were replated in the absence of FCS and Mn2 (RPMI 1640, 2 mM CaCl2, 1
mM MgCl2, and 0.5% BSA), and anti–integrin v5 mAb clone 15F11
(Chemicon) was used for staining. Anti-Flag mAb M2 (Sigma-Aldrich) was
used for Flag tag staining. For quantification of cells with lamellipodial
PAK4 localization, six microscopic fields were chosen randomly and
counted directly through 20	 objective. Statistical analysis was performed
using Origin version 6.0 (Microcal Software, Inc.). Stained cells were pho-
tographed by fluorescent microscopy using a digital camera. Time-lapse
studies were performed 30 min after plating EGFP–PAK4 stably trans-
fected MCF-7 cells onto VN-coated chamber slides in the absence of FCS
using a fluorescent microscope (Leica). Pictures were captured every
minute using Slidebook software version 2.06 (Intelligent Imaging Innova-
tions, Inc.). The acquired pictures were further processed and assembled
using Adobe Photoshop® 5.0 and Adobe Illustrator® 8.0.
Cell migration and cell adhesion assays
Haptotactic cell migration assays were performed using Transwell cham-
bers (Costar Inc.) with 8.0 m pore size. The Transwell membranes were
coated with VN (10 g/ml), collagen type I (10 g/ml), or 1% BSA at the
bottom surfaces for 2 h at 37C. MCF-7 cells were transfected with EGFP or
EGFP–PAK4 for 48 h, and then cells were trypsinized, washed, and
counted in the presence of soybean trypsin inhibitor (0.25 mg/ml). Cells
(1 	 105) were then added on the top of Transwell membranes and al-
lowed to migrate toward VN or collagen type I in the presence or absence
of anti–integrin v3 mAb LM609 (Chemicon) or anti-v5 mAb P1F6 (25
g/ml) for 6 h at 37C in migration buffer (RPMI 1640, 2 mM CaCl2, 1 mM
MgCl2, 0.2 mM MnCl2, and 0.5% BSA). After thoroughly cleaning the up-
per chambers of the Transwells, the migrated cells expressing EGFP or
EGFP–PAK4 were counted using a fluorescent microscope; typically 12
microscopic fields were randomly chosen and counted. For comparison,
the number of migrating cells was calibrated to the transfection efficiency
within the cell population as determined by flow cytometry. Quantifica-
tion of stably transfected cells was performed by staining using crystal vio-
let followed by counting of random microscopy fields. For the cell adhe-
sion assay, nontreated 48-well plates (Corning Costar Corp.) were used.
Wells were coated with 0.5–10 g/ml VN overnight at 4C. 1% heat-dena-
tured BSA was applied to block nonspecific adhesion. MCF-7 cells stably
transfected with EGFP–PAK4 or EGFP control were plated into the wells in
triplicate at 5 	104 cells/well in cell adhesion buffer (RPMI 1640, 2 mM
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CaCl2, 1 mM MgCl2, 0.2 mM MnCl2, and 0.5% BSA) and allowed to attach
for 60 min. After careful washing of nonbound cells using adhesion buffer,
MTT was used to quantify the number of stably transfected cells attached.
Flow cytometry analyses
The efficiency for cell transfections and the cell surface expression levels
of integrins were analyzed by measurement of EGFP content and phyco-
erythrin staining intensity, respectively, by FACScan® flow cytometer using
CellQuest software (Becton Dickinson) after staining with anti–integrin
v5 mAb P1F6 and a phycoerythrin-conjugated secondary goat anti–
mouse pAb (Jackson ImmunoResearch Laboratories).
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Cell-to-extracellular matrix adhesion is regulated by a multitude of pathways initiated distally to the core cell–matrix
adhesion machinery, such as via growth factor signaling. In contrast to these extrinsically sourced pathways, we now
identify a regulatory pathway that is intrinsic to the core adhesion machinery, providing an internal regulatory feedback
loop to ﬁne tune adhesion levels. This autoinhibitory negative feedback loop is initiated by cell adhesion to vitronectin,
leading to PAK4 activation, which in turn limits total cell–vitronectin adhesion strength. Speciﬁcally, we show that PAK4
is activated by cell attachment to vitronectin as mediated by PAK4 binding partner integrin v5, and that active PAK4
induces accelerated integrin v5 turnover within adhesion complexes. Accelerated integrin turnover is associated with
additional PAK4-mediated effects, including inhibited integrin v5 clustering, reduced integrin to F-actin connectivity
and perturbed adhesion complex maturation. These speciﬁc outcomes are ultimately associated with reduced cell
adhesion strength and increased cell motility. We thus demonstrate a novel mechanism deployed by cells to tune cell
adhesion levels through the autoinhibitory regulation of integrin adhesion.
INTRODUCTION
Integrins, a cell surface receptor family, mediate cell adhe-
sion to the extracellular matrix (ECM) and trigger intracel-
lular signaling pathways that regulate cell spreading and
migration (Hynes, 2002). On cell binding to the ECM, inte-
grins cluster within the plasma membrane and associate
with numerous proteins to form organized adhesive contact
sites: cell–matrix adhesion complexes (CMACs), containing
large protein networks (Lock et al., 2008). Examples of such
CMACs include both focal complexes (FCs) and focal adhe-
sions (FAs; Zamir and Geiger, 2001; Berier and Yamada,
2007; Lock et al., 2008). The abbreviation CMAC is used here
to refer to all integrin–ECM adhesions, and the terms FC and
FA are reserved for speciﬁc CMAC subsets in cases where it
is possible to distinguish them. FCs are small, transient
adhesions at the cell periphery believed to be important in
mediating the attachment of the extending lamellipodium to
the ECM (Lauffenburger and Horwitz, 1996). FCs either
disassemble within a short time of their formation or mature
into more stable FAs (Zamir and Geiger, 2001; Berier and
Yamada, 2007). Somewhat counterintuitively, integrins in
stable, high-density FAs undergo rapid turnover in compar-
ison to integrins clustered in less stable FCs, indicating a
disconnection between the stability of CMACs as a whole
and their core integrin components (Ballestrem et al., 2001).
Also somewhat surprising is that in FAs, the stabilization of
CMACs and stress ﬁbers is associated with an increased
adhesion strength that usually counteracts cell motility
(Webb et al., 2002). Thus, fast cell migration typically corre-
lates with intermediate rates of CMAC assembly and disas-
sembly as well as with the rapid turnover of structural
components such as integrins within CMACs (Gupton and
Waterman-Storer, 2006). Although these preconditions for
rapid migration are becoming more clearly characterized,
the cellular signaling and molecular mechanisms that gov-
ern these dynamic properties of the cell adhesion–migration
system are still poorly understood.
p21-activated kinases (PAKs) are effectors for the Rho
GTPases Cdc42 and Rac. The group 1 PAK family members
PAK1 and PAK2 have previously been shown to affect cell
migration in distinct manners (Coniglio et al., 2008), and
qualitative studies also suggest a possible role for PAK1 in
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the regulation of FA morphology (Manser et al., 1997;
Kiosses et al., 1999). We now further investigate the mecha-
nisms by which PAK4, a member of the group 2 PAKs,
mediates cell adhesion and migration because our previous
studies have demonstrated that PAK4 regulates MCF-7 cell
migration on vitronectin (VN) and that PAK4 kinase activity
is responsible for this reaction (Zhang et al., 2002; Li et al.,
2010). PAK4 may also exert an inﬂuence on the actin micro-
ﬁlament system, because overexpression of PAK4 can in-
duce localized actin polymerization and ﬁlopodia formation
(Abo et al., 1998; Dan et al., 2001; Callow et al., 2005), al-
though whether these effects are direct or indirect remains
unclear. As a corollary, overexpression of a hyperactive
PAK4 mutant (S445N) in ﬁbroblasts or activation of PAK4
by HGF can cause a reduction in stress ﬁber prominence,
decreased adhesion to the ECM, and cell rounding (Qu et al.,
2001; Wells et al., 2002). Conversely, mouse embryonic ﬁbro-
blasts (MEFs) lacking PAK4 display enhanced focal adhe-
sions, indicating a role for PAK4 in CMAC regulation (Qu et
al., 2003). However, both the mechanisms and contextual
signiﬁcance of these PAK4 effects remain elusive.
Here, we ﬁrst determined that PAK4 is activated by liga-
tion of its binding partner, integrin v5, to the ECM ligand
VN. Next, we deployed quantitative imaging-based analyses
to characterize the speciﬁc effects of PAK4 on adhesion
structures and their core adhesive machinery. By these
methods we revealed that PAK4 acts at the molecular level
of adhesion complexes to accelerate integrin v5 turnover
within CMACs while concurrently reducing integrin clus-
tering density and integrin-to-F-actin connectivity, ulti-
mately destabilizing CMACs and reducing cell attachment
strength. Strikingly, these results delineate a novel autoin-
hibitory negative feedback loop initiated within the core
adhesion machinery by integrin v5 and acting via PAK4
to limit total v5-mediated cell adhesion to VN. These
ﬁndings provide a potential mechanism for the intrinsic ﬁne
tuning of cellular adhesion levels and in this case are con-
sistent with the facilitation of enhanced cell motility.
MATERIALS AND METHODS
Mammalian Cell Expression Vectors
Hemagglutinin (HA)-PAK4-wild type (WT), Flag-PAK4-WT, Flag-PAK4-
K350M, Flag-BAP, and pEGFP-PAK4-WT were previously described (Zhang
et al., 2002). An enhanced green ﬂuorescent protein (EGFP)-tagged PAK4–
445N, 474E (activated PAK4), was generated using site-directed mutagenesis
(Qu et al., 2001). The WT PAK4 was also subcloned into the HindIII/BamHI
sites of a monomeric red ﬂuorescent protein vector (pmRFP) kindly provided
by Roger Tsien (University of California, San Diego). Full-length integrin 5
cDNA kindly provided by Errki Ruoslahti (Burnham Institute) was cloned
into the HindIII/EcoRI sites of the pEGFP-N1 vector (Clontech, Palo Alto,
CA).
Antibodies and Recombinant Proteins
The anti-HA (Y11) pAb was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA); anti-integrin v5 mAb (clone 15F11) from Chemicon Interna-
tional (Temecula, CA); anti-Flag mAb M2 from Sigma (St. Louis, MO); and
tubulin- Ab-2 mAb from Lab Vision (Fremont, CA). The anti-actin mAb
JLA20 was provided by Developmental Studies Hybridoma bank at Univer-
sity of Iowa (Iowa City, IA). The anti-PAK4 (total) pAb was generated in our
laboratory.
Cell Culture and Transient Transfections
African green monkey kidney COS-7 cells and human breast carcinoma
MCF-7 cells were grown in DMEM, supplemented with 10% fetal bovine
serum (FBS) and 10 g/ml gentamicin (Invitrogen, Carlsbad, CA), and main-
tained in a humidiﬁed incubator at 37°C with 5% CO2 , 4–8 g of total DNA
was transfected in 100-mm cell culture dishes (80–90% conﬂuence of COS-7 or
MCF-7 cells) using LipofectAmine Plus or LipofectAmine 2000 (Invitrogen),
according to the manufacturer’s protocol.
Generation of Stable PAK4 Clones
MCF-7 cells were stably transfected with Flag-BAP or Flag-PAK4-WT using
LipofectAmine Plus (Invitrogen) according to manufacturer‘s instructions.
Twenty-four hours after transfection, selection with 300 g/ml G418 (Invitro-
gen) was initiated. After 7–10 d of selection, colonies were isolated and
screened for Flag expression by immunoblotting using anti-Flag mouse mAb
M2 (Sigma). Clones were maintained in medium supplemented with 150
g/ml G418 (Invitrogen).
Small Interfering RNA Experiments
For the knockdown of PAK4, two small interfering RNA (siRNA) sequences
targeting human PAK4 (no. 273: CAUGUCGGUGACACGCUCCAA and no.
1093: AACGAGGUGGTAAUCAUGAGG) were purchased from Qiagen (Chats-
worth, CA); and the control siRNA was previously described (Zhang et al., 2004).
MCF-7 cells at 50% conﬂuence were transfected with siRNA using Lipofectamine
RNAiMAX reagent according to the manufacturer‘s protocol (Invitrogen). At 2–4
d after transfection, the endogenous levels of PAK4 were measured by immu-
noblotting (IB) using anti-PAK4 pAb and tubulin- Ab-2 mAb (Lab Vision). For
PAK4-shRNA constructs and for stable transfection, an shRNA sequencing cor-
responding to positions 273–291 of the human PAK4 gene was used; the sense
oligonucleotide contained the following PAK4 targeting sequence (underlined):
5-GATCCCCCATGTCGGTGACACGCTCCTTCAAGAGAGGAGCGTGT-
CACCGAGATGTTTTTA-3; and the antisense oligonucleotide: 5-AGCTTAAA-
AACATGTCGGTGACACGCTCCTCTCTTGAAGGAGCGTGTCACCGAG-
ATGGGG-3. To generate a shRNA duplex, the sense and antisense
oligonucleotides were annealed, and double-stranded oligonucleotides were
cloned into the pSuper vector. Two shRNA-resistant PAK4 cDNAs (EGFP-PAK4-
AC285, 288GA and EGFP-PAK4-M350AC285, 288GA) were generated by chang-
ing the targeted sequence of shRNA (no. 273) in EGFP-PAK4-WT construct to the
sequence 5-CATGTCGGTGACGCGATCCAA-3 (mutated nucleotides are un-
derlined) by PCR-based site-directed mutagenesis. To establish PAK4 shRNA-
stable clones, the pSuper-PAK4 shRNA plasmid or a control shRNA (Numakawa
et al., 2004) plasmid with the pCI-neo vector was cotransfected into MCF-7 cells
using LipofectAmine Plus. Cells were selected with medium containing 300
g/ml G418. After selection, all clones were maintained in medium supple-
mented with 150 g/ml G418.
PAK4 Activation and In Vitro Kinase Activity Assay
COS-7 cells transiently transfected with HA-PAK4-WT or MCF-7 cells stably
expressing Flag-PAK4-WT or Flag BAP were starved in serum-free DMEM
overnight to minimize endogenous signaling. The cells were trypsinized and
suspended for 30 min in adhesion buffer (RPMI 1640, 2 mM CaCl2, 1 mM
MgCl2, 0.2 mM MnCl2, and 0.5% bovine serum albumin [BSA]) and then
plated on vitronectin (VN; 10 g/ml)-coated suspension dishes for various
times. Cells were lysed in a phosphate-buffered saline (PBS)-TDS lysis buffer
(1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 0.14 M NaCl, 2.8 mM
KCl, 10 mM Na2HPO4, 1.5 mM KH2PO4). In vitro PAK4 kinase activity
analyses were performed as described (Zhang et al., 2002). Brieﬂy, extracts
(100–1500 g of protein) were enriched by immunoprecipitation (IP) using
anti-HA (Y11), anti-Flag (M2), or anti-PAK4 (Zhang et al., 2002) antibodies
and collected by protein A or protein G-Sepharose beads (Amersham Phar-
macia Biotech, Piscataway, NJ) and then mixed with 5 g of MBP substrate
(Sigma) in the presence of [-32P]ATP (Amersham Biosciences), followed by
SDS-PAGE. The radioactivity incorporated into the substrate was then visu-
alized and quantiﬁed using a PhosphorImager system (Molecular Imager FX,
Bio-Rad, Hercules, CA).
Immunoblotting
Each sample was run on an SDS-polyacrylamide gel, and proteins were
transferred to Immobilon-P Membrane (Millipore, Bedford, MA). Membranes
were probed with various antibodies as described, and proteins were detected
by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech); band
intensities were quantiﬁed using Kodak 1D image analysis software Eastman
Kodak, Rochester, NY).
Cell Adhesion Assay
Cell adhesion assays were performed as described (Yebra et al., 1996). Brieﬂy,
nontreated 48-well cluster plates (Corning Costar, Acton, MA) were coated
with different concentrations of VN and blocked by 1% heat-denatured BSA.
MCF-7 cells (n 5 104) per well were seeded in wells and allowed to attach
at 37°C in adhesion buffer for 15–45 min. The amount of attached cells was
quantiﬁed by an MTT assay. For PAK4-siRNA knockdown experiments,
MCF-7 cells were transiently transfected with PAK4 siRNA or control siRNA.
After 4 d, cell adhesion assays were performed as described above. In RNA
interference (RNAi) rescue, a control shRNA MCF-7 clone was transiently
transfected with EGFP, and a PAK4 shRNA clone was transiently transfected
with EGFP (as a control) or EGFP-PAK4-AC285, 288GA. After 27 h, 5 104 of
these cells were seeded in each well and allowed to attach at 37°C for 15–45
min. The attached EGFP-positive cells were counted using a microscope (10
objective). For comparison, the number of EGFP-containing adhered cells was
Z. Li et al.
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calibrated to the transfection efﬁciency within the cell population as deter-
mined by counting of the starting population using ﬂuorescent microscopy.
Immunoﬂuorescence Staining, Microscopy, and Focal
Adhesion Quantiﬁcation
For immunostaining, MCF-7 cells transfected with HA-tagged or Flag-tagged
PAK4 or shRNA constructs were detached and plated onto VN-coated cover
slips in adhesion buffer for 3–6 h. Cells were ﬁxed with 4% paraformaldehyde
in PBS for 15 min at room temperature. The ﬁxed cells were permeabilized
with 0.2% Triton X-100, and nonspeciﬁc binding was blocked by using 5%
BSA in PBS for 1 h at room temperature. The cells were then costained with
primary anti-integrin v5 mAb 15F11 (Chemicon) or anti-vinculin mAb
(Sigma), followed by a ﬂuorescein isothiocyanate (FITC)-conjugated second-
ary antibody (Jackson ImmunoResearch, West Grove, PA) for adhesion struc-
tures and anti-HA pAb Y11 (Santa Cruz Biotechnology) , followed by rho-
damine-conjugated secondary antibody (Jackson ImmunoResearch) for PAK4
or rhodamine-conjugated phalloidin (Molecular Probes, Eugene, OR) for ac-
tin. For negative controls, the samples were incubated with either of the
primary antibodies without the corresponding secondary antibody or the
secondary antibodies without any primary antibody. The slides were exam-
ined by using an IX71 Olympus microscope with a 100/1.35 oil objective
(Melville, NY) and a Hamamatsu CCD camera (Bridgewater, NJ) or a Zeiss
LSM510 confocal microscope with a 63/1.4 oil objective (Thornwood, NY).
Wasabi software (http://www.wasabisystems.com/) and Zeiss LSM Im-
age Browser Version 4.2.0121 software were used to generate digital images.
The numbers of focal CMACs at the cellular periphery were quantiﬁed
manually or by automation using Patch Morphology Assay 5.2.0 software for
systems microscopy (Digital Cell Imaging Labs, Edegem, Belgium; Lock and
Stro¨mblad, 2010) or ImageJ software (http://rsb.info.nih.gov/ij/; National
Institutes of Health). The peripheral area was deﬁned as a 5-m-wide region
at the cell border. Quantiﬁcation of the number of adhesion complexes in the
cell periphery in control and PAK4-overexpressing cells was performed by
counting the number of adhesion complexes in a square of a deﬁned size for
each cell among 25–50 cells in three independent experiments. Statistical
signiﬁcance was calculated using an unpaired, two-tailed t test. The 95%
conﬁdence intervals were calculated using TEMPLO software (Noraxon, Co-
logne, Germany).
Determination of Cell Spreading
MCF-7 cells with or without transfections were plated in adhesion buffer for
1–6 h onto VN-coated coverslips. Cells were ﬁxed and stained for F-actin with
rhodamine-labeled phalloidin as described above. Images were acquired by
an Olympus IX71 microscope with a 20 oil objective and photographed with
a Hamamatsu CCD camera. Cell areas were determined for each condition
from three separate experiments using ImageJ software. Cells were manually
outlined based on phalloidin labeling of actin, and the area was calculated in
pixels using an automation tool in ImageJ. This number was then converted
to m2 by recalculation. Only cells not in contact with neighboring cells were
analyzed.
Cell Migration Assay
A haptotactic cell migration assay was performed using Transwell chambers
(Corning Costar) with 8.0-m pore size as described (Yebra et al., 1996).
Brieﬂy, MCF-7 cells transiently transfected with EGFP (as a control), EGFP-
PAK4-WT, or control shRNA and PAK4 shRNA clones transiently transfected
with EGFP (as a control) or EGFP-PAK4-AC285, 288GA, and after 48-h
transfection, 1–3  105 cells were added on top of the Transwell membranes,
the bottom surface of which was coated with VN (10 g/ml), and were
allowed to migrate toward VN for 3–6 h at 37°C in adhesion buffer. All of the
migrated EGFP-positive cells in each the well were counted using ﬂuorescent
microscopy. For comparisons, the migrated cells were calibrated to the trans-
fection efﬁciency within the cell population as determined by counting using
the ﬂuorescent microscope of the starting population. For the knockdown of
PAK4, stable PAK4 overexpression clones or transient transfection of PAK4
siRNAs, 1  105 cells were added on top of the Transwell membranes coated
with VN (10 g/ml) at the bottom and were allowed to migrate toward VN
for 3–6 h at 37°C in adhesion buffer. All the migrated cells in each of the wells
were stained by crystal violet and were counted using microscopy.
Wound Healing Assay
Forty-eight–well plates were coated with VN (10 g/ml) at 37°C for 1 h,
followed by blocking with 1% BSA for 1 h at 37°C. Cells were trypsinized with
trypsin-EDTA, washed twice with PBS, and replated in serum-free DMEM 4 h
before wounding at conﬂuence. The cell monolayers were wounded by ap-
plying a p200 pipette tip. Cells were then incubated in serum-free DMEM,
and images from 3 representative wounded areas per condition were ac-
quired by microscope (Zeiss Axiovert S100) with a digital camera (Axiocam
MRC) and software (Axivision AC) at 0, 30,and 55 h. Wound closure rates
were determined using the initial and ﬁnal wound areas during the wound-
ing experiments, with the percentage wound closure calculated as [(initial 
ﬁnal)/initial]  100.
Fluorescence Recovery After Photobleaching)
MCF-7 cells that were cotransfected 48 h previously with mRFP and 5-EGFP
or mRFP-PAK4 and 5-EGFP were replated onto Matek dishes coated with 10
g/ml VN in DMEM (Invitrogen). After 16 h, cells were washed three times
in F12 medium (Invitrogen) supplemented with 1 mM CaCl2, 1 mM MgCl2,
and 0.5% BSA and imaged within this medium at 37°C in 5% CO2 using an
LSM510 confocal microscope (Zeiss). Integrin 5-EGFP was bleached using 40
iterations at 40% of total laser power from the 488-nm line of a four-line argon
laser (Coherent, Palo Alto, CA). 5-EGFP was imaged before (3) and after
(31) bleaching using 0.24% of total 488-nm laser power at an interval of 30 s.
Monomeric red ﬂuorescent protein (mRFP) was imaged using 35% of total
laser power from a 543-nm laser (Coherent). Entire adhesions were bleached,
and recovery of adhesions were measured using free-drawn regions of inter-
est, and mean intensity was quantiﬁed in ImageJ software (version 1.32),
followed by analysis using Microsoft Ofﬁce Excel 2003 (Redmond, WA). The
mean diffuse plasma membrane intensity of integrin was subtracted from all
data points, and corrections were applied to remove the effect of nonspeciﬁc
bleaching during the recovery process. Maximal diffusive recovery of integrin
within the plasma membrane occurs within 120 s for bleached areas of
equivalent size to that of typical focal adhesions (data not shown). The data
analysis therefore only includes recovery data starting 2 min into the process.
Average values of intensity were calculated at each point in time in the two
sets of recovery curves, with and without PAK4, respectively. Using a non-
linear algorithm in the Matlab Curve Fitting toolbox (The Mathworks, Natick,
MA), an exponential function on the form:
y a b exp(kt) (1)
was ﬁtted to the curves. This gave the parameter a, the ﬁnal value of recovery,
in the two sets. b is the amount of ﬁrst-order recovery, and k is the corre-
sponding rate. Curve ﬁtting was also obtained for individual recovery curves.
However, nonlinear curve ﬁtting was not possible for the individual recovery
curves because the estimate of parameters is sensitive to noise. Instead, in this
case, the ﬁnal value of recovery, a, was kept constant at the number calculated
above for each of the two data sets. This made it possible to use linear curve
ﬁtting by calculating log [ a  I(t)], where I(t) is the intensity at time t, and
ﬁtting this expression to log b kt, where the parameters correspond to those
in Equation 1. For statistical analyses, data were analyzed for statistical
signiﬁcance using an unpaired two-tailed t test in Microsoft Ofﬁce Excel 2003.
RESULTS
Cell Attachment to VN Activates PAK4
Cell adhesion to the ECM triggers a variety of intracellular
signaling cascades, including the activation of PAK1 (Price et
al., 1998). However, it is unclear whether PAK4 activity is
regulated by cell attachment. To this end, COS-7 cells tran-
siently transfected with HA-PAK4-WT were replated onto
VN in the absence of serum. PAK4 was markedly activated
within 5 min of replating, with a sustained enhancement of
activity detected for at least 60 min by an in vitro kinase assay
(Figure 1A). Also, stably overexpressed Flag-PAK4-WT and
endogenous PAK4 kinase activities in MCF-7 cells were in-
duced by integrin v5–mediated attachment to VN with a
peak activity at about 10 min (Figure 1, B–D). Although WT
PAK4 displayed substantial endogenous activity, an inactive
PAK4-K350M mutant was analyzed as a control and showed
no kinase activity compared with PAK4-WT (Supplemental
Figure 1). The level of PAK4 activation in MCF-7 cells upon VN
attachment was lower than in COS-7 cells, which may be due
to cell type–speciﬁc differences. These results demonstrate that
integrin-mediated attachment to VN activates PAK4. Consid-
ering also that PAK4 is relocalized upon replating of MCF-7
cells from a diffuse cytosolic appearance to be enriched at the
cellular periphery where most CMACs are formed (Zhang et
al., 2002), the change in the local amount of active PAK4 at
these adhesion sites is several times that of the increase in total
PAK4 activity.
PAK4 Expression Reduces Cell Attachment to VN
To examine whether cell attachment-induced PAK4 activa-
tion may play a role in integrin v5–mediated cellular
functions, we used the human breast carcinoma cell line,
MCF-7, which expresses only integrin v5 as its VN recep-
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tor. In concordance with our previous ﬁndings (Zhang et al.,
2002), MCF-7 cells stably expressing Flag-PAK4 display re-
duced cell attachment to VN compared with control cells
(Figure 2A). Note that the expression of Flag-PAK4-WT in
MCF-7 stable clones produced an approximately twofold
increase in PAK4 protein levels compared with control
MCF-7 cells, thereby closely mimicking the activity increase
induced by replating (Figures 1 and 2A). In addition, it is
also important to note that unlike group I PAKs, PAK4 has
a constitutive basal kinase activity (Supplemental Figure 1;
Abo et al., 1998; Li et al., 2010). Together, this indicates that
overexpression of PAK4 can mimic the increased activity
levels obtained after replating. Conversely, RNAi-mediated
knockdown of PAK4 enhanced cell attachment compared
with control cells (Figure 2, B and C). On reexpression of an
RNAi-resistant mutant of EGFP-PAK4, this phenotype was
rescued (Figure 2, C and D). These results suggest that PAK4
plays an important role in the regulation of integrin v5–
mediated cell adhesion.
PAK4 Regulates Integrin v5–mediated Cell Motility
and Spreading
Although overexpression of EGFP-PAK4 markedly pro-
moted cell migration on VN (Zhang et al., 2002), it has
remained unclear whether endogenous PAK4 is required for
migration of breast carcinoma cells, within which PAK4 has
been indicated to be overexpressed in patients (Liu et al.,
2008). Consistent with our previous ﬁndings, overexpres-
sion of WT PAK4 in MCF-7 cells did indeed enhance cell
migration on VN in transwell migration assays by2–3-fold
compared with controls (Supplemental Figure 2, A and B).
Two distinct PAK4 siRNAs had the converse effect, sup-
pressing MCF-7 cell migration on VN (Supplemental Figure
2C). Suppression of migration was also seen in stable clones
expressing PAK4-shRNA (Supplemental Figure 2D). Criti-
cally, this phenotype could be reversed by reexpression of
an EGFP-PAK4 siRNA-resistant mutant (Supplemental Fig-
ure 2E). PAK4 depletion also caused a marked inhibition of
cell migration in wound closure assays (Supplemental Fig-
ure 2F). In fact, at 55 h after wounding, PAK4-depleted cells
had only migrated to cover 50% of the wounded area,
whereas control cells had virtually closed the wound. To-
gether, these results suggest that PAK4 plays a key role in
cell migration.
Cell motility is closely related to cell spreading. Although
overexpression of EGFP-PAK4 markedly promoted cell mi-
gration onto VN (Zhang et al., 2002) and a hyperactive PAK4
mutant caused cell rounding (Qu et al., 2001), it has been
unclear to what extent PAK4 may affect cell spreading. To
test the inﬂuence of PAK4 on cell spreading, MCF-7 cell area
was quantitatively compared after replating onto VN in the
presence or absence of overexpressed PAK4. HA-PAK4–
overexpressing cells displayed signiﬁcantly less cell spreading
than control cells (Supplemental Figure 3A), and transient
overexpression of a hyper-active form of PAK4 (EGFP-
PAK4–445N, 474E) caused even stronger inhibition of cell
spreading than EGFP-PAK4-WT (Supplemental Figure 3, B
and C). Stable overexpression of Flag-PAK4-WT also inhib-
ited cell spreading (Supplemental Figure 3D). Furthermore,
we created two MCF-7 cell clones stably expressing PAK4-
shRNA resulting in more than 80% knockdown of PAK4
protein levels (Supplemental Figure 3E). ShRNA-mediated
PAK4 knockdown substantially induced cell spreading com-
pared with control shRNA cells (Supplemental Figure 3F).
This phenotype was rescued by reexpression of an EGFP-
PAK4 siRNA-resistant mutant, but not by a kinase-dead
EGFP-PAK4 siRNA-resistant mutant (Supplemental Figure
3G). Thus, our ﬁndings indicate that PAK4 kinase activity is
required in the regulation of carcinoma cell spreading and
migration. Taken together with the physical and functional
links between PAK4 and integrin v5, these data called for
a more detailed elucidation of PAK4 effects and mechanisms
within the core migration machinery, namely, integrin-me-
diated CMACs (Webb et al., 2002; Lock et al., 2008).
Figure 1. PAK4 activation by cell attachment onto vitronectin
(VN). (A) Activation of transiently expressed HA-tagged PAK4 in
COS-7 cells. COS-7 cells with transiently transfected HA-PAK4 were
plated onto VN-coated dishes for the indicated times. PAK4 was
immunoprecipitated (IP) from cell lysates, and kinase activity was
determined by an in vitro kinase assay using myelin basic protein
(MBP) as substrate (top). Quantiﬁed PAK4 kinase activities relative
to the zero time point of PAK4 activity are indicated below. Bottom
panel, lysate content of HA-PAK4 by immunoblotting (IB). (B)
Activation of transiently expressed Flag-PAK4 in MCF-7 cells.
Mixed MCF-7 cell clones stably expressing Flag-PAK4 were plated
onto VN and analyzed for PAK4 kinase activity as described above
(top). Middle, lysate content of proteins detected by anti-FLAG;
bottom, Coomassie blue gel staining of MBP loading. (C) Autophos-
phorylation of stable expressed Flag-PAK4 in MCF-7 cells. Mixed
MCF-7 cell clones stably expressing Flag-PAK4 were plated onto
VN and analyzed for PAK4 autophosphorylation as described
above (top). Bottom, quantiﬁed PAK4 autophosphorylation relative
to the zero time point of PAK4 autophosphorylation are indicated
below. Bottom panel, lysate content of proteins detected by anti-
FLAG. (D) Activation of endogenous PAK4 in MCF-7 cells. MCF-7
cells were plated onto VN, and after anti-PAK4 IP, endogenous
PAK4 activity was analyzed (top). Bottom, lysate contents of PAK4
protein. The displayed results in Figure 1 are representative among
at least three experiments. Note that Figure 1D, top panel, stems
from the same gel and was rearranged for display purpose.
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PAK4 Inhibits Integrin Clustering, Integrin–F-Actin
Connection, and Adhesion Complex Maturation
Detailed, quantitative, imaging-based analyses of the impact
of PAK4 in hundreds of cells and on several thousand
CMACs were performed. We focused on the impact of PAK4
on peripheral CMACs, deﬁned as those found within 5 m
of the cell border, because this region gives rise to the key
assemblages of cell motility, including lamellipodia and
ﬁlopodia (Wehrle-Haller and Imhof, 2003). Strikingly, HA-
PAK4 overexpression resulted in a shift in CMAC popula-
tions toward smaller integrin v5–containing structures
with the appearance of focal complexes, whereas control
cells displayed larger and brighter CMACs (Figure 3A).
Semiautomated quantiﬁcation also revealed a signiﬁcant de-
crease in peripheral CMAC numbers in PAK4-overexpress-
ing cells (Figure 3B). It is notable that PAK4 overexpression
preferentially inhibited the presence of larger CMACs that
in size and structure correspond to FAs (Figure 3, C and D).
In fact, the number of FAs (size 2 m2) per cell was
reduced by 75% in the presence of WT PAK4 overexpres-
sion (Figure 3D). Consistent with the results of transient
PAK4 overexpression, cells stably overexpressing PAK4 also
showed decreased numbers of integrin v5 and vinculin-
containing CMACs (Figure 3, E and F). We next used cus-
tom-developed software to perform fully automated quan-
tiﬁcation of CMAC properties, as described in Materials and
Methods (Figure 4). This revealed that overexpression of
EGFP-tagged PAK4 (EGFP-PAK4) reduced CMAC number
compared with EGFP control (Figure 5A). Additionally,
EGFP-PAK4 expression reduced the density of integrin clus-
tering in CMACs, an effect also observed in the presence of
HA- and FLAG-tagged PAK4. In control cells, integrin den-
sity (resulting from integrin clustering and indicated by
mean v5 mAb labeling intensity per CMAC) increased
signiﬁcantly as CMAC area increased, delineating the pro-
gression of CMAC maturation. In contrast, integrin density
did not increase substantially as CMAC area increased in
cells expressing EGFP-PAK4, resulting in CMACs with re-
duced densities in all size classes from the smallest, nascent
adhesions, to the largest FAs wherein the effect was most
pronounced (Figure 5B). Remarkably, EGFP-PAK4 also dra-
matically inhibited integrin–F-actin connectivity, as indi-
cated by substantially reduced colocalization between v5
mAb and phalloidin labeling within individual CMACs,
without signiﬁcantly altering local F-actin levels (Figure 5, C
and D). This effect was also exacerbated in large CMACs.
Thus, these ﬁndings indicate that PAK4 overexpression
causes a general depletion of CMAC number, size, integrin
clustering density, and integrin–F-actin connectivity, with
an especially potent effect on the development of larger
adhesion complexes, implying a key role for PAK4 in the
inhibition of CMAC and particularly FA maturation. Impor-
tantly, stable PAK4-shRNA expression caused a marked
Figure 2. Role of PAK4 in MCF-7 cell adhesion on VN. (A) Left,
cell attachment of MCF-7 cells stably expressing Flag-PAK4 or
Flag-BAP at different coating concentrations of VN was determined.
Graph shows means of optical density  95% conﬁdence intervals;
n  3 from one representative experiment. Right, the protein levels
of endogenous PAK4 and stably expressed Flag-PAK4-WT or Flag-
BAP (as a control) in MCF-7 cells were detected by IB using anti-
PAK4 pAb (top panel), anti-Flag (M2) mAb (middle panel) with
anti-actin mAb as loading control (bottom panel). (B) Left, cell
attachment of MCF-7 cells transiently expressing PAK4-siRNA or
control siRNA at different coating concentrations of VN was deter-
mined. Graph shows means of optical density  95% conﬁdence
intervals; n 3 from one experiment. Right, PAK4 siRNA-mediated
knockdown was determined by IB using tubulin as loading control.
(C) Cell attachment was determined of MCF-7 stably expressing
control shRNA and stable PAK4 shRNA expressing MCF-7 cells
transiently transfected with EGFP (as a control) or EGFP-PAK4-
AC285, 288GA (RNAi-resistant PAK4) at different coating concen-
trations of VN. Graph shows means of number of cells per ﬁeld 
95% conﬁdence intervals; n  3 from one experiment. (D) PAK4
shRNA-mediated knockdown and expression levels of EGFP and
EGFP-PAK4 for cells used in C were determined by IB using actin
as loading control. All experiments in Figure 2 were repeated at
least three times with similar results. p values are indicated for
statistically discernable differences compared with control (A and B)
or to PAK4-shRNA cells (C) according to unpaired two-tailed t test
(*p  0.05; **p  0.01; ***p  0.001).
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increase in the number and size of CMACs, in particular
among larger adhesions where a 10-fold increase in fre-
quency was observed (Figure 6, A–C). Interestingly, knock-
down of PAK4 also promoted enhanced integrin clustering,
with small CMACs displaying a higher integrin clustering
density than controls (Figure 6D) and an apparently accel-
erated (with respect to CMAC area) maturation to maximal
integrin density. However, PAK4 knockdown did not sig-
niﬁcantly intensify the maximal clustering density observed
in large CMACs, suggesting that both control and PAK4
knockdown conditions permit maximal integrin clustering
density, perhaps limited here by other factors such as ECM
ligand concentration or allosteric hindrance. PAK4 knock-
down also signiﬁcantly increased the amount of F-actin
recruited to CMACs (Figure 6E) without changing colocal-
ization values (Figure 6F), implying an increased total con-
nectivity (indicated by F-actin intensities) of these complexes
to the actin cytoskeleton compared with control cells, but
with a similar spatial organization (indicated by no detect-
able change in colocalization values). Overall, CMACs in the
absence of PAK4 matured more efﬁciently, as denoted by
enhanced integrin clustering with respect to CMAC area, as
well as more frequently and with greater actin connectivity
than CMACs in control shRNA-expressing cells.
It is worth noting here that at no time was it possible to
detect signiﬁcant PAK4 association with CMACs, despite
the consistent observation that PAK4 is recruited to the cell
periphery during the spreading process that follows cell
attachment (Zhang et al., 2002). This is true of endogenous
and exogenous PAK4 observed via immunoﬂuorescence la-
beling and of exogenous EGFP- and mRFP-tagged PAK4
observed in live and ﬁxed cells. This suggests that PAK4 acts
either indirectly on integrins or that it acts directly but in a
location outside of large adhesion complexes, most likely on
the nonclustered, diffusing integrin population.
PAK4 Induces Increased Integrin v5 Turnover within
CMACs
Although PAK1 has been suggested to regulate overall
CMAC stability (Manser et al., 1997; Kiosses et al., 1999;
Stofega et al., 2004), it has been unclear whether PAKs may
affect integrin molecular turnover within CMACs. Given
that mature, relatively stable FAs have been shown to dis-
play higher integrin turnover rates than smaller, more im-
mature and less stable FCs (Ballestrem et al., 2001; Wehrle-
Haller and Imhof, 2003), the inhibitory effect of PAK4 on
CMAC maturation was expected to correlate with decreased
integrin turnover. Surprisingly, however, ﬂuorescence re-
covery after photobleaching (FRAP) analysis of integrin
turnover revealed that PAK4 overexpression instead accel-
erated integrin turnover. MCF-7 cells were cotransfected
with integrin 5-EGFP and mRFP-PAK4 or a control mRFP
Figure 3. Inﬂuence of PAK4 transient or stable overexpression on CMAC size and number. (A) Images from control MCF-7 cells or MCF-7
cells transiently expressing HA-PAK4-WT 3 h after replating onto VN, stained for integrin v5 and HA-tag as indicated. Bar, 20 m. (B)
Quantiﬁcation of CMAC numbers at the cellular periphery. The results are displayed as means  SEM of the number of peripheral CMACs
within 5 m of the cell border per cell; between three independent experiments. (C and D) Quantiﬁcation of CMAC sizes at the cellular
periphery. The sizes of the CMACs are categorized into small (1 m2), medium (from1 to2 m2), and large (2 m2) adhesions. Values
represent the percentage distribution (C) or number per cell (D) for each group expressed as mean  SEM between three independent
experiments. (E and G) MCF-7 cells stably expressing Flag-BAP or Flag-PAK4-WT were plated onto VN and ﬁxed after 6 h. Cells were stained
with anti-v5 (E) or anti-vinculin (G) antibodies and costained with rhodamine-phalloidin. Bar, 25 m. (F and H) Quantiﬁcation of the
number of CMACs at the cellular periphery as described in Materials and Methods. Graphs show means of CMACs per cell  95%
conﬁdence intervals; n  48 (F) and n  40 (H). In addition to effects by PAK4 on CMACs, we observed fewer actin stress ﬁbers and
also an induction of ﬁlopodia (arrows) in some WT PAK4-overexpressing cells compared with controls. p values indicated according
to unpaired two-tailed t test.
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vector, followed by time-lapse imaging of photobleached
regions to allow visualization and quantiﬁcation of 5-EGFP
recovery after bleaching. The recovery kinetics correspond
to the replacement of 5-EGFP initially localized in the
bleached CMACs and highlight a dramatic increase in total
recovery and recovery speed induced by mRFP-PAK4, indi-
cating enhanced 5-EGFP turnover at sites of adhesion (Fig-
ure 7, A–C).
It is noteworthy here that ﬂuorescence recovery immedi-
ately after photobleaching results from at least two additive
processes, one being random intra-plasma membrane diffu-
sion of individual integrin heterodimers and microclusters
and the second being the selective recruitment and concen-
tration of integrins into existing CMAC structures. To better
analyze the latter process of selective integrin recruitment,
we performed FRAP studies of 5-EGFP in plasma mem-
brane regions devoid of CMACs to determine the time frame
of diffusional recovery in cells expressing mRFP or mRFP-
PAK4 (Figure 7D). This revealed that diffusional recovery is
essentially complete under both conditions after 120 s and
surprisingly, that PAK4 induces enhanced diffusional recov-
ery of 5-EGFP. This effect implies that PAK4 may either
Figure 4. Quantitative image analysis of CMAC component intensity and colocalization. Three-channel confocal images were acquired of
a single MCF7 cell expressing either EGFP (A–F) or EGFP-PAK4 (J–O) and labeled for integrin v5 (A, D, J, and M) and F-actin (B, E, K,
and N). Cell boundaries were deﬁned using F-actin labeling (green lines in images D, E, M, and N cropped from yellow regions of images
A, B, J, and K). CMACs within these boundaries were then detected and deﬁned using the integrin v5 channel (red outlines in D, E, and
M, N; blue lines within individual CMACs indicate CMAC major axes). CMAC center of mass coordinates (X and Y), CMAC area, mean
CMAC intensity (v5 and F-actin), and intra-CMAC colocalization (as deﬁned by Pearson’s r within each CMAC) of v5 and F-actin were
measured. Cropped, merged raw images of integrin v5 (green) and F-actin (red) as well as either EGFP (blue, F) or EGFP-PAK4 (blue, O)
show F-actin extending in protrusive structures beyond the existing CMACs, as well as strong colocalization (yellow) between integrin v5
and F-actin in EGFP- but not EGFP-PAK4–expressing cells. Quantitative data (G–I and P–R) derived from cropped regions show each
detected CMAC distributed according to its original X,Y coordinates, with dot size quantitatively reﬂecting original CMAC area. Dot color
and associated number indicate mean integrin v5 intensity (G, P), mean F-actin intensity (H and Q), or intra-CMAC colocalization of v5
and F-actin (I and R), per CMAC. Color scales for v5 intensity, F-actin intensity, and v5/F-actin colocalization are shown to the right
of P, Q, and R, respectively. These data demonstrate the method of quantitative data extraction and show directly the visual and quantitative
evidence for reduced colocalization between F-actin and integrin v5 within CMACs in cells overexpressing EGFP-PAK4 (see Figure 5
where equivalent data for 100s of cells and 1000s of CMACs are summarized). (S) The outcomes of Pearson’s r analyses of two-channel
colocalization. The distributions of red and green intensity information within Adhesion “X” reﬂect a strong spatial and intensity correlation
between these two channels, resulting in a positive correlation score (a perfect positive correlation  1; however, much lower values are
typically detected in biological images due largely to poor signal to noise ratios). Red and green intensity distributions within Adhesion “Y”
are inversed, resulting in a negative correlation (a perfect negative correlation  1). Red and green intensity distributions appear unrelated
in Adhesion “Z”, resulting in an r-value close to zero.
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alter integrin diffusion by, for example, inhibiting protein–
protein interactions or that PAK4 alters membrane lipid
ordering to facilitate faster maximal diffusion speeds. To test
this, we monitored the recovery of membrane-associated
lipid dyes after photobleaching and could distinguish no
difference in the presence or absence of overexpressed PAK4
(data not shown). This suggests that PAK4 actively regulates
integrin v5 interactions and dynamics outside of detect-
able CMACs.
We next utilized these ﬁndings to exclude the ﬁrst 120 s of
5-EGFP recovery in CMACs, thereby removing the inﬂu-
ence of diffusional 5-EGFP recovery within the plasma
membrane, allowing the extraction of ﬁrst order recovery
kinetics (Figure 7, E and F). These kinetics revealed an
increased maximal recovery (typically called mobile frac-
tion; Wehrle-Haller, 2007) of 5-EGFP within the CMACs of
mRFP-PAK4–expressing cells (Figure 7E), indicating that
more of the clustered integrin population was mobile and
available for turnover within the recovery period. Further-
more, the rate of recovery (excluding diffusional recovery)
was also greatly enhanced in the presence of mRFP-PAK4
(Figure 7F). Both of these features indicate that the stability
of CMAC-associated integrins was reduced under condi-
tions of PAK4 overexpression. Combined with data indicat-
ing reduced CMAC number, size, density, and F-actin con-
nectivity, these ﬁndings clearly identify a role and plausible
mechanism for PAK4 in the destabilization of v5-medi-
ated CMACs, ultimately resulting in reduced cell-ECM ad-
hesion strength.
DISCUSSION
We here demonstrate that integrin v5 binding to vitro-
nectin leads to PAK4 activation and that activated PAK4
functions to limit integrin-mediated vitronectin adhesion,
thereby reducing total cell–ECM adhesion and facilitating
enhanced cell migration. This pathway represents a novel
autoinhibitory negative feedback loop that is initiated
within the core machinery of cell adhesion and that then acts
through an associated kinase, PAK4, to down-regulate ad-
hesion machinery function, at least in part through the
mechanism of accelerated or destabilized integrin kinetics.
This intrinsic regulatory pathway is distinct from the vast
array of pathways that also act on adhesion componentry
but are initiated extrinsically to this machinery. Thus our
ﬁndings crystallize an important new concept in PAK4 func-
tion. Integrin activation and ECM binding induce integrin
clustering, leading to the formation of CMACs composed of
large intracellular protein networks that are fundamental to
the adhesive and migratory capacities of cells (Lock et al.,
2008). CMACs act as hubs for the input and output of
information from the numerous signaling pathways that
impinge upon these structures (Lauffenburger and Horwitz,
1996; Hynes, 2002; Kaverina et al., 2002; Lock et al., 2008).
CMACs simultaneously transmit and adapt to these signals
through structural alteration of their gross morphology and
through regulation of their molecular content and kinetics,
thereby concurrently reﬂecting and regulating cellular ad-
hesion status. Thus, CMAC characteristics, such as number,
size, density, content, turnover, and distribution are detect-
able features as well as key factors in the regulation of
adhesion strength (Gupton and Waterman-Storer, 2006). For
example, several reports demonstrate that a preponderance
of small CMACs may facilitate rapid cell migration (Chrza-
nowska-Wodnicka and Burridge, 1996; Lee and Jacobson,
1997; Beningo et al., 2001; Nayal et al., 2006), whereas larger
and temporally more stable focal adhesions tend to inhibit
cell migration (Webb et al., 2002; Nayal et al., 2006). Our
ﬁndings correlate with these reports by showing that WT
PAK4 overexpression induced a shift in CMAC populations
by reducing the average number, size, and density of
CMACs, while concurrently reducing cell spreading capac-
ity and enhancing cell migration. Conversely, knockdown of
PAK4 in MCF-7 cells increased the frequency, size, and
density of CMACs, while simultaneously inducing greater
cell spreading and reduced cell migration. Similar results
Figure 5. Inﬂuence of PAK4 overexpression
on CMAC size, number, integrin clustering
density, and integrin–actin connectivity. (A)
Quantiﬁcation of CMAC numbers at the cel-
lular periphery from MCF-7 cells transiently
expressing EGFP or EGFP-PAK4-WT. Graph
shows means of the number of peripheral
CMACs per cell  95% conﬁdence intervals
from 47 (EGFP control cells) and 48 (PAK4-
overexpressing cells). (B) Quantiﬁcation of
integrin clustering density in CMACs at the
cellular periphery. The mean intensity of en-
dogenous v5 labeling in CMACs 	5 m
from the cell border. The results are dis-
played as means of all CMACs in the desig-
nated size classes (m2)  95% conﬁdence
intervals. (C) Quantiﬁcation of v5 versus
F-actin colocalization in CMACs 	5 m
from the cell border. Calculated and dis-
played per CMAC using Pearson’s r (r) 
95% conﬁdence intervals. (D) Quantiﬁcation
of F-actin mean intensity (labeled by phal-
loidin) in CMACs (the area overlaying v5
labeling) 	5 m from the cell border as
displayed in Figure 4G. Panels G, H, and I in
Figure 4 are representative images showing
the measurement of 4036 CMACs taken
from 47 EGFP control cells and 2789 CMACs
from 48 EGFP-PAK4-overexpressing cells. All data in Figure 5 are derived from at least three distinct experiments.
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were obtained by Qu et al. (2003) using PAK4-null MEFs,
wherein CMAC size was also increased, a molecular effect
coinciding with a neuronal migration defect in PAK4 null
embryos. Together with our results, this suggests that PAK4
substantially inﬂuences cell adhesion strength, and thereby
cell spreading and migration, through a general depletion of
CMAC populations. Our detailed interrogation of CMAC
characteristics and CMAC population distributions, as well
as our analyses of integrin turnover kinetics within CMACs,
now allow us to more clearly deﬁne the mechanisms asso-
ciated with PAK4 regulation of cellular adhesion and migra-
tion. First, by sorting CMACs into subpopulations based on
their area, we can clearly observe the enhanced inhibitory
effects of PAK4 on larger adhesions, both in terms of their
absolute number and their proportion of the total CMAC
population. Although total numbers of adhesions are indeed
reduced by PAK4 overexpression and increased by PAK4
knockdown, it is clear that the most dramatic effects occur in
the larger adhesion classes, with implications both for the
function of PAK4 and for the relative functional signiﬁcance
of different CMAC classes. In terms of PAK4, this data
implies a clear role for PAK4 in the inhibition of CMAC
maturation (to larger, denser adhesions), whereas it is also
implicit that larger adhesions have a strong inhibitory im-
pact on the process of cell migration. By depleting these
structures selectively, PAK4 has a potent de-inhibitory effect
on cell migration.
Mechanistically, our analyses indicate that PAK4 may
achieve inhibition of CMAC maturation by inhibiting inte-
grin v5 clustering capacity, especially in larger adhesions.
In PAK4-overexpressing cells, integrin density increased
only marginally as CMACs matured to larger sizes, meaning
that the limited number of CMACs that achieve a large area
display integrin densities equivalent to only the smallest and
Figure 6. Inﬂuence of PAK4 knockdown on
CMAC size, number, integrin-clustering den-
sity, and actin content. (A) MCF-7 cells stably
expressing PAK4-shRNA or control shRNA
were plated onto VN and ﬁxed 3 h after replat-
ing. Cells were stained with an anti-integrin
v5 antibody and costained with rhodamine-
phalloidin. Bar, 20 m. (B) Quantiﬁcation of
the number of CMACs 	5 m from the cellu-
lar periphery. The results are presented as
mean of number of CMACs per cell  95%
conﬁdence intervals; n  36 (shRNA control
cells) and 40 (PAK4-shRNA cells); p values
according to unpaired two-tailed t test. (C)
Distribution of CMAC sizes 	5 m from the
cellular periphery; fold change in frequency of
different CMAC size classes. (D) Quantiﬁca-
tion of integrin clustering density in CMACs at
the cellular periphery. The mean intensity of
endogenous v5 labeling in CMACs 	5 m
from the cell border was analyzed. The results
are displayed as means of all CMACs in the
designated size classes (m2)  95% conﬁ-
dence intervals. (E) Quantiﬁcation of F-actin
mean pixel intensity (labeled by phalloidin) in
CMACs (the area overlaying v5 labeling)
	5 m from the cell border, displayed as in D.
(F) Quantiﬁcation of v5 versus F-actin colo-
calization in CMACs 	5 m from the cell bor-
der. Calculated and displayed per CMAC us-
ing Pearson’s r (r)  95% conﬁdence intervals.
Data for D–F are derived from three indepen-
dent experiments measuring 4666 CMACs (36
shRNA control cells) and 9235 CMACs (40
PAK4 shRNA cells). All of the experiments in
Figure 6 were repeated at least three times
with similar results.
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most immature CMACs in control cells. Associated with
these effects on integrin density are consistent effects on
integrin v5 to F-actin connectivity. Intriguingly, PAK4
overexpression did not signiﬁcantly alter the total levels of
F-actin detected in individual CMACs, but had a striking
inhibitory effect on the degree of colocalization (both spatial
and intensity-based) between integrins and F-actin. In con-
trast, PAK4 knockdown signiﬁcantly increased the absolute
levels of F-actin detectable in individual CMACs. Com-
bined, these data imply that PAK4 perturbs the ability of
v5 integrins to recruit and associate with F-actin, an effect
that would naturally inhibit CMAC maturation toward FAs
because maturation of these structures is dependent on F-
actin–mediated tensile forces and requires strong F-actin
association (Albiges-Rizo et al., 2009). This implies initially
that PAK4 may alter CMAC structures through a mecha-
nism predominantly dependent on the inhibition of integrin
v5 to F-actin association.
However, our results from integrin 5-EGFP FRAP sup-
port an alternative hypothesis, when considered in the light
of previous ﬁndings comparing the kinetics of small (FCs)
and large adhesions (FAs), presumably with low and high
actin connectivity, respectively. As outlined previously, ear-
lier reports have demonstrated somewhat counterintuitively
that large, temporally stable FA structures contain integrins
that undergo relatively rapid turnover when compared with
the integrins found in smaller, temporally unstable FCs
(Ballestrem et al., 2001). Here, we demonstrated that PAK4
induced reductions in CMAC size, integrin density and
F-actin connectivity—morphological changes that ostensibly
imply a shift toward a focal complex–oriented CMAC pop-
ulation. However, FRAP analyses indicate a concurrent ac-
celeration of integrin turnover, a phenomenon that does not
correlate with typical FC characteristics. We propose that if
the effects of PAK4 were mediated predominantly through
the inhibition of integrin-to-F-actin connectivity (or through
negative regulation of actin ﬁlaments or contractility), then
the smaller CMACs produced should mimic normal FCs,
which combine small area and limited F-actin connectivity
with low integrin turnover. In fact, we observe both smaller
adhesions and accelerated integrin turnover in the presence
of overexpressed PAK4 and surmise instead that accelerated
integrin v5 turnover may be the primary result of PAK4
regulation, with reduced CMAC size, clustering density,
and F-actin connectivity being secondary effects. This
implies actin-independent regulatory effects of PAK4 on
integrin v5–mediated adhesion. This interpretation is
strongly supported by the signiﬁcant differences in integrin
Figure 7. PAK4 promotes integrin v5
turnover within CMACs. FRAP analysis of in-
tegrin 5-EGFP turnover in focal adhesions of
(A) MCF-7 cells coexpressing mRFP and 5-
EGFP or (B) mRFP-PAK4 and 5-EGFP. En-
larged images are shown (from boxes in A and
B) containing individually bleached adhesions
before bleaching, immediately after bleaching,
and after 900-s recovery (arrowheads in bot-
tom panels of A and B indicates bleached focal
adhesions). Bar, 25 m. (C) Quantiﬁed inte-
grin 5-EGFP recovery in CMACs after
bleaching of cells coexpressing mRFP-PAK4
or mRFP control. The mean ﬂuorescence in-
tensity in the bleached region was quantiﬁed
and expressed as the percentage recovery rel-
ative to the mean of three prebleached values
(for that region). Background diffuse integrin
intensity within the plasma membrane was
subtracted from all values and further correc-
tions were applied for nonspeciﬁc bleaching.
Values represent means  SEM from three
experiments, each with a minimum of ﬁve
cells per condition, with a total of 100 adhe-
sions analyzed after photobleaching. Statisti-
cally discernable difference between mRFP
and mRFP-PAK4 recovery curves was as-
sessed at each time point; with p  0.018 at
30 s after bleaching, and p 	 0.001 at all times
after 30 s according to a two-tailed unpaired t
test. (D) Equivalent analysis of 5-EGFP re-
covery after bleaching of plasma membrane
regions devoid of CMACs in cells coexpress-
ing mRFP-PAK4 or mRFP control. Values rep-
resent means from three distinct experiments
including eight cells and 13 bleached regions
per condition. A two-tailed unpaired t test of
the means at all time points reveals a statisti-
cally discernable difference p  0.011, and t
test using all samples and all time points in-
dicates p  1.7  109. Fitted lines represent free diffusion recovery functions as previously described (Scott et al., 2006). (E and F) Analysis
of the ﬁrst order recovery (excluding the ﬁrst 120 s after bleaching that include recovery from free diffusion within the plasma membrane)
of 5-EGFP in CMACs reveals signiﬁcantly enhanced percentage of recovery (E) and recovery rate (F) in the presence of mRFP-PAK4. p
values were calculated using two-tailed unpaired t tests. Representative FRAP Movies for Figure 7 are presented in the supplementary
information.
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v5 clustering density observed with or without EGFP-
PAK4 within the smallest CMACs (0–0.5 m2), which dis-
play no detectable F-actin association under either condition
(zero colocalization), and hence are likely unresponsive to
changes in F-actin connectivity. In addition, our observation
that PAK4 enhances 5-EGFP diffusional recovery outside of
CMACs also supports a regulatory effect of PAK4 indepen-
dent of actin, because the individual integrin heterodimers
and microclusters that comprise the diffusing population are
unlikely to be substantially connected to actin ﬁlaments.
Thus, this PAK4 effect is far more likely to be mediated
through inhibitory regulation of transient integrin interac-
tions with either the ECM or cellular binding partners (cy-
toplasmic or membrane-bound)—interactions that would
normally reduce the apparent diffusion rates of plasma
membrane–localized integrins and that are prerequisite to
the formation of new CMACs. Inhibition by PAK4 of these
transient CMAC-precursor interactions may also explain the
reduced frequency of small, nascent CMACs observed with
PAK4 overexpression. In addition to these results, a direct
effect of PAK4 on integrin clustering and function is also
supported by our earlier identiﬁcation of a direct interaction
between integrin 5 and PAK4 (Zhang et al., 2002) and even
more so by our recent ﬁndings that PAK4 directly phosphor-
ylates the 5 cytoplasmic tail at two serine residues, the
mutation of which blocks PAK4-induced cell migration (Li et
al., 2010).
The regulation of integrin function within CMACs is the
subject of enormous interest because, perhaps unsurpris-
ingly, the majority of direct integrin (and hence CMAC)
regulation is thought to occur in this localized context. This
view is reinforced by the technical challenges involved in
distinguishing clustered and nonclustered integrin popula-
tions experimentally, particularly using the traditional bio-
chemical methods deployed to study, for example, protein
interactions. Even with modern imaging techniques, it re-
mains difﬁcult to characterize diffuse protein populations
and their interactions. However, it is easy to conceptualize
possible modes of direct “extra-CMAC” integrin regulation,
such as a situation where the binding to or modiﬁcation (e.g.
phosphorylation) of diffusing integrins by a regulatory part-
ner could subtly or potently affect functional outcomes, from
signaling to adhesion to motility. The same properties that
are extensively regulated within CMACs, such as integrin–
ECM afﬁnity and integrin-clustering efﬁciency, could be
modulated by binding of factors that, for example, increase
integrin–ECM afﬁnity or cytoplasmic binding partner re-
cruitment. This combinatorial extra-CMAC effect does, in
fact, exactly reﬂect the role of talin. However, because talin
binding to integrins is widely regarded as the initiation step
in the long cascade of CMAC maturation, the extra-CMAC
regulatory role of talin might wrongly be considered an
exception, with other direct regulatory interactions thought
to occur subsequently within the conﬁnes of the CMAC
structure (Tadokoro et al., 2003). Intriguingly though, two
more putative examples of extra-CMAC integrin regulation
already exist. Integrin cytoplasmic domain–associated pro-
tein 1 (ICAP-1) binds to the cytoplasmic domain of inte-
grin 1A and appears to compete with talin binding, result-
ing in accelerated FA turnover, reduced FA number and
maturation, reduced cell adhesion, and enhanced cell motil-
ity—effects closely mimicking those of PAK4 (Bouvard et al.,
2003; Millon-Fremillon et al., 2008). Remarkably, ICAP-1 is
undetectable in CMACs using ﬂuorescence techniques and
is instead diffusely distributed within the cell cytoplasm,
except during early cell spreading when, like PAK4, it may
be recruited to peripheral membrane rufﬂes. Consequently,
given the strong evidence that the ICAP-1 mechanism is
dependent on direct ICAP-1-integrin 1A interaction, it
seems highly probable that ICAP-1 is acting directly on
integrin 1A outside of CMACs to perturb integrin recruit-
ment to existing CMACs and possibly also the formation of
new CMACs. Remarkably, DOK1, which also competes with
talin for binding to 1, 3, and 7 integrin tails (Oxley et al.,
2008; Anthis et al., 2009), shows a highly analogous effect
proﬁle and mechanism to ICAP-1. Thus, given that PAK4
shows a similar diffuse distribution and little if any detect-
able colocalization with v5-containing CMACs and that
PAK4 promotes the diffusion rate of integrins outside of
CMACs, it appears likely that PAK4 may also act to regulate
integrin v5 interaction kinetics outside of CMACs, possi-
bly through inhibitory phosphorylation of the 5 cytoplas-
mic tail (Li et al., 2010).
The capacity for integrin clustering may involve regula-
tion of intracellular integrin transport (Caswell and Nor-
man, 2006; Pellinen et al., 2006), and/or altered binding
capacity for either intracellular CMAC components or ECM
ligands. In each case, the degree of integrin clustering is
directly reﬂected by integrin density within CMACs. Thus,
our analysis of integrin density (intensity) is a measure of
the integrin-clustering capacity. Further, PAK4-mediated
regulation of integrin interactions with VN and/or cellular
binding partners inevitably impacts on integrin afﬁnity (of
individual heterodimers for VN) and/or valency (the capac-
ity to cluster), which are the two core molecular features
underlying overall integrin–ECM binding strength (avidity)
(Carman and Springer, 2003). Unfortunately, these mecha-
nisms are tightly intertwined, and we are unable to distin-
guish the primacy of either mechanism in the current study,
because both can result in altered integrin turnover, cluster-
ing density, CMAC component recruitment, CMAC matu-
ration, and overall adhesion status.
PAK4 can undoubtedly promote rearrangements of the
actin microﬁlament system, possibly through the regulation
of LIM kinase, which inactivates the actin de-polymerizing
factor coﬁlin (Zhdankina et al., 2001; Soosairajah et al., 2005),
and/or GEF-H1, affecting Rho A functions (Xu et al., 2003;
Callow et al., 2005; Shemesh et al., 2005). For example, an
HGF–PAK4–LIMK1–coﬁlin pathway identiﬁed in prostate
cancer cells may be responsible for actin ﬁlament reorgani-
zation (Ahmed et al., 2008). Thus, although we propose a
direct molecular effect for PAK4 on integrin clustering and
overall integrin–ECM cell adhesion, PAK4 most likely pro-
motes cell motility by exerting a broad-acting motility cue
targeting both cytoskeletal remodeling and CMACs, which
together represent the two core functional and regulatory
machineries of cell motility (Lock et al., 2008). The relative
contributions of direct and indirect regulation, perhaps in
part through F-actin modulation, need to be further inves-
tigated in order to fully understand the role of PAK4. Also
the exact mechanism for PAK4 activation upon cell attach-
ment needs further investigation, with upstream regulatory
candidates, including the small GTPase Cdc42, which is also
activated by ECM attachment (Price et al., 1998; Bao et al.,
2002) and can activate PAK4 (Abo et al., 1998; Callow et al.,
2002).
In conclusion, we herein demonstrate that PAK4 can be
activated by integrin v5 ligation to VN and that activated
PAK4 in turn regulates integrin v5–mediated adhesion.
We show that PAK4 markedly inhibits integrin clustering
into dense, actin-connected CMACs, resulting in fewer,
smaller, and less mature adhesion complexes. Importantly,
PAK4 enhances integrin v5 molecular turnover within
CMACs, thereby de-stabilizing these CMACs and likely caus-
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ing the inhibition of integrin clustering, as well as of CMAC
maturation and F-actin association. PAK4 is also shown to act
upon integrins in environments, such as in nascent CMAC
clusters and outside of detectable CMACs, which are devoid of
detectable actin connectivity, thereby supporting an actin-in-
dependent regulatory capacity. Together, these data show that
PAK4 is activated by integrin v5 ligation to VN and that
active PAK4 can then act to de-stabilize integrin-mediated
adhesion structures to limit cellular adhesion levels. This bio-
logical circuit represents a novel autoinhibitory feedback loop
that is intrinsic to the core machinery of cell adhesion, provid-
ing cells the capacity to autonomously tune and optimize total
cell-ECM adhesion levels.
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S-Figure 1: PAK4 activity assay toward MBP.  Flag-BAP (as control), Flag-PAK4-WT or 
Flag-PAK4-K350M were transiently transfected in COS-7 cells. PAK4 was 
immunoprecipitated (IP) by anti-Flag antibody from cell lysates and kinase activity was 
determined by an in vitro kinase assay using myelin basic protein (MBP) as substrate (top 
panel). Mid panel shows comassie blue gel staining of MBP loading and bottom panel shows 
lysate content of proteins detected by anti-FLAG mAb.  
S-Figure 2: Role of PAK4 in MCF-7 cell migration onto VN. MCF-7 cells transiently 
transfected with control EGFP or EGFP-PAK4-WT (A) or stable over-expression with control 
Flag-BAP or Flag-PAK4-WT (B) as indicated were analyzed for haptotactic cell migration 
towards VN. Mean values ± SEM are displayed. (C) MCF-7 cells were transfected with a 
non-targeting negative control siRNA and two different PAK4-siRNAs as described in 
Materials and methods. After 48 h, haptotactic cell migration towards VN was quantified for 
each of the siRNA. Left: the graph displays cell migration mean values relative to control ± 
SEM. Right: PAK4-siRNA-mediated knock-down determined by IB (upper panel), using 
tubulin as a loading control (lower panel). (D-F) Migration of MCF-7 cells stably expressing 
PAK4-shRNA. Cells stable expressing control shRNA or PAK4-shRNA was assessed for cell 
migration. (D) Left graph displays haptotactic cell migration towards VN.  Mean ± SEM 
relative to control of three independent experiments. Right: PAK4 shRNA-mediated knock-
down was determined by IB using actin as loading control (lower panel). (E) Rescue of PAK4 
shRNA-reduced migration by over-expression of a shRNA-resistant EGFP-PAK4-AC285, 
288GA. Left: Bar graph shows haptotactic cell migration onto VN relative to the EGFP 
control (error bars: mean r 95% confidence intervals, n = 8). Right: Expression of EGFP and 
PAK4 was determined by IB. (F) Effects of PAK4 knock-down on MCF-7 cell migration in a 
wound healing assay. Images were taken at the indicated times after scraping of cell 
monolayer. The dotted line shows the edge of the wound at the zero time directly after 
wounding the cell monolayer. Wound closure was measured by comparing the final ‘wound’ 
area to the initial area, and the results are expressed as % wound closure (means r 95% 
confidence intervals, n = 6); *** : P < 0.001. P-values indicate statistically discernable 
differences compared to control according to unpaired two-tailed t-test are indicated. 
2
3S-Figure 3: PAK4 regulates MCF-7 cell spreading onto VN. (A) Cell areas were quantified in 
MCF-7 cells with or without transient expression of HA-PAK4 3 h after re-plating onto VN. 
Error bars represent as means ± SEM between three independent experiments. (B) Kinase 
activity of the EGFP-tagged PAK4-WT or the double point mutant EGFP-PAK4-445N, 474E 
was analyzed in an in vitro kinase assay using MBP as a substrate (upper panel). Numbers 
indicate the quantified relative activities. IB shows lysate contents of EGFP-tagged proteins 
(lower panel). (C) Cell areas were quantified in MCF-7 cells with transient expression of 
EGFP, EGFP-PAK4-WT or EGFP-PAK4-445N, 474E; 5 h after re-plating onto VN. Error 
bars represent means ± 95% confidence intervals from 55 (EGFP control), 58 (EGFP-PAK4-
WT) and 51 (EGFP-PAK4-445N474E) cells. (D) Images (upper panel) from MCF-7 cells 
stably expressing Flag-BAP (left column) or Flag-PAK4-WT (right column) re-plated onto 
VN for 5 h and analyzed for their size as described in Materials and methods. Histograms 
(lower panel) represent the entire distribution of individual cell areas from three independent 
experiments with a total of 124 cells per condition. The Mean ± SD, Median and cell numbers 
(n) are indicated. (E) MCF-7 cells stable expressing PAK4-shRNA were analyzed by IB with 
anti-PAK4 antibody (upper panel), using tubulin as a loading control (lower panel). (F) 
Images (upper panel) from MCF-7 cells stably expressing control shRNA clone 4 (left 
column), PAK4 shRNA clone 2 (middle column) or PAK4 shRNA clone 10 (right column) 
plated onto VN for 5 h and analyzed for their size as described in Materials and methods. 
Histograms represent the entire distribution of individual cell areas from three independent 
experiments with a total of 100 cells per condition (lower panel). (G) Cell areas were 
quantified in MCF-7 cells stably expressing control shRNA with transient expression of 
EGFP or PAK4-shRNA MCF-7 clones with transient expression of EGFP, EGFP-PAK4-285, 
288GA or EGFP-PAK4-M350-285, 288GA; 1 h after re-plating onto VN. Error bars represent 
Means ± SEM between three independent experiments.  All experiments in Fig. 3 were 
repeated at least three times with similar results. P-values for statistically discernable 
differences compared to controls according to unpaired two-tailed t-test are indicated. Note 
that in S-Fig. 3 B, intermediate lanes have been removed. 
4
5Supplementary movies for Figure 7 
Movie #1. FRAP analysis of ȕ5-EGFP-labelled focal adhesions in MCF-7 cells co-expressing 
mRFP. Shown here is a representative movie of an MCF-7 cell co-expressing ȕ5-EGFP and 
mRFP approximately 48 h after transfection and 16 h after replating onto a Matek dish coated 
with 10 Pg/ml of Vitronectin in DMEM growth media plus 1 mM CaCl2, 1 mM MgCl2 and 
0.5% BSA. Cells were imaged at 37˚C in 5% CO2 using a 63× Plan-Apochromat oil 
immersion objective (NA 1.4) mounted on an LSM510 confocal microscope (Zeiss). 8 bit 
images were collected at 2048x2048 pixels with no zoom to maximize spatial resolution while 
minimizing non-specific bleaching effects. Integrin ȕ5-EGFP was bleached within manually 
selected ROIs delineating individual adhesions using 40 iterations at 40% of total laser power 
from the 488 nm line of a 4-line argon laser (Coherent). ȕ5-EGFP was imaged pre (× 3) and 
post (× 31) bleaching using 0.24% total 488 nm laser power at an interval of 30 s. mRFP was 
imaged using 35% total laser power from a 543 nm laser (Coherent). Movie playback is at a 
rate of 16 frames/s and can be played using Quicktime software. 
Movie #2. FRAP analysis of E5-EGFP-labelled focal adhesions in MCF-7 cells co-expressing 
mRFP-PAK4. Shown here is a representative movie of an MCF-7 cell co-expressing ȕ5-
EGFP and mRFP-PAK4. Conditions are the same as for Movie #1. 
                                                                                                                                                                       
                                                                                                                                                                       
p21-activated Kinase 4 Phosphorylation of Integrin 5
Ser-759 and Ser-762 Regulates Cell Migration*
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Modulation of integrinv5 regulates vascular permeability,
angiogenesis, and tumor dissemination. In addition, we previ-
ously found a role for p21-activated kinase 4 (PAK4) in selective
regulation of integrin v5-mediated cell motility (Zhang, H.,
Li, Z., Viklund, E. K., and Stro¨mblad, S. (2002) J. Cell Biol. 158,
1287–1297). This report focuses on the molecular mechanisms
of this regulation. We here identified a unique PAK4-binding
membrane-proximal integrin 5-SERS-motif involved in con-
trolling cell attachment and migration. We also mapped the
integrin 5-binding site within PAK4. We found that PAK4
binding to integrin 5 was not sufficient to promote cell migra-
tion, but that PAK4 kinase activity was required for PAK4 pro-
motion of cell motility. Importantly, PAK4 specifically phos-
phorylated the integrin 5 subunit at Ser-759 and Ser-762
within the 5-SERS-motif. Point mutation of these two serine
residues abolished the PAK4-induced cell migration, indicating
a functional role for these phosphorylations in migration. Our
results may give important leads to the functional regulation of
integrin v5, with implications for vascular permeability,
angiogenesis, and cancer dissemination.
Integrins are heterodimers composed of  and  subunits
that contain a large extracellular domain with ligand binding
capacity, a transmembrane domain, and a short cytoplasmic
domain (2). Integrins mediate cell adhesion and thereby play a
central role in cell migration. Integrins also participate in bi-
directional signaling processes across the plasma membrane
where ligand binding to the extracellular matrix generates
intracellular signals (outside-in) and where signaling affecting
integrin cytoplasmic tails can lead to regulation of the integrin
extracellular binding capacity (inside-out) (3–6).
The membrane-proximal regions of the cytoplasmic
domains of the integrin heterodimer interact with each other
via a salt bridge. Disruption of this salt bridge can change the
integrin affinity state, indicating that the short cytoplasmic
domains of integrins are essential for both inside-out and out-
side-in signaling (3, 7).One importantmechanismwhereby cel-
lular signaling influences cellular behavior is through the inter-
action and/or phosphorylation of integrin cytoplasmic tails by
intracellular proteins (8–12). Interactions and/or phosphory-
lation of integrin cytoplasmic tails may also regulate the activa-
tion state of integrins, for example,  integrin tyrosine phos-
phorylation can regulate talin-induced integrin activation (11,
13–16).
Integrin phosphorylation at tyrosine residues has been found
in the cytoplasmic domains of 6A, 1, 3, and 4 (17–22).
Also, serine/threonine phosphorylation of integrin cytoplasmic
domains has been found in 4, 1, 2, 3, and 7 subunits
(23–31). However, so far only a few protein kinases have been
identified that phosphorylate integrin cytoplasmic domains.
c-Src was found to be responsible for tyrosine phosphorylation,
whereas protein kinase C and integrin-linked kinasemaymedi-
ate serine/threonine phosphorylation of integrins (29, 32, 33).
Integrin v5 mediates cell attachment and migration on
vitronectin (2, 6, 34, 35). Integrin v5 is induced in keratino-
cytes during wound healing and facilitates vascular endothelial
growth factor-induced vascular permeability (36–38). In addi-
tion, growth factor activation of integrin v5-mediated cell
motility has been functionally linked to angiogenesis as well as
carcinoma cell dissemination (39–41). However, how integrin
v5 itself may be controlled and the role of its cytoplasmic
domains are both unclear.
Overexpression of p21-activated kinase 4 (PAK4)5 can
induce localized actin polymerization and filopodia formation
(42) and affect cell adhesion and anchorage-independent
growth of rodent fibroblasts (43, 44). We previously found that
PAK4 interacts with the integrin 5 cytoplasmic tail and pro-
motes integrin v5-mediated cell migration (1). However,
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whether PAK4 promotes cell motility through its interaction
with integrin v5 and/or its effects on the actin cytoskeleton
remains unknown.
In this study, we used site-directed mutagenesis to map the
PAK4-binding site within integrin 5 as well as the integrin
5-binding site within PAK4. Importantly, we also identified
PAK4-mediated phosphorylation of two serine residues in the
integrin 5 cytoplasmic domain that are involved in the regu-
lation of cellmotility. These results provide important informa-
tion regarding the intracellular regulation of v5 activity.
EXPERIMENTAL PROCEDURES
Reagents—Anti-FLAG mouse mAb M2 was acquired from
Sigma, anti-integrin v5 (P1F6) mouse mAb from Invitrogen,
rabbit anti-HA (Y11) pAb from Santa Cruz Biotechnology, and
rabbit anti-human integrin 5 cytoplasmic tail fromChemicon
Int. Cell culture media, Lipofectamine Plus, and Lipofectamine
2000 were purchased from Invitrogen. An ECL detection kit,
protein G-Sepharose, and glutathione-Sepharose were from
Amersham Biosciences. [-32P]ATP was from Amersham Bio-
sciences. Vitronectin was purified from human serum as
described previously (45). 3-(4,5-Dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide, myelin basic protein (MBP), and
all other chemicals were obtained from Sigma.
Yeast Two-hybrid Assay—Yeast mating test assay was per-
formed using the DupLEX-A Yeast Two-Hybrid System
(OriGen Technologies) as previously described (46). The PAK4
C terminus (CT) (amino acids 396–591)was subcloned into the
EcoRI and XhoI sites of the pJG4–5 prey vector and trans-
formed into the EGY48 yeast strain, including the pSH18–34
reporter gene (lacZ) plasmid. The integrin 5 cytoplasmic
domain (5-aa-753–799) and various fragments thereof were
subcloned into the EcoRI and XhoI sites of the pEG202 bait
vector. Point mutations in the integrin 5 tail were generated
with the QuikChange site-Directed mutagenesis kit using
pEG202-5-tail as a template and then transformed into the
yeast strain RFY206. The correct reading frames and sequences
were verified by sequencing. Yeastmating tests were performed
by using the RFY206 strain, including different integrin 5-tail
constructs with the EGY48 strain, including the PAK4-CT
construct.
Mammalian Cell Expression Vectors—FLAG-PAK4-WT,
FLAG-PAK4-K350M, FLAG-PAK4-IBD, and FLAG-BAP
(bacterial alkaline phosphatase) were previously described (1).
The truncated forms of PAK4, N-terminal amino acid 1–322
(NT), kinase domain amino acid 323–591 (KD), andC-terminal
amino acid 396–591 (CT), were amplified by PCR using wild-
type (WT) human PAK4 cDNA as a template and subcloned
into the HindIII/BamHI site of 3 FLAG-CMVTM-10 expres-
sion vector (Sigma-Aldrich). Nine PAK4 point mutations
within its integrin-binding domain (IBD) and a PAK4 deletion
mutant, PAK4-69–221, were generated using the FLAG-
PAK4-WT and QuikChange (Stratagene). To construct
Enhanced green fluorescent protein (EGFP)-PAK4-WT and
mutants, HindIII/BamHI fragments from FLAG-PAK4 were
inserted into the HindIII/BamHI sites of the pEGFP C3 vector
(Clontech Laboratories, Inc.). The human integrin 5 full-
length cDNAwas subcloned into the EcoRI site of the pcDNA3
vector (Invitrogen). Integrin 5 mutants of pCDNA3-
5-ER760,761RE, pcDNA3-5-SERS, pCDNA3-5-SS769,
762AA, and pCDNA3-5-SS759,762EE, were generated by the
QuikChange Kit (Stratagene) using pCDNA3-5-WT as a tem-
plate. Insertion of CMV-5 or CMV-5 mutants into FLAG-
PAK4-WT generated FLAG-PAK4-CMV-5 double cassette
constructs.
Cell Culture—African greenmonkey kidney COS-7 cells and
human breast carcinoma MCF-7 cells were grown in Dulbec-
co’s modified Eagle’s medium. CS-1 hamster melanoma cells
kindly made available by Dr. Caroline Damsky, University of
California at San Francisco, were grown in RPMI. All tissue
culture media were supplemented with 5% fetal bovine serum
and 10 g/ml Gentamycin (Invitrogen). Cells were maintained
in a humidified incubator with 5%CO2. The CS-1-stable clones
were grown under the same conditions as parental CS-1 cells,
but in the presence of 500 g/ml G418 (Invitrogen).
Cell Transfection—4–8 g of total DNA was transfected in
10-cm cell culture dishes (80–90% confluence of COS-7 or
MCF-7 cells), using Lipofectamine PlusTM (Invitrogen),
according to the manufacturer’s protocol, and cells were used
30–48 h after transfection. For transfection of CS-1 cells, 4–8
g of total DNA was transfected in 6-well plates (1 106 cells/
well) using the Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocol. CS-1 cells stably transfected with
integrin 5 WT or mutant clones were established in medium
containing 600 g/ml G418. Selected cell colonies were trans-
ferred to separate culture dishes and were subsequently grown
in 500 g/ml G418 medium. Pools of mixed populations of
stable transfectant CS-1 cells expressing comparable levels of
each of the wild-type or mutant integrins were established by
three times consecutive fluorescence-activated cell sortingwith
anti-integrin v5 mAb P1F6 performed over a 3-month
period.
Pulldown Assay—For in vitroGST pulldown assays, the inte-
grin1-tail,5-tail (amino acids 753–799), and5-tailmutants
were individually expressed as GST fusion proteins using the
bacterial expression vector pGEM-1T (Amersham Bio-
sciences). GST fusion proteins were produced and purified
using glutathione-Sepharose beads (Amersham Biosciences)
according to themanufacturer’s protocol.GSTpulldown assays
were performed as described (1). Briefly, 200g of lysates from
COS-7 cells overexpressing various hPAK4 constructs were
incubated with 5 g of GST fusion proteins. The result was
visualized by immunoblotting, and band intensities were mea-
sured using Kodak one-dimensional image analysis or ImageJ
1.43 software (National Institutes of Health).
Kinase Activity Assay and Phosphopeptide Mapping—Vari-
ous PAK4 constructs were expressed in COS-7 cells and lysed
in kinase lysis buffer (50mMTris-HCl, pH 7.5, 5 mMMgCl2, 1%
Nonidet P-40, 10% glycerol 150 mM NaCl) with addition of
fresh protease inhibitors (0.5 g/ml leupeptin, 1 mM EDTA, 1
g/ml pepstatin A, 0.2 mM phenylmethylsulfonyl fluoride) and
a serine/threonine protein phosphatase inhibitor mixture
(Sigma), followed by immunoprecipitation. PAK4 kinase activ-
ity was determined in a kinase buffer (50 mMHepes, pH 7.5, 10
mMMgCl2, 2mMMnCl2, 0.2mM dithiothreitol) in the presence
of 30 M cold ATP and 10 Ci of [-32P]ATP (3000 Ci/nM,
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AmershamBiosciences) and in the presence of 5g of substrate
(MBP, GST, GST-1 tail, or GST-5 tail) for 30 min at 30 °C.
Incubation was stopped in Laemmli buffer, and samples were
heated at 95 °C for 4 min. Phosphorylated proteins were sepa-
rated by 12.5% SDS-PAGE. The gel was dried and visualized by
autoradiography. Phosphorylation sites in GST-5 were
mapped as described previously (47). Briefly, phosphopeptides
were resolved by 10% SDS-PAGE and transferred to nitrocellu-
lose membrane. GST or GST-5 corresponding bands were
excised and digested with trypsin as described (48). The first
dimension electrophoresis was carried out in a pH 1.9 buffer,
and the second dimension separation was performed using
TLC in isobutyric acid buffer. The chromatography plates were
exposed using Fuji Bas Bio-Imaging Analyzer, and radioactive
peptides were scraped off the plate, followed by sequencing
and phosphoamino acid analysis. For Edman degradation,
phosphopeptides were coupled to Sequelon-AA membranes
(Millipore) according to the manufacturer’s instructions and
sequenced on anApplied BiosystemsGas Phase sequencer. The
activity in released phenylthiohydantoin derivatives from each
FIGURE 1. Identification of an integrin 5 SERS-motif in PAK4 binding. A, schematic diagram of the yeast two-hybrid system used in Fig. 1. B, yeast
two-hybrid mating test assay. The integrin 5-tail (aa 753–799) and fragments thereof were mated with PAK4-CT. The strength of the interactions judged by
the intensity of blue after 48 h is indicated on the far right. C, the schematic diagram shows the GST-integrin 5 tail and the 5 fragments used in the GST
pulldown assay in panel D.D, GST pulldown assay of PAK4-WT usingGST-integrin5-tail and fragments thereof (upper panel). Pulldown of PAK4-WT usingGST
alone served as a negative control. The input lane using a lysate of PAK4 WT-transfected cells marks the size of PAK4-WT. The relative band intensities are
indicated below. Coomassie Brilliant Blue gel staining shows the loading of GST proteins (lower panel). E, an alignment of partial amino acids sequences of
integrin cytoplasmic tailswith the corresponding regions of the integrin5PAK4-bindingmotif. The SERS-motif and conserved aminoacidwithin are inbold.
F, the indicated integrin 5-tail point mutations were introduced within the PAK4-binding region, and the resulting products were mated with PAK4-CT as
described in A–B. G, GST pulldown of PAK4-WT using GST, GST-5-tail, and GST-5-ER760,761RE mutants. The input lanes show the position of PAK4-WT by
direct immunoblot of lysate (upper panel). The relative band intensities are displayed below. Coomassie Brilliant Blue gel staining shows the loading of GST
fusion proteins (lower panel). Displayed results are representative of three or more experiments.
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cycle was quantified using the Bio-Imaging Analyzer. For phos-
phoamino acid analysis, peptides were lyophilized and thereaf-
ter hydrolyzed in 6 M HCl for 1 h at 110 °C, followed by TLC as
described (49). To determine PAK4 phosphorylation of the
integrin 5 subunit in living cells, COS-7 cells transfected with
HA-PAK4 underwent a phosphate starvation for 6 h at 40 h
post transfection, followed by metabolic labeling with 300 Ci
of [-32P]ATP for 2 h at 37 °C. Cells were then washed twice
with phosphate-free Dulbecco’s modified Eagle’s medium and
lysed in radioimmune precipitation assay buffer. Integrin v5
was immunoprecipitated by mAb P1F6, and the phosphoryla-
ted 5 subunit was visualized by autoradiography.
Cell AdhesionAssay—Acell adhesion assaywas performed as
described (35). Briefly, non-treated 48-well cluster plates
(Corning Costar Corp.) were coated with vitronectin (VN) and
blocked by 1% heat-denatured bovine serum albumin. 5 104
CS-1 cells/well transfected to express integrin 5, integrin 5
mutants, or co-transfected to express integrin 5 and PAK4,
were seeded in wells and allowed to attach at 37 °C for 30 min.
The attached cells were counted using a microscope (10
objective) after cell staining by crystal violet or, alternatively,
quantified using by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay.
Cell Migration Assay—Haptotactic cell migration assays
were performed using Transwell chambers (Costar Inc.) with
8.0-mpore size as described before (1). Briefly, 1 105MCF-7
cells transiently transfectedwith EGFP, pEGFP-PAK4, or PAK4
mutantswere added on top of theTranswellmembranes coated
with VN on the bottom and allowed to migrate toward VN for
6 h at 37 °C in adhesion buffer (1, 35). The migrated cells were
counted using a fluorescence microscope, and adjustment was
made for the transfection rate of each population as determined
by flow cytometry or by manual counting using fluorescence
microscopy. For CS-1 cell migration assay, 1  105 CS-1 cells
transiently transfected or stable clones with pcDNA3 empty
vector, integrin 5, or 5 mutants were added into the Tran-
swell membranes and allowed tomigrate toward VN for 24 h at
37 °C. Themigrated cells were stained by 0.5% crystal violet and
counted using a microscope (10 objective). For CS-1 cells
stably expressing integrin 5 or mutant 5 that were co-trans-
fected to express EGFP or EGFP-PAK4, cell migration was
quantified as described above for EGFP/EGFP-PAK4 co-trans-
fected MCF-7 cells.
Flow Cytometry Analysis—Cell surface expression levels of
integrins were analyzed bymeasurement of fluorescein isothio-
cyanate staining intensity by FACScan flow cytometer using
CellQuest software (BD Biosciences) after staining with anti-
integrin v5 mAb P1F6 and a fluorescein isothiocyanate-
conjugated goat anti-mouse secondary antibody (Jackson
ImmunoResearch Laboratories) essentially as described by
Bao and Stro¨mblad (50).
Statistical Analysis—Datawere analyzed for statistical signif-
icance using an un-paired two-tailed t test.
RESULTS
Identification of an Integrin 5 Cytoplasmic Tail SERS-motif
Involved in PAK4 Binding—We previously found that PAK4
binds to the integrin 5-subunit and promotes integrin v5-
mediated cell motility (1). We here mapped the PAK4-binding
site within the integrin 5-subunit cytoplasmic domain at the
amino acid level. Firstly, we analyzed PAK4 interaction in yeast
two-hybrid mating tests (a schematic outline is shown in Fig.
1A) of WT 5 and 13 deletion mutants or fragments thereof as
indicated in Fig. 1B. The smallest 5 fragment maintaining full
binding strength to PAK4 contained a 10-amino acid N-termi-
nal 5-tail sequence (5–753-762). Any further deletions of
this fragment caused loss or partial loss of PAK4 binding. Fur-
ther, truncation of this 10-amino acid fragment revealed that a
5-SERS motif (5–759-762) was required for PAK4 binding.
Thus, the results suggest that full PAK4 binding requires a
FIGURE 2. Mutation or deletion of the integrin 5 tail SERS-motif affects
cell attachment andmigration. A, the integrin v5 cell surface expression
levels of CS-1 cells transiently transfected with integrin 5-WT or
5-ER760,761REwere analyzedby flowcytometry.Non-transfectedCS-1 cells
servedas a control for theFACS settings. Thegivenpercentages represent the
fraction of cells displayingv5-staining above untransfected CS-1 cells, and
M1 shows mean intensity of the cells expressing v5. These cells were then
used for cell attachmentandmigrationassays.BandC,bargraphs showquan-
tification of cell attachment (B) or cell migration (C) on VN of CS-1 cells tran-
siently expressing integrin5-WT or5-ER760,761RE, where5-WT-express-
ingcells aredefinedas control.D, flowcytometry analysis of integrinv5cell
surface expression in CS-1 cells with or without stable expression of integrin
5 or mutants thereof. M1 is the mean intensity of the cells expressing v5.
E and F, cell attachment and (G) motility on VN of CS-1 cells stably expressing
integrin 5 or indicated 5 mutants. E, cell attachment onto different VN-
coating concentrations and (F) to VN-coating using 2.5g/ml. Bars represent
mean values  S.E. (B, C, F, G) or S.D. (E) (n  3). Statistically discernable
differences as determined by t test are indicated (**, p  0.01). Displayed
results are representative of three or more experiments.
PAK4 Phosphorylation of Integrin5 Tail
23702 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 31•JULY 30, 2010
 at Karolinska institutet library, on O
ctober 20, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
10-aa region of the integrin 5 tail (aa 753–762) and that the
membrane-proximal SERS-motif (aa 759–762) within 5 is
critical for PAK4 binding. These results were verified in mam-
malian cells by GST pulldown analyses, where the 5–753-762
fragment pulled down the same amount of PAK4 as the5-WT
cytoplasmic tail (Fig. 1, C and D). However, deletion of the
5-SERS-motif (aa 759–762) abolished PAK4 binding (Fig.
1D). Among integrins, the SERS amino acid sequence only
appears in the integrin 5 cytoplasmic tail, although ERS is
found at the same position within integrin 6 and ER within
integrin 3 (Fig. 1E).
Using yeast two-hybrid mating tests, we then fine-mapped
the ten amino acidswithin the integrin5membrane-proximal
region involved in PAK4 binding (Fig. 1F). Mutations of 5 aa
756, 757, 758, 759, or 762 did not affect its ability to bind PAK4.
However, mutation of 5-EF 753 and 754 to alanine residues
partially disrupted PAK4 binding, and reversing the charges
by swapping ER 760 and 761 to RE completely abolished
PAK4 binding. However, mutation of aa ER 760 and 761 to
alanine residues did not influence PAK4 binding. The effect
of the ER to RE swap of 5 aa 760 and 761 for binding to
PAK4 in mammalian cells was verified by a GST pulldown
assay (Fig. 1G). Together, this identified amino acids 753,
754, 760, and 761 in integrin 5 as involved in PAK4 binding
and the SERS-motif as critical for PAK4 binding to the inte-
grin 5 subunit.
The Integrin 5 Tail SERS-motif
Affects Cell Attachment and
Motility—To test the potential role
of the integrin 5 SERS-motif in
regulation of cell adhesion and
migration, full-length integrin
5 (5-WT) and two mutants,
5-SERS and 5-ER760,761RE,
were expressed in CS-1 hamster
melanoma cells that do not express
endogenous integrin 3 or 5 sub-
units and therefore are unable to
attach to VN (51). The cell surface
expression levels of WT 5 and
5-ER760,761RE were similar upon
transient transfection when ana-
lyzed by FACS using anti-integrin
v5 mAb P1F6 (Fig. 2A). Untrans-
fected CS-1 cells did not attach or
migrate on VN (data not shown).
Interestingly, CS-1 cells transiently
transfected with 5-ER760,761RE
displayed a significantly lower at-
tachment to VN as compared with
cells transfected with 5-WT (Fig.
2B). In parallel, 5-ER760,761RE-
transfected CS-1 cells exhibited
markedly increased cell motility as
compared with WT 5-transfected
cells (Fig. 2C) displaying an inverse
correlation between cell attachment
and motility. Likewise, CS-1 cells
stably expressing similar levels of WT 5, 5-ER760,761RE
or 5-SERS were analyzed (Fig. 2D). Cells expressing
5-ER760,761REor5-SERSdisplayed amarked reduction in
cell attachment combined with a 3- to 6-fold increase in cell
motility on VN as compared withWT 5-transfected cells (Fig.
2, E–G). These results indicate that the membrane-proximal
SERSmotif in the integrin 5 cytoplasmic tail affects the extra-
cellular function of integrin v5.
PAK4 Regulation of Integrin v5-mediated Cell Attachment
and Migration May Involve the Integrin 5-tail SERS-motif—
Overexpression of WT PAK4 in MCF-7 cells stimulated inte-
grin v5-mediated cell migration on VN (1). To determine
whether the SERS-motif in the integrin 5-tail may play a role
in PAK4-mediated regulation of cellmotility, we co-transfected
WT PAK4 with WT integrin 5 or with non-PAK4-binding
integrin 5 SERS-motif mutants in CS-1 cells. These trans-
fected cells were analyzed for the effects on integrin v5-me-
diated cell attachment and migration. When CS-1 cells were
transiently transfected withWT FLAG-PAK4 andWT integrin
5 using a double-cassette vector, cell attachment decreased
and cell migration increased as compared with cells transfected
withWT 5 alone (Fig. 3, A–D). Consistently, CS-1 cells stably
expressing WT 5 were markedly affected by EGFP-PAK4
overexpression resulting in decreased cell attachment and
increased cell migration on VN as compared with EGFP con-
trol-transfected cells (Fig. 3, E and F). Interestingly, CS-1 cells
FIGURE 3. The PAK4-binding integrin5 tail SERS-motif regulates cell attachment andmigration. A and
B, the expression levels of CS-1 cells transiently transfected with integrin 5-WT or co-transfected with
integrin 5-WT and FLAG-PAK4-WT analyzed by immunoblotting (A) or flow cytometry (B) with untrans-
fected CS-1 cells as negative control and actin as a loading control. Percentages and M1 values are as
shown as in Fig. 2. C, cell attachment and (D) cell motility on VN (10 g/ml) of CS-1 cells transiently
transfected with5-WT or co-transfected with integrin5-WT and PAK4-WT. E, cell attachment and (F) cell
motility on VN of stable clones of CS-1-5-WT, CS-1-5-ER760,761RE, and CS-1-5-SERS transiently
co-expressing EGFP (open bars) or EGFP-PAK4 (solid bars). Parental CS-1 cells transfected with EGFP or
EGFP-PAK4 served as background control (not shown). Values obtained with CS-1-5-WT co-transfected
with EGFP empty vector were defined as control. Bars represent mean values  S.E. (n  3). Statistically
discernable differences as determined by t test are indicated (*, p  0.05; **, p  0.01). Displayed results
are representative of three or more experiments.
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stably expressing 5-ER760,761RE or 5-SERS displayed
similar levels of cell attachment and migration as whenWT 5
expressing cells were co-transfected with PAK4. However, no
significant changes in cell attachment or migration were
observed when either of the mutant 5 expressing cells were
transfected with EGFP-PAK4 as compared with control-trans-
fected cells (Fig. 3, E and F). This suggests that the PAK4-bind-
ing 5-SERS-motif may be involved in PAK4-mediated regula-
tion of cell attachment and migration.
Mapping of the Integrin 5-binding Site within PAK4—To
further elucidate the role of the PAK4 to integrin 5 interac-
tion, the 5-binding site in PAK4 was mapped. The PAK4
C-terminal region (PAK4-CT, aa 396–591) directly interacts
with integrin 5 in yeast two-hybrid mating tests and the crit-
ical IBD was located within aa 505–533 (1). To analyze if this
region of PAK4 was also critical for association with integrin
v5 in mammalian cells, FLAG-PAK4-WT, a kinase-inactive
PAK4 mutant (K350M), FLAG-PAK4-505–533 (IBD), and
FLAG-PAK4-69–221 (Fig. 4A) were transiently expressed in
COS-7 cells, and a GST pulldown assay was performed (Fig.
4B). Cell extracts of FLAG-PAK4-WT and 69–221 were
pulled down by GST-5 tail fusion protein but not K350M or
IBD. This showed that the PAK4-IBD was required for inte-
grin 5-association in mammalian cells. Surprisingly, the
kinase-inactive PAK4-K350M that contains the IBD did not
associate with integrin 5. This is in contrast with our previous
results from yeast two-hybrid mating tests where a C-terminal
PAK4 fragment with a K350M mutation could still interact
with integrin 5 (1). This may be explained by conformation
differences between the K350M-mutated full-length PAK4 and
a mutated PAK4 C-terminal fragment. However, the fact that
eliminating the PAK4 kinase activity also blocked its integrin
binding capacity raised the question whether PAK4 kinase
activity may be correlated to integrin binding. Therefore, the
kinase activity of the PAK4 constructs was tested. FLAG-BAP,
PAK4-WT, K350M, IBD, and 69–221 were transiently
transfected into COS-7 cells, and the FLAG-PAK4 immuno-
precipitates were used in an in vitro kinase activity assay. WT
PAK4 and PAK4-69–221 displayed autophosphorylation and
phosphorylated the substrate MBP, whereas K350M and IBD
did not (Fig. 4C). Together, this indicates that the PAK4-IBD is
required for integrin binding and that the PAK4 kinase activity
correlates with integrin 5 binding in mammalian cells.
To further reveal the relationship between the PAK4 integrin
binding capacity and its kinase activity, we sought to separate
the kinase activity of PAK4 from its integrin binding capacity by
introducing nine different point mutations into PAK4-IBD at
amino acids conserved among the PAK family (Fig. 5,A and B),
because other PAKs can also bind integrins.6 To test the effect
of these PAK4mutations on PAK4 association with integrin 5
inmammalian cells, a GST pulldown assay was performed with
lysates fromCOS-7 cells overexpressing FLAG-tagged bacterial
alkaline phosphatase (BAP) used as negative control, PAK4-
WT, PAK4-K350M, and the nine PAK4 point mutations intro-
duced in full-length WT PAK4. As shown in Fig. 5C, the
mutants K350M; PP513,514AA; PP519,520AA; and A523P dis-
played no or weak association with the integrin5-tail inmam-
malian cells, whereas all the other PAK4 point mutants tested
displayed a similar positive 5 association as WT PAK4.
The effect of the nine point mutations on PAK4 kinase activ-
ity was analyzed using an in vitro kinase assay (Fig. 5D). We
observed that the kinase-defective PAK4-K350M as well as
three other PAK4 mutants; PP513,514AA; PP519,520AA; and
A523P displayed no significant kinase activity. These were the
same four PAK4 full-length mutants that also showed no or
weak integrin binding capacity. All other mutants displayed
equal or stronger PAK4 kinase activity and autophosphoryl-
ation compared with WT PAK4. Given that the same four
point mutants that lacked kinase activity were also impaired6 H. Zhang and S. Stro¨mblad, unpublished observation.
FIGURE4.Mappingof the integrin5binding regionwithinPAK4andthe
roleof the IBD forPAK4kinaseactivity.A, the schematic diagram shows the
domain composition of PAK4 and the PAK4 mutants used in this figure. CRIB
denotes the Cdc42- and Rac-binding domain. The ATP-binding domain
(ATPBD) and the integrin-binding domain (IBD) are situated within the kinase
domain (KD) of PAK4. B, GST pulldown assay of PAK4 mutants. Cell lysates
from COS-7 cells transiently expressing FLAG-tagged WT PAK4 (WT), PAK4-
IBD, PAK4-K350M, or PAK4-69–221were pulled downby aGST-5-WT-tail
fusion protein (top panel). PAK4-WT in combination with GST was used as a
negative control (top panel). The quantified relative band intensities are
shown below. The middle panel shows the used amounts of overexpressed
PAK4 analyzed by immunoblotting (IB). Coomassie Brilliant Blue gel staining
shows the relative amountofGST fusionproteins (lower panel).C, PAK4kinase
assay. Immunoprecipitates from COS-7 cells transiently transfected with
PAK4 constructs were used in an in vitro kinase assay using myelin basic pro-
tein (MBP) as a substrate (top panel). The kinase activities of PAK4 mutants
were quantified using a PhosphorImager, and numbers relative to WT PAK4
activity for MBP phosphorylation are indicated below. FLAG-BAP was used as
a negative control. Themiddle panel shows Coomassie Brilliant Blue gel stain-
ing of MBP loading, and the lower panel shows loading of overexpressed
proteins detected by immunoblot (IB).
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in associating with integrin 5, we were unable to separate
the kinase activity of PAK4 and its integrin binding capacity.
Based on this, we hypothesize that the PAK4 integrin-bind-
ing site might be located in a substrate-binding pocket of
PAK4. Alternatively, PAK4 kinase activity may be required
for full-length PAK4 integrin binding.
Effects of PAK4 Mutations on Integrin v5-mediated Cell
Motility—We previously demonstrated that overexpression of
PAK4 induced integrin v5-mediated carcinoma cell migra-
tion (1). We now analyzed if the mutations of PAK4-IBD that
disrupted integrin binding also affected the capacity of PAK4 to
induce integrin v5-mediated cell migration (Fig. 5E). Con-
FIGURE 5. Mapping of the PAK4 integrin-binding site at the amino acid level and function of PAK4-IBD point mutations for PAK4 kinase activity and
cellmigration.A, the schematic diagram shows thePAK4pointmutations createdwithin thePAK4 IBD.B, alignment of the integrin-bindingmotif of PAK4with
the corresponding regions of human PAKs, the Drosophila PAK4 homologue mushroom bodies tiny (MBT) gene and yeast STE20. Amino acids in bold show
conservation among the PAKs, which was used as the basis for the PAK4-IBD point mutation design. C, GST-5-tail pulldown of lysates from COS-7 cells
transfectedwith FLAG-tagged full-length PAK4 and pointmutants thereof as indicated (top panel). FLAG-BAPwas used as a negative control. Immunoblotting
shows loading of FLAG-tagged proteins (middle panel). The migration rate of the mutant PP513,534AA protein consistently appeared higher than other
mutants. Thismay be caused by proteolysis as a result of themutagenesis. The relative band intensity of pulled down PAK4 is indicated in the lower bar graph,
and the band intensity was set to 0 for the FLAG-BAP control and100%of control for PAK4-WT. Bars representmean intensity S.E. among three experiments.
Statistically discernable differences compared with PAK4-WT according to t test are indicated (**, p  0.01; ***, p  0.001). D, FLAG-tagged proteins were
analyzed in a kinase assay using MBP as a substrate (top panel). The FLAG-BAP and lysate of non-transfected COS-7 cells were used as negative controls.
Coomassie Brilliant Blue gel staining shows the loading of MBP (upper middle panel), and immunoblotting shows the loading of FLAG-tagged proteins (lower
middle panel). The relative activities quantified by PhosphorImager are shown in the lower panel (bar graph) for PAK4 MBP substrate phosphorylation activity.
The kinase activity was set to 0 for the FLAG-BAP control and 100% of control for PAK4-WT. Bars represent mean values S.E. for three distinct experiments.
Statistically discernable differences compared with PAK4-WT according to t test are indicated (*, p 0.05; **, p 0.01). E, MCF-7 cells transiently transfected
with control EGFP, EGFP-PAK4 WT, or EGFP-PAK4 mutants as indicated were analyzed for haptotactic cell motility toward VN. Bar graphs show quantified cell
motility relative to the EGFP control (mean value  S.E. of at least three experiments). Statistically discernable differences compared with EGFP control
according to t test are indicated (*, p 0.05; **, p 0.01).
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sistent with our previous findings, overexpression ofWTPAK4
in MCF-7 cells induced integrin v5-mediated cell migration
on VN 2–3 times above control levels. However, the kinase-
inactive PAK4-K350M and the PAK4-IBD mutants failed to
stimulatev5-mediated cellmigration (Fig. 5E). Furthermore,
the three point mutations in PAK4-IBD that disrupted the
PAK4 integrin binding capacity together with the PAK4 kinase
activity did not promote MCF-7 cell migration, whereas WT
PAK4 and all other six PAK4-IBD point mutants were able to
significantly induce cellmotility (Fig. 5E). This suggests that the
integrin binding capacity, kinase activity, and the capability to
induce cell motility of PAK4 are correlated.
PAK4-mediated Integrin 5 Binding Is Not Sufficient to Pro-
mote Cell Migration—PAK4-CT, which lacks the PAK4 ATP-
binding pocket, strongly interacted with the integrin 5 cyto-
plasmic domain in yeast mating tests (1). We compared
PAK4-NT (N-terminal aa 1–322) and two C-terminal trun-
cated mutants, PAK4-KD (kinase domain, aa 323–591) and
PAK4-CT (C-terminal, aa 396–591) (Fig. 6A), for association
with integrin 5 in mammalian cells by a GST pulldown assay
(Fig. 6B). Although PAK4-WT, PAK4-KD, and PAK4-CT were
pulled down by the GST-5 tail
fusion protein, PAK4-NT was not.
Thus, deletion of the NT domain or
the ATP-binding domain did not
affect the binding capacity of PAK4
to integrin 5 in mammalian cells.
Given that PAK4-CT lacks the
PAK4 ATP-binding pocket, it is
conceivable that it also lacks kinase
activity. To test this, we measured
the kinase activity of PAK-CT and
compared it to that of PAK4-WT,
PAK4-NT, and PAK4-KD (Fig. 6C).
Although PAK4-WTand PAK4-KD
displayed high kinase activities,
PAK4-CT and PAK4-NT did not
show any significant kinase activity
above background. This way, we
identified a PAK-CT fragment that
lacked kinase activity, but with an
intact integrin binding capacity.
To test if PAK4-CT affected cell
motility, we overexpressed PAK-
WT, PAK4-NT, PAK-KD, and the
PAK4-CT and analyzed integrin
v5-mediated cell motility of
MCF-7 cells. We found that over-
expression of PAK4-WT and
PAK4-KD consistently enhanced
cell motility (Fig. 6D). However,
PAK4-CT as well as PAK4-NT
failed to induce any substantial
cell motility (Fig. 6D). This indi-
cates that PAK4 kinase activity is
required for promotion of cell
motility, and that PAK4 integrin
binding is not sufficient. Taken
together, our results indicate that PAK4 kinase activity is
critical to promote integrin v5-mediated cell motility.
PAK4 Phosphorylates Integrin 5 Cytoplasmic Domain in
Vitro and in Living Cells—Given the role of PAK4 kinase activ-
ity in promotion of cell motility, we examined PAK4-mediated
phosphorylation of the integrin 5 cytoplasmic tail. Using HA-
PAK4 immunoprecipitate prepared from transiently trans-
fectedCOS-7 cells togetherwith aGST-5 cytoplasmic domain
fusion protein, we found that the 5 cytoplasmic domain was a
specific substrate for PAK4 in vitro, whereas GST-1 integrin
was not (Fig. 7A, top panel). Likewise, purified v5 from
human placenta could also be phosphorylated by PAK4 on its
5 subunit (Fig. 7B). Importantly, we also found that integrin
5 was phosphorylated in cells transfected with PAK4, as
detected bymetabolic 32P labeling, but not inmock-transfected
cells (Fig. 7C).
PAK4 Phosphorylates Integrin 5 at theMembrane Proximal
Ser-759 and Ser-762—To determine the location of PAK4
phosphorylation within integrin 5, we employed phospho-
peptide mapping. GST-5 tail and GST control proteins were
treated with PAK4 in the presence of [-32P]ATP, trypsinized,
FIGURE 6. Elucidation of the role of PAK4 integrin binding capacity for cell motility. A, schematic diagram
shows common structural features of PAK4 and the PAK4 mutations: PAK4-NT (aa 1–322), PAK4-KD (aa 323–
591), and PAK4-CT (aa 396–591). B, GST pulldown assay of PAK4 mutants. Cell lysates from COS-7 cells tran-
siently expressing FLAG-tagged WT PAK4 (WT), PAK4-NT, PAK4-KD, or PAK4-CT were pulled down by a GST-
5-tail fusion protein (top panel). PAK4-WT in combinationwithGSTwas used as a negative control (top panel).
The quantified relative band intensities are shown below. Lower panel shows the loading of overexpressed
PAK4 analyzed by immunoblotting (IB). The GST fusion protein relative amounts used are shown in Fig. 4B.
C, PAK4 kinase assay. Immunoprecipitates from COS-7 cells transiently transfected with FLAG-tagged
PAK4-WT, PAK4-NT, PAK4-KD, or PAK4-CTwereused in an in vitro kinase assayusingmyelinbasic protein (MBP)
as a substrate (top panel). PAK4-WT in combination with a normal mouse IgG was used as a negative control.
The kinase activities of PAK4mutantswerequantifiedusingaPhosphorImager, and thenumbers relative toWT
PAK4 activity for MBP phosphorylation are indicated below. The middle panel shows Coomassie Brilliant Blue
gel staining of MBP loading, and the lower panel shows loading of overexpressed proteins detected by immu-
noblot (IB). D, cell migration assays of PAK4 mutants. MCF-7 cells were transiently transfected with control
EGFP, EGFP-PAK4-WT, EGFP-PAK4-NT, EGFP-PAK4-KD, or EGFP-PAK4-CTmutants. Thedata represent themean
for three separate experiments  S.E. Statistically discernable differences compared with EGFP control ana-
lyzed by t test are indicated (*, p 0.05; **, p 0.01).
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and subjected to two-dimensional electrophoresis on TLC
plates. Two spots (b and c) appeared in the GST-5 tail sample
that were not found in the GST control (Fig. 8A, upper). Fol-
lowing phosphoamino acid analysis, both spots b and c were
identified as serines by comparison with the standard marker
(Fig. 8A, middle and lower in boxes). Edman sequencing of the
spot b and c peptides by 18 cycles of degradation showed that
the spot b peptide contained a high level of 32P at the first amino
acid, whereas the spot c peptide at the third amino acid con-
tained the most radioactivity. Thus, we identified two distinct
PAK4 phosphorylation sites at amino acids Ser-759 and Ser-
762 using the GST-5 cytoplasmic tail as a substrate (Fig. 8, A
andB). One additional spot immediately to the left of spot cwas
also repeatedly observed and was identified as a serine in the
third position, consistent with a phosphorylation of Ser-759 in
an incompletely cleaved fragment. However, potential addi-
tional phosphorylation site(s) cannot be excluded due to the
built-in limitations of the two-dimensional-gel electrophoretic
separation. Given that PAK4 is a serine/threonine kinase, we
then mutated Ser-759 and Ser-762 to Thr-759 and Thr-762,
and prepared GST-5-S759T; GST- 5-S762T, and the double
mutant GST-5-SS759,762TT to further examine the specific-
ity of the PAK4-mediated phosphorylation sites in the 5 tail.
In the wild type peptide, spot b contained only phosphorylated
serine (Fig. 8C), whereas in the5-S762T and5-SS759,762TT
mutants, it contained phosphorylated threonine. Further, spot c
displayed only serine phosphorylation inWT 5 that was com-
pletely reverted to threonine phosphorylation in the 5-S759T
and5-SS759,762TTmutants. This confirms that both the ser-
ine residues 759 and 762 of integrin 5 were phosphorylated by
PAK4.However, we cannot exclude additional5 phosphoryla-
tion sites, as may be suggested by the observation that spot b
displayed serine phosphorylation also upon mutation of GST-
5-S762 to threonine. To further test if the two identified phos-
phorylation sites were responsible for the observed PAK4phos-
phorylation, we generated a mutant with mutation of both
Ser-759 and Ser-762 to alanine residues. As shown in Fig. 8D,
PAK4 phosphorylated GST-5-WT significantly above GST
control background, but not GST-5-SS759,762AA, indicating
that Ser-759 and Ser-762 were responsible for the observed
PAK4 phosphorylation. Amino acid sequence alignment of the
human  integrin cytoplasmic domains sharing high homology
with integrin5 indicates that Ser-759 is unique to 5, whereas
Ser-762 is conserved between 5, 6, and 8, but with no cor-
responding residues in 1, 2, 3, or 7 (Fig. 1E). This suggests
that phosphorylation of serine residues within the membrane-
proximal PAK4-binding SERS-motif is integrin-selective.
Role of Integrin 5 Ser-759 and Ser-762 in PAK4 Regulation
of Cell Motility—Mutations of the integrin 5 to
5-SS759,762AA and 5-SS759,762EE did not influence PAK4
binding in yeast two-hybrid mating tests (Fig. 1F). To deter-
mine whether the two serines in the integrin 5 SERS-motif
may play a role in PAK4-mediated regulation of cell motility,
we made CS-1 cells stably expressing integrin 5-WT,
5-SS759,762AA, or 5-SS759,762EE. The cell surface expres-
sion levels of integrin5were similar to5-WT, as determined
by FACS analysis using anti-integrin v5mAb P1F6 (Fig. 9A).
We then analyzed the effects on integrin v5-mediated cell
migration. When CS-1 cells stably expressing WT integrin 5
were transiently co-transfectedwithEGFP-PAK4-WT,cellmigra-
tion increased compared with the same cells co-transfected with
EGFP control. CS-1 cells expressing 5-SS759,762AA or
5-SS759,762EEmutants displayed a similar level of cellmigra-
tion as WT 5-expressing CS-1 cells. However, no significant
changes in cell migration were observed when the mutant
5-expressing cells were co-transfected with WT PAK4, in
contrast with the WT 5-expressing cells (Fig. 9B). This dem-
onstrates that integrin 5 Ser-759 and Ser-762 are critical for
PAK4-induced cell motility and thus that PAK4-mediated
phosphorylation of 5 cytoplasmic tail appears to regulate cell
motility. This also indicates that a negative charge at positions
759 and 762 in the 5 cytoplasmic tail was not sufficient to
promote cell migration.
FIGURE 7. PAK4 phosphorylates the integrin5 subunit. PAK4 was immu-
noprecipitated using an anti-HA mAb from COS-7 cells transfected with an
HA-PAK4 vector and incubated with integrins in the presence of [-32P]ATP.
A, PAK4 phosphorylation of integrin 5 cytoplasmic domain analyzed by in
vitro phosphorylation using purified GST, GST-1, or GST-5 cytoplasmic
domain as substrates. PAK4 levels detected by immunoblot (middle panel)
and the amounts of GST fusion proteins used are indicated by staining with
Coomassie Brilliant Blue (lower panel). B, in the samemanner, 5g of purified
integrin v5 was analyzed for phosphorylation by immunoprecipitated
PAK4, separated by 7.5% SDS-PAGE, and visualized by autoradiography. C,
PAK4 phosphorylates 5 subunit in living cells. Cells underwent phosphate
starvation and then metabolic labeling as described under “Experimental
Procedures.” Integrin v5 was immunoprecipitated in cells with or without
overexpressed HA-PAK4, exposed to SDS-PAGE and autoradiography (upper
panel). The lower panel shows the immunoblot for HA-PAK4 expression.
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DISCUSSION
Cytoplasmic tails of integrins play key roles in a variety of
integrin-mediated events, including adhesion and migration
(2). The phosphorylation of integrin cytoplasmic tails has been
proposed as a means of regulating integrin functions (10). Our
data show that the integrin 5 subunit cytoplasmic tail is a
substrate of PAK4. This is the first example of phosphorylation
of integrin v5, and how its extracellular functions may be
controlled by intracellular phosphorylation. This also adds to
the relatively few known substrates of PAK4 (52, 53), thereby
extending the knowledge about the immediate signal transduc-
tion capacity of PAK4.
The relationship between cell adhesion and migration is
complex. Our results showed that, when compared with WT
integrin5, the5-SERSmutations resulted in amarked induc-
tion of integrin v5-mediated cell migration accompanied by
a decrease in v5-mediated cell attachment. This could
potentially be explained by the fact that cell migration com-
pared with attachment strength can follow an approximate
bell-shaped curve (54). The rate of cellmigration is a function of
matrix concentration, integrin abundance, and the integrin
activation state. Change in any one of these properties will
affect the rate of cellmigration in amanner that is dependent on
the original position of the cell on the bell-shaped curve (54,
55). Further, overexpression of PAK4 mimicked the effect on
cell motility and attachment of the SERS mutations in the
5-tail. Together, v5 in its normal constitutionmaymediate
cell attachment that is too strong for optimal motility, whereas
PAK4 phosphorylation or SERS-motif mutation may lower the
attachment strength and resultantly increased cell motility.
FIGURE 8. Mapping of PAK4 phosphorylation sites within the integrin 5 cytoplasmic domain. A, PAK4-phosphorylated GST-5 was separated by
two-dimensional-gel electrophoresis after trypsindigestion.Spotsmarkedwithband cappearedconsistently in the same location indifferent experiments and
didnot occur in theGST control. These two spotswere further analyzedbyphosphopeptidemapping and identified as serines 759 and762 (middle andbottom
panels). The inset shows results of phosphoamino acid analysis. B, arrowheads point out the two PAK4-induced phosphorylation sites within the integrin 5
membrane-proximal region at serine residues 759 and 762. C, phosphoamino acid content of peptides from spots b and c, analyzed from GST-5-WT,
GST-5-S759T, GST-5-S762T, andGST-5-SS759,762TT, andGST fusionproteinswerephosphorylated in vitrobyPAK4.Migratingpositions of phosphoamino
acidmarkers are shown in the panel to the right.D, the two phosphorylation sites at Ser-759 and Ser-762weremutated to alanine residues to further elucidate
the identity of the two phosphorylatable residues. PAK4 phosphorylation of GST-5 was compared with GST and the GST-5 alanine mutant.
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The conserved-integrinmembrane-proximal regionwhere
PAK4 binds to and phosphorylates 5 is important for integrin
oligomerization, inhibition of integrin conformational changes,
and tethering of an integrin in the inactive state (56–58). How-
ever, although it is possible that PAK4binding to andphosphor-
ylation of integrin 5 cytoplasmic tail membrane-proximal
region may affect the association between integrin v and 5
subunits and/or binding between v5 and VN, further studies
are required to elucidate if the phosphorylation of 5-subunit
by PAK4 can affect integrin hinge formation or change the con-
formation of integrin extracellular domain.
Two other interesting proteins, theta-associated protein 20
(TAP20) and the scaffolding protein, receptor for activated C
kinase (RACK1) can also interact with the integrin 5 cytoplas-
mic tail. TAP20 binds to the integrin 5 tail and reduces inte-
grinv5-mediated cell migration by a protein kinase C signal-
ing pathway (59, 60). RACK1 interacts with a conserved
membrane-proximal region of the integrin  subunit cytoplas-
mic domain and decreased Chinese hamster ovary cell motility
in a manner that may also involve its interaction with protein
kinase C (59, 61). The RACK1-binding site in integrin 5 is
overlapping with that of PAK4. However, further experiments
are required to elucidate whether TAP20 and/or RACK1 may
be functionally related to PAK4 in the regulation of integrin
v5-mediated cell motility.
Phosphorylation of integrin cytoplasmic tails can have both
negative and positive roles in integrin regulation, possibly
reflecting the importance of dynamically regulated phosphoryl-
ation in the integrin function (10). Integrin 5 tail can also be
phosphorylated by protein kinase C, but the one or more spe-
cific serines to be phosphorylated were not identified (62). In
this study, we demonstrate that PAK4 phosphorylation of
serines 759/762 in the integrin 5 cytoplasmic tail promoted
CS-1 cell migration. Among integrins, the SERS amino acid
sequence only appears in the 5 cytoplasmic tail, although ERS
is found at the same position within 6, ER within 3, and
Ser-762 within 8. Therefore, PAK4 may also be able to phos-
phorylate also the integrin 6 and 8 cytoplasmic domains.
We demonstrate that phosphorylation of serine residues 759
and 762 in the integrin 5 cytoplasmic tail is necessary for
PAK4-mediated promotion of cell migration. Growth factor
stimulation can promote v5-mediated cancer cell migration
and dissemination as well as induce v5-mediated angiogen-
esis and vascular permeability (35, 36, 39, 41, 63). Interestingly,
PAK4 kinase can be activated by growth factors, such as Hepa-
tocyte growth factor (64). It will therefore be interesting to elu-
cidate the potential role of PAK4 in growth factor stimulation
of angiogenesis, vascular permeability, and cancer cell migra-
tion and dissemination and determine if PAK4-mediated phos-
phorylation of integrin5 serine residues 759 and 762may play
any role. However, PAK4 may also promote cell motility by
phosphorylation of additional substrates involved in the con-
trol of cell motility, for example by regulation of the actin
microfilament system (43).
In summary, we found that a unique membrane-proximal
SERS-motif within the integrin 5 cytoplasmic domain can be
phosphorylated by PAK4 and that this phosphorylation regu-
lates integrinv5-mediated carcinoma cell motility. Thismay
also contribute to the understanding of intracellular signaling
behind vascular permeability, angiogenesis, and carcinoma cell
dissemination (36, 39, 63).
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